RD modification,NAME,CAS,SMILES,Canonical_Smiles,IUPAC,UNO,Convention,EU,EU Annex/Category 273/2004,EU Annex/Category 111/2005,Belgian annex,Belgian code,
6/9/2017,1-(2-METHOXYPHENYL)PIPERAZINE,35386-24-4,COC1=CC=CC=C1N2CCNCC2,COc1ccccc1N1CCNCC1,,/,/,,,,Annex IVa - piperazine 6b,856000,
6/9/2017,1-(4-METHOXYPHENYL)PIPERAZINE,38212-30-5,COC1=CC=C(C=C1)N2CCNCC2,COc1ccc(N2CCNCC2)cc1,,/,/,,,,Annex IVa - piperazine 6b,855000,
6/9/2017,1-benzoyl-1-(isobutylamino)-3-methylbutane ,,CC(=O)N[C@@H]1[C@H](C[C@](O[C@H]1[C@@H]([C@@H](CO)O)O)(C(=O)O)O)O,CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)O[C@](O)(C(=O)O)C[C@@H]1O,1-benzoyl-1-(isobutylamino)-3-methylbutane ,/,/,,,,annex IVa - cathinone,,
8/2/2023,1B-LSD,2349376-12-9,CCCC(=O)N1C=C2C[C@@H]3C(=C[C@H](CN3C)C(=O)N(CC)CC)C4=C2C1=CC=C4,CCCC(=O)n1cc2c3c(cccc31)C1=C[C@@H](C(=O)N(CC)CC)CN(C)[C@@H]1C2,"(8β)-1-Butyryl-N,N-diethyl-6-methyl-9,10-didehydroergoline-8-carboxamide",/,/,,,,Annex IVb,,
24/4/2024,1cP AL-LAD (1-CYCLOPROPIONYL-6-ALLYL-6-NOR-LSD),,CC(=O)N[C@@H]1[C@H](C[C@](O[C@H]1[C@@H]([C@@H](CO)O)O)(C(=O)O)O)O,CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)O[C@](O)(C(=O)O)C[C@@H]1O,"(6aR,9R)-4-(cyclopropanecarbonyl)-N,N-diethyl-7-prop-2-enyl-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide",/,/,,,,Annex IIb,,
27/12/2021,1-CYCLOPROPIONYL-LSD (1CP-LSD),,CC(=O)N[C@@H]1[C@H](C[C@](O[C@H]1[C@@H]([C@@H](CO)O)O)(C(=O)O)O)O,CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)O[C@](O)(C(=O)O)C[C@@H]1O,"(6aR,9R)-4-(cyclopropanecarbonyl)-N,N-diethyl-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide",/,/,,,,Annex IVb,,
26/9/2011,1-NAPHYRONE,850352-53-3,CCCC(C(=O)C1=CC2=CC=CC=C2C=C1)N3CCCC3,CCCC(C(=O)c1ccc2ccccc2c1)N1CCCC1,1-naphthalen-1-yl-2-pyrrolidin-1-yl-pentan-1-one,/,/,,,,Annex IVa - cathinone,,
6/9/2017,1-PHENYLPIPERAZINE,92-54-6,C1CN(CCN1)C2=CC=CC=C2,c1ccc(N2CCNCC2)cc1,,/,/,,,,Annex IVa - piperazine 6b,854000,
27/12/2021,1-PROPIONYL-LSD (1P-LSD),2349358-81-0,CCC(=O)N1C=C2C[C@@H]3C(=C[C@H](CN3C)C(=O)N(CC)CC)C4=C2C1=CC=C4,CCC(=O)n1cc2c3c(cccc31)C1=C[C@@H](C(=O)N(CC)CC)CN(C)[C@@H]1C2,"(8β)-N,N-Diethyl-6-methyl-1-propionyl-9,10-didehydroergoline-8-carboxamide",/,/,,,,Annex IVb,,
8/2/2023,1V-LSD (1-VALEROYL LSD),,CC(=O)N[C@@H]1[C@H](C[C@](O[C@H]1[C@@H]([C@@H](CO)O)O)(C(=O)O)O)O,CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)O[C@](O)(C(=O)O)C[C@@H]1O,"(6aR,9R)-N,N-Diethyl-7-methyl-4-propanoyl-4,,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide",/,/,,,,Annex IVb,,
,"2,5-DIMETHOXY-4-ETHYLAMPHETAMINE (DOET)",22004-32-6,CCC1=CC(=C(C=C1OC)CC(C)N)OC,CCc1cc(OC)c(CC(C)N)cc1OC,"±)-4-ethyl-2,5-dimethoxy-α-methylphenethylamine",Schedule I,1971,,,,Annex IIa,406000,
6/9/2017,"2,5-Dimethoxy-4-iodoamphetamine (DOI)",64584-34-5,CC(CC1=CC(=C(C=C1OC)I)OC)N,COc1cc(CC(C)N)c(OC)cc1I,"1-(4-Iodo-2,5-dimethoxyphenyl)propan-2-amine",/,/,,,,Annex IVa - amfetamine,866000,
,"2,5‐DIMETHOXYAMPHETAMINE (DMA)",2801-68-5,CC(CC1=C(C=CC(=C1)OC)OC)N,COc1ccc(OC)c(CC(C)N)c1,"(±)-2,5-dimethoxy-α-methylphenethylamine",Schedule I,1971,,,,Annex IIa,403000,
25/11/2015,25B-NBOMe (2C-B-NBOMe),1026511-90-9,COC1=CC=CC=C1CNCCC2=CC(=C(C=C2OC)Br)OC,COc1cc(CCNCc2ccccc2OC)c(OC)cc1Br,"2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine",Schedule I,1971,,,,Annex IIa,427000,
25/11/2015,25C-NBOMe (2C-C-NBOMe),1227608-02-7,COC1=CC=CC=C1CNCCC2=CC(=C(C=C2OC)Cl)OC,COc1cc(CCNCc2ccccc2OC)c(OC)cc1Cl,"2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine",Schedule I,1971,,,,Annex IIa,428000,
25/11/2015,25I-NBOMe (2C-I-NBOMe),919797-19-6,COC1=CC=CC=C1CNCCC2=CC(=C(C=C2OC)I)OC,COc1cc(CCNCc2ccccc2OC)c(OC)cc1I,"2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine",Schedule I,1971,2014/688/EU + 2015/1875,,,Annex IIa,429000,
30/4/2002,2C-B,66142-81-2,COC1=CC(=C(C=C1CCN)OC)Br,COc1cc(CCN)c(OC)cc1Br,"4-bromo-2,5-dimethoxyphenethylamine",Schedule II,1971,,,,Annex IIb,520000,
27/1/2023,2C-B Fly,733720-95-1,C1COC2=C(C3=C(C(=C21)CCN)OCC3)Br,NCCc1c2c(c(Br)c3c1OCC3)OCC2,"2-(4-Bromo-2,3,6,7-tetrahydrofuro[2,3-f][1]benzofuran-8-yl)ethanamine",/,/,,,,Annex IVa - 2C-X,,
8/2/2023,2C-B-FLY,733720-95-1,C1COC2=C(C3=C(C(=C21)CCN)OCC3)Br,NCCc1c2c(c(Br)c3c1OCC3)OCC2,"2-(4-Bromo-2,3,6,7-tetrahydrofuro[2,3-f][1]benzofuran-8-yl)ethanamine",/,/,,,,Annex IVb,,
25/11/2015 + 27/01/2023,2C-C,88441-14-9,COC1=CC(=C(C=C1CCN)OC)Cl,COc1cc(CCN)c(OC)cc1Cl,"2-(4-chloro-2,5-dimethoxyphenyl)ethan-1-amine",/,/,,,,Annex IVa - 2C-X,,
25/11/2015 + 27/01/2023,2C-D,24333-19-5,CC1=CC(=C(C=C1OC)CCN)OC,COc1cc(CCN)c(OC)cc1C,"2-(2,5-dimethoxy-4-methylphenyl)ethan-1-amine",/,/,,,,Annex IVa - 2C-X,,
25/11/2015 + 27/01/2023,2C-E,71539-34-9,CCC1=CC(=C(C=C1OC)CCN)OC,CCc1cc(OC)c(CCN)cc1OC,"2-(4-ethyl-2,5-dimethoxyphenyl)ethan-1-amine",/,/,,,,Annex IVa - 2C-X,,
18/10/2004 + 27/01/2023,2C-l,69587-11-7 ,COC1=CC(=C(C=C1CCN)OC)I,COc1cc(CCN)c(OC)cc1I,"2-(4-iodo-2,5-dimethoxyphenyl)ethanamine",/,/,,,,Annex IVa - 2C-X,,
25/11/2015 + 27/01/2023,2C-P,207740-22-5,CCCC1=CC(=C(C=C1OC)CCN)OC,CCCc1cc(OC)c(CCN)cc1OC,"2-(2,5-dimethoxy-4-propylphenyl)ethan-1-amine",/,/,,,,Annex IVa - 2C-X,,
18/10/2004,2C-T-2,207740-24-7,CCSC1=C(C=C(C(=C1)OC)CCN)OC,CCSc1cc(OC)c(CCN)cc1OC,"2-(4-ethylsulfanyl-2,5-dimethoxyphenyl)ethanamine",/,/,,,,Annex IVa - 2C-X,,
18/10/2004,2C-T-7,207740-26-9,CCCSC1=C(C=C(C(=C1)OC)CCN)OC,CCCSc1cc(OC)c(CCN)cc1OC,"2-(2,5-dimethoxy-4-propylsulfanylphenyl)ethanamine",/,/,,,,Annex IVa - 2C-X,,
25/11/2015,2-FLUORO-ISOMETHCATHINONE,,CC(=O)N[C@@H]1[C@H](C[C@](O[C@H]1[C@@H]([C@@H](CO)O)O)(C(=O)O)O)O,CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)O[C@](O)(C(=O)O)C[C@@H]1O,1-(2-fluorophenyl)-1-(methylamino)propan-2-one,/,/,,,,Annex IVb,,
25/11/2015,2-FMA (2-Fluoromethamphetamine),1017176-48-5,CC(CC1=CC=CC=C1F)NC,CNC(C)Cc1ccccc1F,[1-(2-fluorophenyl)propan-2-yl](methyl)amine,/,/,,,,Annex IVa - amfetamine,,
20/3/2013,2-METHYLAMPHETAMINE,5580-32-5,CC1=CC=CC=C1CC(C)N,Cc1ccccc1CC(C)N,1-(2-methylphenyl)propan-2-amine,/,/,,,,Annex IVa - amfetamine,,
24/4/2024,2-METHYL-AP-237,98608-61-8,CCCC(=O)N1CCN(CC1C)C/C=C/C2=CC=CC=C2,CCCC(=O)N1CCN(C/C=C/c2ccccc2)CC1C,1-[2-Methyl-4-(3-phenyl-2-propen-1-yl)-1-piperazinyl]-1-butanone,Schedule I,1961,,,,Annex Ia,,
25/11/2015,"3,4-DMMC (3,4-Dimethylmethcathinone)",1081772-06-6,CC1=C(C=C(C=C1)C(=O)C(C)NC)C.Cl,CNC(C)C(=O)c1ccc(C)c(C)c1.Cl,"1-(3,4-dimethylphenyl)-2-(methylamino)propan-1-one",/,/,,,,Annex IVa - cathinone,,
25/11/2015,"3,4-MDPPP (3',4'-Methylenedioxy-α-pyrrolidinopropiophenone)",783241-66-7,CC(C(=O)C1=CC2=C(C=C1)OCO2)N3CCCC3,CC(C(=O)c1ccc2c(c1)OCO2)N1CCCC1,"1-(2H-1,3-benzodioxol-5-yl)-2-(pyrrolidin-1-yl)propan-1-one",/,/,,,,Annex IVa - cathinone,,
6/9/2017,"3,4-Methylendioxycathinone (Bk – MDA)",38061-37-9,CC(C(=O)C1=CC2=C(C=C1)OCO2)N.Cl,CC(N)C(=O)c1ccc2c(c1)OCO2.Cl,,/,/,,,,annex IVa - cathinone,,
25/11/2015,3C-E,146849-92-5 ,CCOC1=C(C=C(C=C1OC)CC(C)N)OC,CCOc1c(OC)cc(CC(C)N)cc1OC,"1-(4-ethoxy-3,5-dimethoxyphenyl)propan-2-amine",/,/,,,,Annex IVa - amfetamine,,
6/09/2017 + 8/02/2023,3-CMC (3-CHLOROMETHCATINONE),1049677-59-9,CC(C(=O)C1=CC(=CC=C1)Cl)NC,CNC(C)C(=O)c1cccc(Cl)c1,1-(3-Chloro-phenyl)-2-methylamino-propan-1-one,/,/,2022/1326,,,Annex IIc,865000,
25/11/2015,3C-P,501700-11-4,CCCOC1=C(C=C(C=C1OC)CC(C)N)OC,CCCOc1c(OC)cc(CC(C)N)cc1OC,"1-(3,5-dimethoxy-4-propoxyphenyl)propan-2-amine",/,/,,,,Annex IVa - amfetamine,,
8/2/2023,"3-DESOXY-MDPV (3-DESOXY-3,4-METHYLENEDIOXYPYROVALERONE)",,CC(=O)N[C@@H]1[C@H](C[C@](O[C@H]1[C@@H]([C@@H](CO)O)O)(C(=O)O)O)O,CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)O[C@](O)(C(=O)O)C[C@@H]1O,"1-(2,3-dihydro-1-benzofuran-5-yl)-2-(pyrrolidin-1-yl)pentan-1-one",/,/,,,,Annex IVb,,
6/9/2017,3-FEA (3-Fluoroethamphetamine),725676-94-8,CCNC(C)CC1=CC(=CC=C1)F,CCNC(C)Cc1cccc(F)c1,N-ethyl-1-(3-fluorophenyl)propan-2-amine,/,/,,,,Annex IVa - amfetamine,,
25/11/2015,3-MEC (3-Methylethcathinone),1439439-83-4,CCNC(C)C(=O)C1=CC=CC(=C1)C,CCNC(C)C(=O)c1cccc(C)c1,2-(ethylamino)-1-(3-methylphenyl)propan-1-one,/,/,,,,Annex IVa - cathinone,,
25/11/2015,3-MeO-PCP ,72242-03-6,COC1=CC=CC(=C1)C2(CCCCC2)N3CCCCC3,COc1cccc(C2(N3CCCCC3)CCCCC2)c1,1-[1-(3-methoxyphenyl)cyclohexyl]piperidine,/,/,,,,Annex IVb,,
24/4/2024,3-Me-PCE (3-METHYLETICYCLIDINE),,CC(=O)N[C@@H]1[C@H](C[C@](O[C@H]1[C@@H]([C@@H](CO)O)O)(C(=O)O)O)O,CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)O[C@](O)(C(=O)O)C[C@@H]1O,N-ethyl-1-(3-methylphenyl)cyclohexan-1-amine,/,/,,,,Annex IVb,,
23/3/2022,3-METHOXYPHENCYCLIDINE ,72242-03-6,COC1=CC=CC(=C1)C2(CCCCC2)N3CCCCC3,COc1cccc(C2(N3CCCCC3)CCCCC2)c1,1-[1-(3-methoxyphenyl)cyclohexyl]piperidine,Schedule II,1971,,,,Annex IIb,,
20/3/2013,3-METHYLAMPHETAMINE,588-06-7,CC1=CC(=CC=C1)CC(C)N,Cc1cccc(CC(C)N)c1,1-(3-methylphenyl)propan-2-amine,/,/,,,,Annex IVa - amfetamine,,
21/12/1988,3-METHYLFENTANYL,42045-86-3,CCC(=O)N(C1CCN(CC1C)CCC2=CC=CC=C2)C3=CC=CC=C3,CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1C,N-[3-methyl-1-(2-phenylethyl)piperidin-4-yl]-N-phenylpropanamide,Schedule I + IV,1961,,,,Annex Ia,,
26/9/2011,3-METHYLTHIOFENTANYL ,86052-04-2,CCC(=O)N(C1CCN(CC1C)CCC2=CC=CS2)C3=CC=CC=C3,CCC(=O)N(c1ccccc1)C1CCN(CCc2cccs2)CC1C,N-[3-methyl-1-[2-(2-thienyl)ethyl]-4-piperidyl]propionanilide,Schedule I + IV,1961,,,,Annex Ia,,
25/11/2015 + 8/02/2023+24/04/2024,3-MMC (3-Methylmethcathinone),1246911-86-3,CC1=CC(=CC=C1)C(=O)C(C)NC,CNC(C)C(=O)c1cccc(C)c1,2-(methylamino)-1-(3-methylphenyl)propan-1-one,Schedule II,1971,2022/1326,,,Annex IIb,,
25/11/2015,"4,4'-DMAR (4,4'-DIMETHYLAMINOREX)",1445569-01-6,CC1C(OC(=N1)N)C2=CC=C(C=C2)C,Cc1ccc(C2OC(N)=NC2C)cc1,"methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine ",Schedule II,1971,2015/1873,,,Annex IIb,,
25/11/2015,4-ACETOXY-DMT (4-AcO DMT),92292-84-7,CC(=O)OC1=CC=CC2=C1C(=CN2)CCN(C)C,CC(=O)Oc1cccc2[nH]cc(CCN(C)C)c12,3-[2-(dimethylamino)ethyl]-1H-indol-4-yl acetate,/,/,,,,Annex IVa - tryptamine,,
6/9/2017,4-CEC (4-Chloroethcathinone),14919-85-8,CCNC(C)C(=O)C1=CC=C(C=C1)Cl,CCNC(C)C(=O)c1ccc(Cl)cc1,1-(4-chlorophenyl)-2-(ethylamino)propan-1-one,/,/,,,,Annex IVa - cathinone,,
25/11/2015,"4-Cl-2,5-DMA",123431-31-2,CC(CC1=CC(=C(C=C1OC)Cl)OC)N,COc1cc(CC(C)N)c(OC)cc1Cl,"1-(4-chloro-2,5-dimethoxyphenyl)propan-2-amine",/,/,,,,Annex IVa - amfetamine,,
6/9/2017,4-CL-PVP,5881-77-6,CCCC(C(=O)C1=CC=C(C=C1)Cl)N2CCCC2,CCCC(C(=O)c1ccc(Cl)cc1)N1CCCC1,,/,/,,,,annex IVa - cathinone,,
25/11/2015 + 27/12/2021,"4-CMC (4-CHLOROMETHCATHINONE, CLEPHEDRONE)",1225843-86-6,CC(C(=O)C1=CC=C(C=C1)Cl)NC,CNC(C)C(=O)c1ccc(Cl)cc1,1-(4-chlorophenyl)-2-(methylamino)-1-propanone,Schedule II,1971,,,,Annex IIb,521000,
25/11/2015,4-EMC (4-Ethylmethcathinone ),1225622-14-9,CCC1=CC=C(C=C1)C(=O)C(C)NC,CCc1ccc(C(=O)C(C)NC)cc1,1-(4-ethylphenyl)-2-(methylamino)propan-1-one,/,/,,,,Annex IVa - cathinone,,
25/11/2015,4F-alpha-PVP,850352-62-4,CCCC(C(=O)C1=CC=C(C=C1)F)N2CCCC2,CCCC(C(=O)c1ccc(F)cc1)N1CCCC1,1-(4-fluorophenyl)-2-(pyrrolidin-1-yl)pentan-1-one,/,/,,,,Annex IVa - cathinone,,
20/03/2013 + 09/12/2019,4-FLUOROAMPHETAMINE (4-FA),459-02-9,CC(CC1=CC=C(C=C1)F)N,CC(N)Cc1ccc(F)cc1,1-(4-Fluorophenyl)propan-2-amine,Schedule II,1971,,,,Annex IIb,,
06/09/2017 + 09/12/2019,"4-FLUOROISOBUTYRFENTANYL (4-FIBF, pFIBF)",244195-32-2,CC(C)C(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=C(C=C3)F,CC(C)C(=O)N(c1ccc(F)cc1)C1CCN(CCc2ccccc2)CC1,N-(4-fluorophenyl)-N-(1-phenetylpiperidin-4-yl)isobutyramide ,Schedule I,1961,,,,Annex Ia,,
23/3/2022,"4F-MDMB-BICA (4F-MDMB-BUTICA, 4F-MDMB-2201)",2682867-53-2,CC(C)(C)[C@@H](C(=O)OC)NC(=O)C1=CN(C2=CC=CC=C21)CCCCF,COC(=O)[C@@H](NC(=O)c1cn(CCCCF)c2ccccc12)C(C)(C)C,"Methyl 2-{[1-(4-fluorobutyl)-1H-indole-3-carbonyl]amino}-3,3-dimethylbutanoate",/,/,2021/802,,,Annex IIc,,
06/09/2017 + 27/12/2021,"4F-MDMB-BINACA (4F-MDMB-BUTINACA, 4F-ADB)",2390036-46-9,CC(C)(C)[C@@H](C(=O)OC)NC(=O)C1=NN(C2=CC=CC=C21)CCCCF,COC(=O)[C@@H](NC(=O)c1nn(CCCCF)c2ccccc12)C(C)(C)C,"Methyl(S)-2-(1-(4-fluorobutyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoat",Schedule II,1971,,,,Annex IIb,,
6/9/2017,4-HO-EPT ,2595431-59-5,CCCN(CC)CCC1=CNC2=C1C(=CC=C2)O,CCCN(CC)CCc1c[nH]c2cccc(O)c12,3-{2-[Ethyl(propyl)amino]ethyl}-1H-indol-4-ol,/,/,,,,Annex IVa - tryptamine,,
6/9/2017,4-HO-MPT ,763035-03-6,CCCN(C)CCC1=CNC2=C1C(=CC=C2)O,CCCN(C)CCc1c[nH]c2cccc(O)c12,3-{2-[Methyl(propyl)amino]ethyl}-1H-indol-4-ol,/,/,,,,Annex IVa - tryptamine,,
,4-Hydroxy MiPT,77872-43-6,CC(C)N(C)CCC1=CNC2=C1C(=CC=C2)O,CC(C)N(C)CCc1c[nH]c2cccc(O)c12,3-[2-[methyl(1-methylethyl)amino]ethyl]-1H-indol-4-ol,/,/,,,,Annex IVa - tryptamine,,
25/11/2015,"4-HYDROXY-N,N-DIISOPROPYLTRYPTAMINE (4-HO-DiPT, 4-HYDROXY DiPT, Iprocin, Isoprocin)",132328-45-1,CC(C)N(CCC1=CNC2=C1C(=CC=C2)O)C(C)C,CC(C)N(CCc1c[nH]c2cccc(O)c12)C(C)C,3-[2-[di(propan-2-yl)amino]ethyl]-1H-indol-4-ol,/,/,,,,Annex IVa - tryptamine,868000,
26/9/2011,4-MBC (BENZEDRONE),1225617-75-3,CC1=CC=C(C=C1)C(=O)C(C)NCC2=CC=CC=C2,Cc1ccc(C(=O)C(C)NCc2ccccc2)cc1,2-(benzylamino)-1-(4-methylphenyl)propan-1-one,/,/,,,,Annex IVa - cathinone,,
25/11/2015,4-MeO-PBP (4-Methoxypyrrolidinobutiophenone),385649-55-8,,,1-(4-methoxyphenyl)-2-(pyrrolidin-1-yl)butan-1-one,/,/,,,,Annex IVa - cathinone,,
20/3/2013,4-MeO-PCP,2201-35-6,COC1=CC=C(C=C1)C2(CCCCC2)N3CCCCC3,COc1ccc(C2(N3CCCCC3)CCCCC2)cc1,1-[1-(4-methoxyphenyl)cyclohexyl]piperidine,/,/,,,,Annex IVb,,
20/3/2013,4-METHYLAMPHETAMINE ,22683-78-9,CC1=CC=C(C=C1)CC(C)N,Cc1ccc(CC(C)N)cc1,1-(4-methylphenyl)propan-2-amine,/,/,2013/129/EU + 2015/1874,,,Annex IIc,,
25/11/2015,4-METHYLBUPHEDRONE,1337016-51-9,CCC(C(=O)C1=CC=C(C=C1)C)NC,CCC(NC)C(=O)c1ccc(C)cc1,2-(methylamino)-1-(4-methylphenyl)butan-1-one,/,/,,,,Annex IVa - cathinone,,
25/11/2015 + 09/12/2019,4-METHYLETHCATHINONE (4-MEC),1225617-18-4,CCNC(C)C(=O)C1=CC=C(C=C1)C,CCNC(C)C(=O)c1ccc(C)cc1,2-(ethylamino)-1-(4-methylphenyl)propan-1-one,Schedule II,1971,,,,Annex IIb,,
6/9/2017,4-Methylmethamphetamine (4-MMA),,CC(=O)N[C@@H]1[C@H](C[C@](O[C@H]1[C@@H]([C@@H](CO)O)O)(C(=O)O)O)O,CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)O[C@](O)(C(=O)O)C[C@@H]1O,N-methyl-1-(4-methylphenyl)propan-2-amine,/,/,,,,Annex IVa - amfetamine,,
6/9/2017,4-MPD ,1373918-61-6,CCCC(C(=O)C1=CC=C(C=C1)C)NC,CCCC(NC)C(=O)c1ccc(C)cc1,,/,/,,,,annex IVa - cathinone,,
16/11/1999 + 25/11/2015,4-MTA,14116-06-4,CC(CC1=CC=C(C=C1)SC)N,CSc1ccc(CC(C)N)cc1,1-[4-(methylsulfanyl)phenyl]propan-2-amine,Schedule I,1971,,,,Annex IIa,812000,
20/3/2013,5-APB,286834-81-9,CC(CC1=CC2=C(C=C1)OC=C2)N,CC(N)Cc1ccc2occc2c1,1-(1-benzofuran-5-yl)propan-2-amine,/,/,,,,Annex IVa - amfetamine,,
25/11/2015,5-APDB,152624-03-8,CC(CC1=CC2=C(C=C1)OCC2)N,CC(N)Cc1ccc2c(c1)CCO2,"1-(2,3-dihydro-1-benzofuran-5-yl)propan-2-amine",/,/,,,,Annex IVa - amfetamine,,
6/9/2017,5C-AKB-48,,CC(=O)N[C@@H]1[C@H](C[C@](O[C@H]1[C@@H]([C@@H](CO)O)O)(C(=O)O)O)O,CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)O[C@](O)(C(=O)O)C[C@@H]1O,,/,/,,,,Annex IVa - synth. cann. 4e,,
8/2/2023,5-EAPB (5-(2-ETHYLAMINOPROPYL)BENZOFURAN),1445566-01-7,CCNC(C)CC1=CC2=C(C=C1)OC=C2,CCNC(C)Cc1ccc2occc2c1,1-(1-benzofuran-5-yl)-N-ethylpropan-2-amine,/,/,,,,Annex IVb,,
25/11/2015,5F-AB-PINACA,,CC(=O)N[C@@H]1[C@H](C[C@](O[C@H]1[C@@H]([C@@H](CO)O)O)(C(=O)O)O)O,CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)O[C@](O)(C(=O)O)C[C@@H]1O,2-{[1-(5-fluoropentyl)-1H-indazol-3-yl]formamido}-3-methylbutanamide,/,/,,,,Annex IVa - synth. cann. 4e,,
06/09/2017 + 09/12/2019,5F-ADB (5F-MDMB-PINACA),1715016-75-3,CC(C)(C)[C@@H](C(=O)OC)NC(=O)C1=NN(C2=CC=CC=C21)CCCCCF,COC(=O)[C@@H](NC(=O)c1nn(CCCCCF)c2ccccc12)C(C)(C)C,"Methyl(2S)-2-{[1-(fluoropentyl)-1H-indazole-3-carbonyl]amino}-3,3-dimethylbutanoate",Schedule II,1971,,,,Annex IIb,,
6/9/2017,5F-ADBICA (5-fluoro ADBICA),1801338-27-1,CC(C)(C)[C@@H](C(=O)N)NC(=O)C1=CN(C2=CC=CC=C21)CCCCCF,CC(C)(C)[C@H](NC(=O)c1cn(CCCCCF)c2ccccc12)C(N)=O,"N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide",/,/,,,,Annex IVa - synth. cann. 4d,,
25/11/2015 + 27/12/2021,"5F-AMB (5F-AMB-PINACA, 5F-MMB-PINACA)",1801552-03-3,CC(C)[C@@H](C(=O)OC)NC(=O)C1=NN(C2=CC=CC=C21)CCCCCF,COC(=O)[C@@H](NC(=O)c1nn(CCCCCF)c2ccccc12)C(C)C,Methyl 2-({[1-(5-fluoropentyl)-1H-indazol3yl]carbonyl}amino)-3-methylbutanoate,Schedule II,1971,,,,Annex IIb,,
25/11/2015 + 09/12/2019,5F-APINACA (5F-AKB-48),1400742-13-3,C1C2CC3CC1CC(C2)(C3)NC(=O)C4=NN(C5=CC=CC=C54)CCCCCF,O=C(NC12CC3CC(CC(C3)C1)C2)c1nn(CCCCCF)c2ccccc12,1-(5-fluoropentyl)-N-(adamantan-1-yl)-1H-indazole-3-carboxamide,Schedule II,1971,,,,Annex IIb,,
8/2/2023,5F-BZO-POXIZID,,CC(=O)N[C@@H]1[C@H](C[C@](O[C@H]1[C@@H]([C@@H](CO)O)O)(C(=O)O)O)O,CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)O[C@](O)(C(=O)O)C[C@@H]1O,"N'-[(3Z)-1-(5-fluoropentyl)-2-oxo-1,2-dihydro-3H-indol-3-ylidene]benzohydrazide",/,/,,,,Annex IVb,,
8/2/2023,5F-CUMYL-PEGACLONE,"2377403-49-9
",,,"5-(5-fluoropentyl)-2,5-dihydro-2-(1-methyl-1-phenylethyl)-1H-pyrido[4,3-b]indol-1-one",/,/,,,,Annex IVb,,
23/3/2022,5F-EDMB-PICA (5-FLUORO EDMB-2201),2666934-54-7,CCOC(=O)[C@H](C(C)(C)C)NC(=O)C1=CN(C2=CC=CC=C21)CCCCCF,CCOC(=O)[C@@H](NC(=O)c1cn(CCCCCF)c2ccccc12)C(C)(C)C,"ethyl 2-[[1-(5-fluoropentyl)indole-3-carbonyl]amino]-3,3-dimethylbutanoate",/,/,,,,Annex IVb,,
23/3/2022,"5-FLUORO MPP-PICA (MPHP-2201, 5F-MPHP-PICA)",,CC(=O)N[C@@H]1[C@H](C[C@](O[C@H]1[C@@H]([C@@H](CO)O)O)(C(=O)O)O)O,CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)O[C@](O)(C(=O)O)C[C@@H]1O,methyl (1-(5-fluoropentyl)-1H-indole-3-carbonyl)-L-phenylalaninate,/,/,,,,Annex IVb,,
06/09/2017 + 27/12/2021,5F-MDMB-PICA (5F-MDMB-2201),1971007-88-1,CC(C)(C)[C@@H](C(=O)OC)NC(=O)C1=CN(C2=CC=CC=C21)CCCCCF,COC(=O)[C@@H](NC(=O)c1cn(CCCCCF)c2ccccc12)C(C)(C)C,"Methyl(S)-2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate",schedule II,1971,,,,Annex IIb,,
25/11/2015,5F-MN-18,1445581-91-8,C1=CC=C2C(=C1)C=CC=C2NC(=O)C3=NN(C4=CC=CC=C43)CCCCCF,O=C(Nc1cccc2ccccc12)c1nn(CCCCCF)c2ccccc12,1-(5-fluoropentyl)-N-(naphthalen-1-yl)-1H-indazole-3-carboxamide,/,/,,,,Annex IVa - synth. cann. 4e,,
06/09/2017 + 09/12/2019,5F-PB-22,1400742-41-7,C1=CC=C2C(=C1)C(=CN2CCCCCF)C(=O)OC3=CC=CC4=C3N=CC=C4,O=C(Oc1cccc2cccnc12)c1cn(CCCCCF)c2ccccc12,Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate,Schedule II,1971,,,,Annex IIb,,
25/11/2015,5F-PB22 (5F-QUPIC),1411742-41-7,,,quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate,/,/,,,,Annex IVa - synth. cann. 4a,,
25/11/2015,5F-PB22-indazole analoog/analogue,,CC(=O)N[C@@H]1[C@H](C[C@](O[C@H]1[C@@H]([C@@H](CO)O)O)(C(=O)O)O)O,CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)O[C@](O)(C(=O)O)C[C@@H]1O,quinolin-8-yl 1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxylate,/,/,,,,Annex IVb,,
20/3/2013,5-IT (5-(2-AMINOPROPYL)INDOLE),3784-30-3,CC(CC1=CC2=C(C=C1)NC=C2)N,CC(N)Cc1ccc2[nH]ccc2c1,1-(1H-indol-5-yl)propan-2-amine,/,/,2013/496/EU + 2015/1876,,,Annex IIc,,
25/11/2015,5-MAPB,1354631-77-8,CC(CC1=CC2=C(C=C1)OC=C2)NC,CNC(C)Cc1ccc2occc2c1,[1-(1-benzofuran-5-yl)propan-2-yl](methyl)amine,/,/,,,,Annex IVa - amfetamine,,
6/9/2017,5-MAPBD,,CC(=O)N[C@@H]1[C@H](C[C@](O[C@H]1[C@@H]([C@@H](CO)O)O)(C(=O)O)O)O,CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)O[C@](O)(C(=O)O)C[C@@H]1O,,/,/,,,,Annex IVa - amfetamine,,
8/2/2023,"5-MeO-AI (5-METHOXY-2-AMINOINDANE, MEAI)",73305-09-06,,,"5-methoxy-2,3-dihydro-1H-inden-2-amine",/,/,,,,Annex IVb,,
25/11/2015,5-MeO-DALT,928822-98-4,COC1=CC2=C(C=C1)NC=C2CCN(CC=C)CC=C,C=CCN(CC=C)CCc1c[nH]c2ccc(OC)cc12,[2-(5-methoxy-1H-indol-3-yl)ethyl]bis(prop-2-en-1-yl)amine,/,/,,,,Annex IVa - tryptamine,,
25/11/2015,5-MeO-DMT,1019-45-0,CN(C)CCC1=CNC2=C1C=C(C=C2)OC,COc1ccc2[nH]cc(CCN(C)C)c2c1,[2-(5-methoxy-1H-indol-3-yl)ethyl]dimethylamine,/,/,,,,Annex IVa - tryptamine,837000,
26/9/2011,5-MeO-DPT,69496-75-9,CCCN(CCC)CCC1=CNC2=C1C=C(C=C2)OC,CCCN(CCC)CCc1c[nH]c2ccc(OC)cc12,N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-propylpropan-1-amine,/,/,,,,Annex IVa - tryptamine,,
25/11/2015,5-MeO-MiPT,96096-55-8,CC(C)N(C)CCC1=CNC2=C1C=C(C=C2)OC,COc1ccc2[nH]cc(CCN(C)C(C)C)c2c1,[2-(5-methoxy-1H-indol-3-yl)ethyl](methyl)(propan-2-yl)amine,/,/,,,,Annex IVa - tryptamine,,
25/11/2015,5-MeO-NBpBrT,155639-13-7,COC1=CC2=C(C=C1)NC=C2CCNCC3=CC=C(C=C3)Br,COc1ccc2[nH]cc(CCNCc3ccc(Br)cc3)c2c1,[(4-bromophenyl)methyl][2-(5-methoxy-1H-indol-3-yl)ethyl]amine,/,/,,,,Annex IVb,,
25/11/2015,6-APB,286834-85-3,CC(CC1=CC2=C(C=C1)C=CO2)N,CC(N)Cc1ccc2ccoc2c1,1-(1-benzofuran-6-yl)propan-2-amine,/,/,,,,Annex IVa - amfetamine,,
25/11/2015,6-APDB,152623-93-3,CC(CC1=CC2=C(CCO2)C=C1)N,CC(N)Cc1ccc2c(c1)OCC2,"1-(2,3-dihydro-1-benzofuran-6-yl)propan-2-amine",/,/,,,,Annex IVa - amfetamine,,
20/3/2013,"A-796,260",895155-26-7,CC1(C(C1(C)C)C(=O)C2=CN(C3=CC=CC=C32)CCN4CCOCC4)C,CC1(C)C(C(=O)c2cn(CCN3CCOCC3)c3ccccc23)C1(C)C,"[1-(2-morpholin-4-ylethyl)indol-3-yl]-(2,2,3,3-tetramethylcyclopropyl)methanone",/,/,,,,Annex IVa - synth. cann. 4a,,
6/9/2017,"A-836,339",959746-77-1,CC1=C(SC(=NC(=O)C2C(C2(C)C)(C)C)N1CCOC)C,COCCn1c(C)c(C)sc1=NC(=O)C1C(C)(C)C1(C)C,"N-[3-(2-methoxyethyl)-4,5-dimethyl-1,3-thiazol-2-ylidene]-2,2,3,3-tetramethylcyclopropane-1-carboxamide",/,/,,,,Annex IVb,847000,
6/9/2017,AB-CHFUPYCA,1870799-79-3,CC(C)C(C(=O)N)NC(=O)C1=CC(=NN1CC2CCCCC2)C3=CC=C(C=C3)F,CC(C)C(NC(=O)c1cc(-c2ccc(F)cc2)nn1CC1CCCCC1)C(N)=O,2-{[1-(cyclohexylmethyl)-3-(4-fluorophenyl)-1H-pyrazol-5-yl]formamido}-3-methylbutanamide,/,/,,,,Annex IVb,,
25/11/2015 + 09/12/2019,AB-CHMINACA,1185887-21-1,CC(C)[C@@H](C(=O)N)NC(=O)C1=NN(C2=CC=CC=C21)CC3CCCCC3,CC(C)[C@H](NC(=O)c1nn(CC2CCCCC2)c2ccccc12)C(N)=O,N-[(2S)-1-Amino-3-methyl-oxobutan-2-yl]-1- (cyclohexylmethyl)-1H-indazole-3-carboxamide,Schedule II,1971,,,,Annex IIb,,
25/11/2015 + 27/12/2021,AB-FUBINACA,1185282-01-2,CC(C)[C@@H](C(=O)N)NC(=O)C1=NN(C2=CC=CC=C21)CC3=CC=C(C=C3)F,CC(C)[C@H](NC(=O)c1nn(Cc2ccc(F)cc2)c2ccccc12)C(N)=O,N-[(2S)-1-amino-3-methyl-1-oxobutan-2-yl]-1-[(4-fluorophenyl)methyl]indazole-3-carboxamide,Schedule II,1971,,,,Annex IIb,,
25/11/2015 + 09/12/2019,AB-PINACA,1445752-09-9,CCCCCN1C2=CC=CC=C2C(=N1)C(=O)N[C@@H](C(C)C)C(=O)N,CCCCCn1nc(C(=O)N[C@H](C(N)=O)C(C)C)c2ccccc21,N-[(2S)-1-Amino-3-methyl-1-oxobutan-2-yl]-1-pentyl-1H-indazole-3-carboxamide,Schedule II,1971,,,,Annex IIb,,
26/9/2011,ACETORPHINE,25333-77-1,CCC[C@](C)([C@H]1C[C@@]23C=C[C@@]1([C@H]4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)OC(=O)C)O4)C)OC)O,CCC[C@@](C)(O)[C@H]1C[C@@]23C=C[C@]1(OC)[C@@H]1Oc4c(OC(C)=O)ccc5c4[C@@]12CCN(C)[C@@H]3C5,"3-O-acetyltetrahydro-7α-(1-hydroxy-1-methylbutyl)-6,14-endo-ethenooripavine",Schedule I + IV,1961,,,,Annex Ia,001000,
21/12/1988,ACETYL-ALPHA-METHYLFENTANYL,101860-00-8,CC(CC1=CC=CC=C1)N2CCC(CC2)N(C3=CC=CC=C3)C(=O)C,CC(=O)N(c1ccccc1)C1CCN(C(C)Cc2ccccc2)CC1,N-[1-(α-methylphenethyl)-4-piperidyl]acetanilide,Schedule I + IV,1961,,,,Annex Ia,004000,
,ACETYLDIHYDROCODEINE,3861-72-1,CC(=O)O[C@H]1CC[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC)CCN3C,COc1ccc2c3c1O[C@H]1[C@@H](OC(C)=O)CC[C@H]4[C@@H](C2)N(C)CC[C@@]341,"[(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,5,6,7,7a,13-octahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-yl] acetate",Schedule II,1961,,,,Annex Ib,201000,
6/9/2017,ACETYLFENTANYL,3258-84-2,CC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,CC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide,Schedule I,1961,,,,Annex Ia,101000,
,ACETYLMETHADOL,509-74-0,CCC(C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2)OC(=O)C,CCC(OC(C)=O)C(CC(C)N(C)C)(c1ccccc1)c1ccccc1,"3-acetoxy-6-dimethylamino-4,4-diphenylheptane",Schedule I,1961,,,,Annex Ia,002000,
06/09/2017 + 09/12/2019,ACRYLOYLFENTANYL (ACRYLFENTANYL),82003-75-6,C=CC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,C=CC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,N-phenyl-N-[1(2-phenylethyl)piperidin-4-yl]prop-2-enamide ,Schedule I,1961,2017/1774,,,Annex Ia,,
6/9/2017,ADB-5'Br-PINACA (ADB-P-5'Br-INACA),,CC(=O)N[C@@H]1[C@H](C[C@](O[C@H]1[C@@H]([C@@H](CO)O)O)(C(=O)O)O)O,CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)O[C@](O)(C(=O)O)C[C@@H]1O,"(S)-N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-5-bromo-1-pentyl-1H-indazole-3-carboxamide",/,/,,,,Annex IVa - synth. cann. 4e,,
06/09/2017+ 24/04/2024,ADB-BUTINACA,2682867-55-4,CCCCN1C2=CC=CC=C2C(=N1)C(=O)N[C@H](C(=O)N)C(C)(C)C,CCCCn1nc(C(=O)N[C@H](C(N)=O)C(C)(C)C)c2ccccc21,"N-[(1S)-1-(aminocarbonyl)-2,2-dimethylpropyl]-1-butyl-1H-indazole-3-carboxamide",Schedule II,1971,,,,annex IIb,,
06/09/2017 + 09/12/2019,ADB-CHMINACA (MAB-CHMINACA),1863065-92-2,CC(C)(C)C(C(=O)N)NC(=O)C1=NN(C2=CC=CC=C21)CC3CCCCC3,CC(C)(C)C(NC(=O)c1nn(CC2CCCCC2)c2ccccc12)C(N)=O,"N-(1-amino-3,3-dimethyl-1-oxo-2-butanyl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide",Schedule II,1971,2018/747,,,Annex IIb,,
6/9/2017,"ADB-FUBIATA (AD-18, FUB-ACADB, ADB-FUBIACA)",,CC(=O)N[C@@H]1[C@H](C[C@](O[C@H]1[C@@H]([C@@H](CO)O)O)(C(=O)O)O)O,CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)O[C@](O)(C(=O)O)C[C@@H]1O,"N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indole-3-acetamide",/,/,,,,Annex IVa - synth. cann. 4d,,
06/09/2017 + 09/12/2019,ADB-FUBINACA,1445583-51-6,CC(C)(C)C(C(=O)N)NC(=O)C1=NN(C2=CC=CC=C21)CC3=CC=C(C=C3)F,CC(C)(C)C(NC(=O)c1nn(Cc2ccc(F)cc2)c2ccccc12)C(N)=O,"N-(1-Amino-3,3-dimethyl-1-oxo-2-butanyl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide ",Schedule II,1971,,,,Annex IIb,,
,ADB-PINACA,1633766-73-0,CCCCCN1C2=CC=CC=C2C(=N1)C(=O)NC(C(=O)N)C(C)(C)C,CCCCCn1nc(C(=O)NC(C(N)=O)C(C)(C)C)c2ccccc21,"N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentylindazole-3-carboxamide",/,/,,,,Annex IVa - synth. cann. 4e,,
24/4/2024,ADINAZOLAM,37115-32-5,CN(C)CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,CN(C)Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2,"1-(8-chloro-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-1-yl)-N,N-dimethylmethanamine",/,/,,,,Annex IVb,,
25/11/2015,AH-7921,55154-30-8,CN(C)C1(CCCCC1)CNC(=O)C2=CC(=C(C=C2)Cl)Cl,CN(C)C1(CNC(=O)c2ccc(Cl)c(Cl)c2)CCCCC1,"3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide",Schedule I,1961,2014/688/EU + 2015/1875,,,Annex Ia,100000,
18/4/1983,ALFENTANIL,71195-58-9,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC,CCC(=O)N(c1ccccc1)C1(COC)CCN(CCn2nnn(CC)c2=O)CC1,"N-[1-[2-(4-ethyl-4,5-dihydro-5-oxo-1H-tetrazol-1-yl)ethyl]-4-(methoxymethyl)-4-piperidinyl]-N-phenylpropanamide",Schedule I,1961,,,,Annex Ia,095000,
24/4/2024,All parts of fungi (e.g. mushrooms and truffles) naturally containing the psilocin or psilocybin subtance,,CC(=O)N[C@@H]1[C@H](C[C@](O[C@H]1[C@@H]([C@@H](CO)O)O)(C(=O)O)O)O,CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)O[C@](O)(C(=O)O)C[C@@H]1O,,/,/,,,,Annex IVb,,
24/4/2024,AL-LAD (6-ALLYL-6-NOR-LSD),65527-61-9,CCN(CC)C(=O)[C@H]1CN([C@@H]2CC3=CNC4=CC=CC(=C34)C2=C1)CC=C,C=CCN1C[C@H](C(=O)N(CC)CC)C=C2c3cccc4[nH]cc(c34)C[C@H]21,"(6aR,9R)-N,N-diethyl-7-prop-2-enyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide",/,/,,,,Annex IVb,,
,ALLOBARBITAL,52-43-7,C=CCC1(C(=O)NC(=O)NC1=O)CC=C,C=CCC1(CC=C)C(=O)NC(=O)NC1=O,"5,5-diallylbarbituric acid",Schedule IV,1971,,,,Annex III,700000,
25/11/2015,ALLYLESCALINE,39201-75-7 ,COC1=CC(=CC(=C1OCC=C)OC)CCN,C=CCOc1c(OC)cc(CCN)cc1OC,"2-[3,5-dimethoxy-4-(prop-2-en-1-yloxy)phenyl]ethan-1-amine",/,/,,,,Annex IVb,,
,ALLYLPRODINE,25384-17-2,CCC(=O)OC1(CCN(CC1CC=C)C)C2=CC=CC=C2,C=CCC1CN(C)CCC1(OC(=O)CC)c1ccccc1,3-allyl-1-methyl-4-phenyl-4-propionoxypiperidine,Schedule I,1961,,,,Annex Ia,003000,
,ALPHACETYLMETHADOL,17199-58-5,CC[C@H](C(C[C@@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2)OC(=O)C,CC[C@@H](OC(C)=O)C(C[C@@H](C)N(C)C)(c1ccccc1)c1ccccc1,"α-3-acetoxy-6-dimethylamino-4,4-diphenylheptane",Schedule I,1961,,,,Annex Ia,098000,
25/11/2015,ALPHA-ETHYLAMINOPENTIOPHENONE,779974-89-9,CCCC(C(=O)C1=CC=CC=C1)NCC,CCCC(NCC)C(=O)c1ccccc1,2-(ethylamino)-1-phenylpentan-1-one,/,/,,,,Annex IVa - cathinone,,
,ALPHAMEPRODINE,468-51-9,CC[C@H]1CN(CC[C@@]1(C2=CC=CC=C2)OC(=O)CC)C,CCC(=O)O[C@]1(c2ccccc2)CCN(C)C[C@@H]1CC,α-3-ethyl-1-methyl-4-phenyl-4-propionoxypiperidine,Schedule I,1961,,,,Annex Ia,005000,
,ALPHAMETHADOL,17199-54-1,CC[C@H](C(C[C@@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2)O,CC[C@@H](O)C(C[C@@H](C)N(C)C)(c1ccccc1)c1ccccc1,"α-6-dimethylamino-4,4-diphenyl-3-heptanol",Schedule I,1961,,,,Annex Ia,006000,
21/12/1988,ALPHA-METHYLFENTANYL,79704-88-4,CCC(=O)N(C1CCN(CC1)C(C)CC2=CC=CC=C2)C3=CC=CC=C3,CCC(=O)N(c1ccccc1)C1CCN(C(C)Cc2ccccc2)CC1,N-[1-(α-methylphenethyl)-4-piperidyl]propionanilide,Schedule I + IV,1961,,,,Annex Ia,,
26/9/2011,ALPHA-METHYLTHIOFENTANYL,103963-66-2,CCC(=O)N(C1CCN(CC1)C(C)CC2=CC=CS2)C3=CC=CC=C3,CCC(=O)N(c1ccccc1)C1CCN(C(C)Cc2cccs2)CC1,N-[1-[1-methyl-2-(2-thienyl)ethyl]-4-piperidyl]propionanilide,Schedule I + IV,1961,,,,Annex Ia,,
25/11/2015,Alpha-PBP,13415-54-8,CCC(C(=O)C1=CC=CC=C1)N2CCCC2.Cl,CCC(C(=O)c1ccccc1)N1CCCC1.Cl,1-​phenyl-​2-​(1-​pyrrolidinyl)-​1-​butanone,/,/,,,,Annex IVa - cathinone,,
06/09/2017 + 27/12/2021,alpha-PHP (α-pyrrolidinohexanophenone),13415-86-6,CCCCC(C(=O)C1=CC=CC=C1)N2CCCC2,CCCCC(C(=O)c1ccccc1)N1CCCC1,(RS)-1-Phenyl-2-(pyrrolidine-1-yl)hexan-1-one,Schedule II,1971,,,,Annex IIb,,
06/09/2017 +24/04/2024,alpha-PiHP,2181620-71-1,CC(C)CC(C(=O)C1=CC=CC=C1)N2CCCC2,CC(C)CC(C(=O)c1ccccc1)N1CCCC1,4-methyl-1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one,Schedule II,1971,,,,Annex IIb,,
25/11/2015,Alpha-PPP,19134-50-0,CC(C(=O)C1=CC=CC=C1)N2CCCC2,CC(C(=O)c1ccccc1)N1CCCC1,1-Phenyl-2-(1-pyrrolidinyl)-1-propanone,/,/,,,,Annex IVa - cathinone,,
,ALPHAPRODINE,77-20-3,CCC(=O)O[C@@]1(CCN(C[C@@H]1C)C)C2=CC=CC=C2,CCC(=O)O[C@]1(c2ccccc2)CCN(C)C[C@@H]1C,"α-1,3-dimethyl-4-phenyl-4-propionoxypiperidine",Schedule I,1961,,,,Annex Ia,007000,
25/11/2015,Alpha-PVP (α-pyrrolidinovalerophenone),14530-33-7,CCCC(C(=O)C1=CC=CC=C1)N2CCCC2,CCCC(C(=O)c1ccccc1)N1CCCC1,1-phenyl-2-pyrrolidin-1-ylpentan-1-one,Schedule II,1971,2016/1070,,,Annex IIb,,
25/11/2015,Alpha-PVT,1400742-66-6,CCCC(C(=O)C1=CC=CS1)N2CCCC2,CCCC(C(=O)c1cccs1)N1CCCC1,2-(pyrrolidin-1-yl)-1-(thiophen-2-yl)pentan-1-one,/,/,,,,Annex IVb,,
,ALPRAZOLAM,28981-97-7,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2,"8-chloro-1-methyl-6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine",Schedule IV,1971,,,,Annex III,701000,
25/11/2015,AM-2201 (JWH-2201),335161-24-5,C1=CC=C2C(=C1)C=CC=C2C(=O)C3=CN(C4=CC=CC=C43)CCCCCF,O=C(c1cccc2ccccc12)c1cn(CCCCCF)c2ccccc12,[1-(5-Fluoropentyl)-1H-indol-3-yl](naphthalen-1-yl)methanone,Schedule II,1971,,,,Annex IIb,515000,
20/3/2013,AM-2233,444912-75-8,CN1CCCCC1CN2C=C(C3=CC=CC=C32)C(=O)C4=CC=CC=C4I,CN1CCCCC1Cn1cc(C(=O)c2ccccc2I)c2ccccc21,(2-iodophenyl)-[1-[(1-methylpiperidin-2-yl)methyl]indol-3-yl]methanone,/,/,,,,Annex IVa - synth. cann. 4a,,
20/3/2013,AM-694,335161-03-0,C1=CC=C2C(=C1)C(=CN2CCCCCF)C(=O)C3=CC=CC=C3I,O=C(c1ccccc1I)c1cn(CCCCCF)c2ccccc12,[1-(5-fluoropentyl)indol-3-yl]-(2-iodophenyl)methanone,/,/,,,,Annex IVa - synth. cann. 4a,,
,AMFEPRAMONE (DIETHYLPROPION),90-84-6,CCN(CC)C(C)C(=O)C1=CC=CC=C1,CCN(CC)C(C)C(=O)c1ccccc1,2-(diethylamino)propiophenone,Schedule IV,1971,,,,Annex IIb,702000,
,AMFETAMINE,300-62-9,CC(CC1=CC=CC=C1)N,CC(N)Cc1ccccc1,(±)-α-methylphenethylamine,Schedule II,1971,,,,Annex IIb,501000,
18/10/2004,AMINEPTINE,57574-09-1,C1CC2=CC=CC=C2C(C3=CC=CC=C31)NCCCCCCC(=O)O,O=C(O)CCCCCCNC1c2ccccc2CCc2ccccc21,"7-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid",Schedule II,1971,,,,Annex IIb,,
,AMINOREX,2207-50-3,C1C(OC(=N1)N)C2=CC=CC=C2,NC1=NCC(c2ccccc2)O1,2-amino-5-phenyl-2-oxazoline,Schedule IV,1971,,,,Annex III,758000,
,AMOBARBITAL,57-43-2,CCC1(C(=O)NC(=O)NC1=O)CCC(C)C,CCC1(CCC(C)C)C(=O)NC(=O)NC1=O,5-ethyl-5-isopentylbarbituric acid,Schedule III,1971,,,,Annex III,601000,
25/11/2015 + 23/03/2022,AMT (alpha-METHYLTRYPTAMINE),299-26-3,CC(CC1=CNC2=CC=CC=C21)N,CC(N)Cc1c[nH]c2ccccc12,1-(1H-Indol-3-yl)-2-propanamine,/,/,,,,Annex IVb,840000,
,ANILERIDINE,144-14-9,CCOC(=O)C1(CCN(CC1)CCC2=CC=C(C=C2)N)C3=CC=CC=C3,CCOC(=O)C1(c2ccccc2)CCN(CCc2ccc(N)cc2)CC1,1-p-aminophenethyl-4-phenylpiperidine-4-carboxylic acid ethyl ester,Schedule I,1961,,,,Annex Ia,008000,
,BARBITAL,57-44-3,CCC1(C(=O)NC(=O)NC1=O)CC,CCC1(CC)C(=O)NC(=O)NC1=O,"5,5-diethylbarbituric acid",Schedule IV,1971,,,,Annex III,703000,
,BENZETHIDINE,3691-78-9,CCOC(=O)C1(CCN(CC1)CCOCC2=CC=CC=C2)C3=CC=CC=C3,CCOC(=O)C1(c2ccccc2)CCN(CCOCc2ccccc2)CC1,,Schedule I,1961,,,,Annex Ia,009000,
,BENZFETAMINE,156-08-1,C[C@@H](CC1=CC=CC=C1)N(C)CC2=CC=CC=C2,C[C@@H](Cc1ccccc1)N(C)Cc1ccccc1,"N-benzyl-N,α-dimethylphenethylamine",Schedule IV,1971,,,,Annex III,704000,
6/9/2017,BENZOYLFENTANYL,2309383-15-9,C1CN(CCC1N(C2=CC=CC=C2)C(=O)C3=CC=CC=C3)CCC4=CC=CC=C4,O=C(c1ccccc1)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,,/,/,,,,Annex IVa - fentanyl 3a,,
6/9/2017,BENZYLFENTANYL,1474-02-8,CCC(=O)N(C1CCN(CC1)CC2=CC=CC=C2)C3=CC=CC=C3,CCC(=O)N(c1ccccc1)C1CCN(Cc2ccccc2)CC1,N-(1-benzyl-4-piperidyl)-N-phenyl-propanamide,/,/,,,,Annex IVa - fentanyl 3b,860000,
,BENZYLMORPHINE,14297-87-1,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OCC6=CC=CC=C6)O[C@H]3[C@H](C=C4)O,CN1CC[C@]23c4c5ccc(OCc6ccccc6)c4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5,3-benzylmorphine,Schedule I,1961,,,,Annex Ia,010000,
,BETACETYLMETHADOL,17199-59-6,CC[C@@H](C(C[C@@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2)OC(=O)C,CC[C@H](OC(C)=O)C(C[C@@H](C)N(C)C)(c1ccccc1)c1ccccc1,"β-3-acetoxy-6-dimethylamino-4,4-diphenylheptane",Schedule I,1961,,,,Annex Ia,011000,
26/9/2011,BETA-HYDROXY-3-METHYLFENTANYL,78995-14-9,CCC(=O)N(C1CCN(CC1C)CC(C2=CC=CC=C2)O)C3=CC=CC=C3,CCC(=O)N(c1ccccc1)C1CCN(CC(O)c2ccccc2)CC1C,N-[1-(β-hydroxyphenethyl)-4-piperidyl]propionanilide,Schedule I + IV,1961,,,,Annex Ia,,
26/9/2011,BETA-HYDROXYFENTANYL,78995-10-5,CCC(=O)N(C1CCN(CC1)CC(C2=CC=CC=C2)O)C3=CC=CC=C3,CCC(=O)N(c1ccccc1)C1CCN(CC(O)c2ccccc2)CC1,N-[1-(β-hydroxyphenethyl)-3-methyl-4-piperidyl]propionanilide,Schedule I + IV,1961,,,,Annex Ia,,
,BETAMEPRODINE,468-50-8,CC[C@@H]1CN(CC[C@@]1(C2=CC=CC=C2)OC(=O)CC)C,CCC(=O)O[C@]1(c2ccccc2)CCN(C)C[C@H]1CC,β-3-ethyl-1-methyl-4-phenyl-4-propionoxypiperidine,Schedule I,1961,,,,Annex Ia,012000,
,BETAMETHADOL,17199-55-2,CC[C@@H](C(C[C@@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2)O,CC[C@H](O)C(C[C@@H](C)N(C)C)(c1ccccc1)c1ccccc1,"β-6-dimethylamino-4,4-diphenyl-3-heptanol",Schedule I,1961,,,,Annex Ia,013000,
,BETAPRODINE,468-59-7,CCC(=O)O[C@@]1(CCN(C[C@H]1C)C)C2=CC=CC=C2,CCC(=O)O[C@]1(c2ccccc2)CCN(C)C[C@H]1C,"β-1,3-dimethyl-4-phenyl-4-propionoxypiperidine",Schedule I,1961,,,,Annex Ia,014000,
5/7/1971,BEZITRAMIDE,15301-48-1,CCC(=O)N1C2=CC=CC=C2N(C1=O)C3CCN(CC3)CCC(C#N)(C4=CC=CC=C4)C5=CC=CC=C5,CCC(=O)n1c(=O)n(C2CCN(CCC(C#N)(c3ccccc3)c3ccccc3)CC2)c2ccccc21,"1-(3-cyano-3,3-diphenylpropyl)-4-(2-oxo-3-propionyl-1-benzimidazolinyl)piperidine",Schedule I,1961,,,,Annex Ia,015000,
25/11/2015 + 27/01/2023,bk-2C-B,807631-09-0,COC1=CC(=C(C=C1C(=O)CN)OC)Br,COc1cc(C(=O)CN)c(OC)cc1Br,"2-amino-1-(4-bromo-2,5-dimethoxyphenyl)ethan-1-one",/,/,,,,Annex IVa - 2C-X,,
6/9/2017,BK-EDPB,,CC(=O)N[C@@H]1[C@H](C[C@](O[C@H]1[C@@H]([C@@H](CO)O)O)(C(=O)O)O)O,CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)O[C@](O)(C(=O)O)C[C@@H]1O,,/,/,,,,annex IVa - cathinone,,
25/11/2015,BREPHEDRONE (4-BROMOMETHCATHINONE),486459-03-4,CC(C(=O)C1=CC=C(C=C1)Br)NC,CNC(C)C(=O)c1ccc(Br)cc1,1-(4-bromophenyl)-2-(methylamino)propan-1-one,/,/,,,,Annex IVa - cathinone,,
,BROLAMFETAMINE (DOB),32156-26-6,CC(CC1=CC(=C(C=C1OC)Br)OC)N,COc1cc(CC(C)N)c(OC)cc1Br,"(±)-4-bromo-2,5-dimethoxy-α-methylphenethylamine",Schedule I,1971,,,,Annex IIa,400000,
,BROMAZEPAM,1812-30-2,C1C(=O)NC2=C(C=C(C=C2)Br)C(=N1)C3=CC=CC=N3,O=C1CN=C(c2ccccn2)c2cc(Br)ccc2N1,"7-bromo-1,3-dihydro-5-(2-pyridyl)-2H-1,4-benzodiazepin-2-one",Schedule IV,1971,,,,Annex III,705000,
27/12/2021,BROMAZOLAM,71368-80-4,CC1=NN=C2N1C3=C(C=C(C=C3)Br)C(=NC2)C4=CC=CC=C4,Cc1nnc2n1-c1ccc(Br)cc1C(c1ccccc1)=NC2,"8-bromo-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine",/,/,,,,Annex IVb,,
8/2/2023,BRORPHINE,2244737-98-0,CC(C1=CC=C(C=C1)Br)N2CCC(CC2)N3C4=CC=CC=C4NC3=O,CC(c1ccc(Br)cc1)N1CCC(n2c(=O)[nH]c3ccccc32)CC1,"1-[1-[1-(4-bromophenyl)ethyl]-piperidin-4-yl}-1,3-dihydro-2H-imidazol-2-one",Schedule I,1961,,,,Annex Ia,,
,BROTIZOLAM,57801-81-7,CC1=NN=C2N1C3=C(C=C(S3)Br)C(=NC2)C4=CC=CC=C4Cl,Cc1nnc2n1-c1sc(Br)cc1C(c1ccccc1Cl)=NC2,"2-bromo-4-(o-chlorophenyl)-9-methyl-6H-thieno[3,2-f]-striazolo[4,3-a][1,4]diazepine",Schedule IV,1971,,,,Annex III,759000,
24/4/2024,BUCINNAZINE (AP-237),17719-89-0,CCCC(=O)N1CCN(CC1)CC=CC2=CC=CC=C2,CCCC(=O)N1CCN(CC=Cc2ccccc2)CC1,1-[4-(3-phenyl-2-propen-1-yl)-1-piperazinyl]-1-butanone,/,/,,,,Annex IVb,,
22/1/1998,BUFOTENINE,487-93-4,CN(C)CCC1=CNC2=C1C=C(C=C2)O,CN(C)CCc1c[nH]c2ccc(O)cc12,3-[2-(dimethylamino)ethyl]-1H-indol-5-ol,/,/,,,,Annex IVa - tryptamine,,
25/11/2015,BUPHEDRONE,408332-79-6,CCC(C(=O)C1=CC=CC=C1)NC,CCC(NC)C(=O)c1ccccc1,2-(methylamino)-1-phenylbutan-1-one,/,/,,,,Annex IVa - cathinone,,
,BUPRENORPHINE,52485-79-7,C[C@]([C@H]1C[C@@]23CC[C@@]1([C@H]4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)(C(C)(C)C)O,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1Cc4ccc(O)c5c4[C@@]3(CCN1CC1CC1)[C@H]2O5,"21-cyclopropyl-7-α-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine",Schedule III,1971,,,,Annex IIb,609000,
,BUTALBITAL,77-26-9,CC(C)CC1(C(=O)NC(=O)NC1=O)CC=C,C=CCC1(CC(C)C)C(=O)NC(=O)NC1=O,5-allyl-5-isobutylbarbituric acid,Schedule III,1971,,,,Annex III,602000,
,BUTOBARBITAL,77-28-1,CCCCC1(C(=O)NC(=O)NC1=O)CC,CCCCC1(CC)C(=O)NC(=O)NC1=O,5-butyl-5-ethylbarbituricacid,Schedule IV,1971,,,,Annex III,706000,
27/12/2021,BUTONITAZENE,95810-54-1,CCCCOC1=CC=C(C=C1)CC2=NC3=C(N2CCN(CC)CC)C=CC(=C3)[N+](=O)[O-],CCCCOc1ccc(Cc2nc3cc([N+](=O)[O-])ccc3n2CCN(CC)CC)cc1,"2-[(4-butoxyphenyl)methyl]-N,N-diethyl-5-nitro-1H-benzimidazole-1-ethanamine",/,/,,,,Annex IVb,,
25/11/2015,BUTYLONE (bk-MBDB),802575-11-7,CCC(C(=O)C1=CC2=C(C=C1)OCO2)NC,CCC(NC)C(=O)c1ccc2c(c1)OCO2,"1-(2H-1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one",/,/,,,,Annex IVa - cathinone,,
06/09/2017 + 09/12/2019,BUTYRFENTANYL,1169-70-6,CCCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,CCCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]butanamide,Schedule I,1961,,,,Annex Ia,,
8/2/2023,BZO-4EN-POXIZID,,CC(=O)N[C@@H]1[C@H](C[C@](O[C@H]1[C@@H]([C@@H](CO)O)O)(C(=O)O)O)O,CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)O[C@](O)(C(=O)O)C[C@@H]1O,"N'-[(3Z)-2-oxo-1-(pent-4-en-1-yl)-1,2-dihydro-3H-indol-3-ylidene]benzohydrazide",/,/,,,,Annex IVb,,
8/2/2023,BZO-CHMOXIZID,1048973-67-6,C1CCC(CC1)CN2C3=CC=CC=C3C(=C2O)N=NC(=O)C4=CC=CC=C4,O=C(N=Nc1c(O)n(CC2CCCCC2)c2ccccc12)c1ccccc1,"N'-[(3Z)-1-(cyclohexylmethyl)-2-oxo-1,2-dihydro-3H-indol-3-ylidene]benzohydrazide",/,/,,,,Annex IVb,,
8/2/2023,BZO-HEXOXIZID,1048973-47-2,CCCCCCN1C2=CC=CC=C2C(=C1O)N=NC(=O)C3=CC=CC=C3,CCCCCCn1c(O)c(N=NC(=O)c2ccccc2)c2ccccc21,"N'-[(3Z)-1-Hexyl-2-oxo-1,2-dihydro-3H-indol-3-ylidene]benzohydrazide",/,/,,,,Annex IVb,,
8/2/2023,BZO-POXIZID,1048973-64-3,CCCCCN1C2=CC=CC=C2C(=C1O)N=NC(=O)C3=CC=CC=C3,CCCCCn1c(O)c(N=NC(=O)c2ccccc2)c2ccccc21,"N'-[(3Z)-2-oxo-1-pentyl-1,2-dihydro-3H-indol-3-ylidene]benzohydrazide",/,/,,,,Annex IVb,,
18/10/2004 + 25/11/2015,BZP (N-BENZYLPIPERAZINE),2759-28-6,C1CN(CCN1)CC2=CC=CC=C2,c1ccc(CN2CCNCC2)cc1,1-benzylpiperazine,Schedule II,1971,2008/206/JBZ,,,Annex IIb,819000,
,CAMAZEPAM,36104-80-0,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)OC(=O)N(C)C)C3=CC=CC=C3,CN(C)C(=O)OC1N=C(c2ccccc2)c2cc(Cl)ccc2N(C)C1=O,"7-chloro-1,3-dihydro-3-hydroxy-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one dimethylcarbamate",Schedule IV,1971,,,,Annex III,707000,
,"CANNABIS (d9THC+d9THCA >0,3%) (flowering or fruiting tops of the cannabisplant from which the resin not has been extracted)",8063-14-7,,,"Belgian legislation: ∆9-THC + THCA > 0,3 %",Scheduel I,1961,,,,Annex Ia,017000,
,"CANNABIS Extracta, Resinae, Tincturae (d9THC+d9THCA >0,3%)",8063-14-7/6465-30-1,,,"∆9-THC + THCA > 0,3 %",Schedule I (+IV),1961,,,,Annex Ia,,
6/9/2017,"CANNABIS PLANT containing d9THC+d9THCA >0,3%",,CC(=O)N[C@@H]1[C@H](C[C@](O[C@H]1[C@@H]([C@@H](CO)O)O)(C(=O)O)O)O,CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)O[C@](O)(C(=O)O)C[C@@H]1O,"∆9-THC + THCA > 0,3 %",/,/,,,,Annex IVb,,
24/01/1984 + 09/12/2019,CARFENTANIL,59708-52-0,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CC=C3)C(=O)OC,CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCc2ccccc2)CC1,methyl 1-(2-phenylethyl)-4-[phenyl(propanoyl)amino]piperidine-4-carboxylate,Schedule I,1961,,,,Annex Ia,096000,
,CATHINE ((+)-NORPSEUDOEPHEDRINE),492-39-7,C[C@@H]([C@H](C1=CC=CC=C1)O)N,C[C@H](N)[C@@H](O)c1ccccc1,(+)-(S)-α-[(S)-1-aminoethyl]benzyl alcohol,Schedule III,1971,,,,Annex IIb,603000,
,CATHINONE,71031-15-7,C[C@@H](C(=O)C1=CC=CC=C1)N,C[C@H](N)C(=O)c1ccccc1,(–)-(S)-2-aminopropiophenone,Schedule I,1971,,,,Annex IIa,401000,
,CHLORDIAZEPOXIDE,58-25-3,CN=C1CN(C(=C2C=C(C=CC2=N1)Cl)C3=CC=CC=C3)O,CN=C1CN(O)C(c2ccccc2)=c2cc(Cl)ccc2=N1,"7-chloro-2-(methylamino)-5-phenyl-3H-1,4-benzodiazepine-4-oxide",Schedule IV,1971,,,,Annex III,708000,
25/11/2015,CHLOROAMPHETAMINE,64-12-0,CC(CC1=CC=C(C=C1)Cl)N,CC(N)Cc1ccc(Cl)cc1,1-(chlorophenyl)propan-2-amine ,/,/,,,,Annex IVa - amfetamine,,
25/11/2015,CHLOROMETHAMPHETAMINE,1199-85-5,CC(CC1=CC=C(C=C1)Cl)NC,CNC(C)Cc1ccc(Cl)cc1,[1-(chlorophenyl)propan-2-yl](methyl)amine,/,/,,,,Annex IVa - amfetamine,,
24/4/2024,CH-PIATA,,CC(=O)N[C@@H]1[C@H](C[C@](O[C@H]1[C@@H]([C@@H](CO)O)O)(C(=O)O)O)O,CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)O[C@](O)(C(=O)O)C[C@@H]1O, N-cyclohexyl-2-(1-pentylindol-3-yl)acetamide,/,/,,,,Annex IVb,,
,CLOBAZAM,22316-47-8,CN1C(=O)CC(=O)N(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,CN1C(=O)CC(=O)N(c2ccccc2)c2cc(Cl)ccc21,"7-chloro-1-methyl-5-phenyl-1H-1,5-benzodiazepine-2,4(3H,5H)-dione",Schedule IV,1971,,,,Annex III,709000,
6/09/2017 + 27/12/2021,CLOBENZOREX,13364-32-4,C[C@@H](CC1=CC=CC=C1)NCC2=CC=CC=C2Cl,C[C@@H](Cc1ccccc1)NCc1ccccc1Cl,N-[(2-chlorophenyl)methyl]-1-phenylpropan-2-amine,/,/,,,,,,
,CLONAZEPAM,1622-61-3,C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3Cl,O=C1CN=C(c2ccccc2Cl)c2cc([N+](=O)[O-])ccc2N1,"5-(o-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one",Schedule IV,1971,,,,Annex III,710000,
23/3/2022,CLONAZOLAM,33887-02-4,CC1=NN=C2N1C3=C(C=C(C=C3)[N+](=O)[O-])C(=NC2)C4=CC=CC=C4Cl,Cc1nnc2n1-c1ccc([N+](=O)[O-])cc1C(c1ccccc1Cl)=NC2,"6-(2-chlorophenyl)-1-methyl-8-nitro-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine",Schedule IV,1971,,,,Annex III,,
,CLONITAZENE,3861-76-5,CCN(CC)CCN1C2=C(C=C(C=C2)[N+](=O)[O-])N=C1CC3=CC=C(C=C3)Cl,CCN(CC)CCn1c(Cc2ccc(Cl)cc2)nc2cc([N+](=O)[O-])ccc21,2-(p-chlorobenzyl)-1-diethylaminoethyl-5-nitrobenzimidazole,Schedule I,1961,,,,Annex Ia,019000,
,CLORAZEPATE,23887-31-2,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)C(=O)O,O=C(O)C1N=C(c2ccccc2)c2cc(Cl)ccc2NC1=O,"7-chloro-2,3-dihydro-2-oxo-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid",Schedule IV,1971,,,,Annex III,711000,
,CLOTIAZEPAM,33671-46-4,CCC1=CC2=C(S1)N(C(=O)CN=C2C3=CC=CC=C3Cl)C,CCc1cc2c(s1)N(C)C(=O)CN=C2c1ccccc1Cl,"5-(o-chlorophenyl)-7-ethyl-1,3-dihydro-1-methyl-2Hthieno[2,3-e]-1,4-diazepin-2-one",Schedule IV,1971,,,,Annex III,712000,
,CLOXAZOLAM,24166-13-0,C1COC2(N1CC(=O)NC3=C2C=C(C=C3)Cl)C4=CC=CC=C4Cl,O=C1CN2CCOC2(c2ccccc2Cl)c2cc(Cl)ccc2N1,"10-chloro-11b-(o-chlorophenyl)-2,3,7,11b-tetrahydrooxazolo-[3,2-d][1,4]benzodiazepin-6(5H)-one",Schedule IV,1971,,,,Annex III,713000,
,COCAE FOLIUM,,CC(=O)N[C@@H]1[C@H](C[C@](O[C@H]1[C@@H]([C@@H](CO)O)O)(C(=O)O)O)O,CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)O[C@](O)(C(=O)O)C[C@@H]1O,,Schedule I,1961,,,,Annex Ia,020000,
,COCAINE,50-36-2,CN1[C@H]2CC[C@@H]1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC,COC(=O)[C@H]1[C@@H](OC(=O)c2ccccc2)C[C@@H]2CC[C@H]1N2C,methyl ester of benzoylecgonine,Schedule I,1961,,,,Annex Ia,021000,
,CODEINE,76-57-3,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O,COc1ccc2c3c1O[C@H]1[C@@H](O)C=C[C@H]4[C@@H](C2)N(C)CC[C@@]341,3-methylmorphine,Schedule II,1961,,,,Annex Ib,202000,
26/9/2011,CODOXIME,7125-76-0,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3C(=NOCC(=O)O)CC4,COc1ccc2c3c1O[C@H]1C(=NOCC(=O)O)CC[C@H]4[C@@H](C2)N(C)CC[C@]314,dihydrocodeinone-6-carboxymethyloxime,Schedule I,1961,,,,Annex Ia,022000,
,CONCENTRATE OF POPPY STRAW (CPS),57-27-2,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O,CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5,CPS ,Schedule I,1961,,,,Annex Ia,023000,
6/9/2017,"CP 47,497 C8-homoloog (Cannabicyclohexanol)",1554485-48-1,CC(C)(CCCCCCCO)C1=CC(=C(C=C1)[C@H]2CCC[C@H](C2)O)O,CC(C)(CCCCCCCO)c1ccc([C@H]2CCC[C@@H](O)C2)c(O)c1,2-(3-hydroxycyclohexyl)-5-(2-methyloctan-2-yl)phenol,/,/,,,,Annex IVb,,
26/9/2011,"CP47,497",70434-82-1,CCCCCCC(C)(C)C1=CC(=C(C=C1)[C@@H]2CCC[C@@H](C2)O)O,CCCCCCC(C)(C)c1ccc([C@@H]2CCC[C@H](O)C2)c(O)c1,2-(3-hydroxycyclohexyl)-5-(2-methylnonan-2-yl)phenol,/,/,,,,Annex IVb,,
6/9/2017,CRA-13,432047-72-8,CCCCCOC1=CC=C(C2=CC=CC=C21)C(=O)C3=CC=CC4=CC=CC=C43,CCCCCOc1ccc(C(=O)c2cccc3ccccc23)c2ccccc12,naphthalen-1-yl-(4-pentoxynaphthalen-1-yl)methanone,/,/,,,,Annex IVb,848000,
06/09/2017 + 27/12/2021,CROTONYLFENTANYL,760930-59-4,C/C=C/C(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,C/C=C/C(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,(E)-N-(1-phenethylpiperidin-4-yl)-N-phenylbut-2-enamide,Schedule I,1961,,,,Annex Ia,,
06/09/2017 + 09/12/2019,CUMYL-4CN-BINACA ,1631074-54-8,CC(C)(C1=CC=CC=C1)NC(=O)C2=NN(C3=CC=CC=C32)CCCCC#N,CC(C)(NC(=O)c1nn(CCCCC#N)c2ccccc12)c1ccccc1,1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide,Schedule II,1971,2018/748 ,,,Annex IIb,,
23/3/2022,CUMYL-PEGACLONE,2160555-55-3,CCCCCN1C2=C(C3=CC=CC=C31)C(=O)N(C=C2)C(C)(C)C4=CC=CC=C4,CCCCCn1c2ccccc2c2c(=O)n(C(C)(C)c3ccccc3)ccc21,"5-pentyl-2-(2-phenylpropan-2-yl)-2,5-dihydro-1H-pyrido[4,3-b]indol-1-one",Schedule II,1971,,,,Annex IIb,,
,CYCLOBARBITAL,52-31-3,CCC1(C(=O)NC(=O)NC1=O)C2=CCCCC2,CCC1(C2=CCCCC2)C(=O)NC(=O)NC1=O,5-(1-cyclohexen-1-yl)-5-ethylbarbituric acid,Schedule III,1971,,,,Annex III,604000,
6/9/2017,CYCLOPENTYLFENTANYL,2088918-01-6,C1CCC(C1)C(=O)N(C2CCN(CC2)CCC3=CC=CC=C3)C4=CC=CC=C4,O=C(C1CCCC1)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,,/,/,,,,Annex IVa - fentanyl 3a,,
06/09/2017 + 09/12/2019,CYCLOPROPYLFENTANYL,1169-68-2,C1CC1C(=O)N(C2CCN(CC2)CCC3=CC=CC=C3)C4=CC=CC=C4,O=C(C1CC1)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,N-Phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide,Schedule I,1961,2018/1463,,,Annex Ia,,
6/9/2017,D9-THCA (Tetrahydrocannabinolic acid),,CC(=O)N[C@@H]1[C@H](C[C@](O[C@H]1[C@@H]([C@@H](CO)O)O)(C(=O)O)O)O,CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)O[C@](O)(C(=O)O)C[C@@H]1O,"6aR)-2-carboxy-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-olate",/,/,,,,Annex IVb,,
24/4/2024,D9-THCB (D9-TETRAHYDROCANNABUTOL),,CC(=O)N[C@@H]1[C@H](C[C@](O[C@H]1[C@@H]([C@@H](CO)O)O)(C(=O)O)O)O,CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)O[C@](O)(C(=O)O)C[C@@H]1O,"3-butyl-6,6,9-trimethyl-6a,7,8,10a-tetrahydro-6H-dibenzo[b,d]pyran-1-ol",/,/,,,,Annex IVb,,
24/4/2024,D9-THCH (D9-TETRAHYDROCANNABIHEXOL),,CC(=O)N[C@@H]1[C@H](C[C@](O[C@H]1[C@@H]([C@@H](CO)O)O)(C(=O)O)O)O,CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)O[C@](O)(C(=O)O)C[C@@H]1O,"3-hexyl-6,6,9-trimethyl-6a,7,8,10a-tetrahydro-6H-dibenzo[b,d]pyran-1-ol",/,/,,,,Annex IVb,,
24/4/2024,D9-THCjd (D9-TETRAHYDROCANNABIOCTYL),,CC(=O)N[C@@H]1[C@H](C[C@](O[C@H]1[C@@H]([C@@H](CO)O)O)(C(=O)O)O)O,CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)O[C@](O)(C(=O)O)C[C@@H]1O,"3-octyl-6,6,9-trimethyl-6a,7,8,10a-tetrahydro-6H-dibenzo[b,d]pyran-1-ol",/,/,,,,Annex IVb,,
24/4/2024,D9-THCP (D9-TETRAHYDROCANNABIPHOROL),,CC(=O)N[C@@H]1[C@H](C[C@](O[C@H]1[C@@H]([C@@H](CO)O)O)(C(=O)O)O)O,CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)O[C@](O)(C(=O)O)C[C@@H]1O,"3-heptyl-6,6,9-trimethyl-6a,7,8,10a-tetrahydro-6H-dibenzo[b,d]pyran-1-ol",/,/,,,,Annex IVb,,
24/4/2024,D9-THCP-A (D9-TETRAHYDROCANNABIPHOROLIC ACID),,CC(=O)N[C@@H]1[C@H](C[C@](O[C@H]1[C@@H]([C@@H](CO)O)O)(C(=O)O)O)O,CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)O[C@](O)(C(=O)O)C[C@@H]1O,"3-heptyl-6a,7,8,10a-tetrahydro-1-hydroxy-6,6,9-trimethyl-6H-dibenzo[b,d]pyran-2-carboxylic acid",/,/,,,,Annex IVb,,
,DELORAZEPAM,2894-67-9,C1C(=O)NC2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3Cl,O=C1CN=C(c2ccccc2Cl)c2cc(Cl)ccc2N1,"7-chloro-5-(o-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one",Schedule IV,1971,,,,Annex III,714000,
8/2/2023,DEOXYMETHOXETAMINE (DMXE),2666932-45-0,CCNC1(CCCCC1=O)C2=CC=CC(=C2)C,CCNC1(c2cccc(C)c2)CCCCC1=O,2-(ethylamino)-2-(3-methylphenyl)cyclohexan-1-one,/,/,,,,Annex IVb,,
24/4/2024,DESALKYLGIDAZEPAM (BROMONORDIAZEPAM),2894-61-3,C1C(=O)NC2=C(C=C(C=C2)Br)C(=N1)C3=CC=CC=C3,O=C1CN=C(c2ccccc2)c2cc(Br)ccc2N1,"7-bromo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one",/,/,,,,Annex IVb,,
8/2/2023,DESCHLOROETIZOLAM,40054-73-7,CCC1=CC2=C(S1)N3C(=NN=C3CN=C2C4=CC=CC=C4)C,CCc1cc2c(s1)-n1c(C)nnc1CN=C2c1ccccc1,"2-ethyl-9-methyl-4-phenyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine",/,/,,,,Annex IVb,,
8/2/2023,DESCHLOROETIZOLAM,40054-73-7,CCC1=CC2=C(S1)N3C(=NN=C3CN=C2C4=CC=CC=C4)C,CCc1cc2c(s1)-n1c(C)nnc1CN=C2c1ccccc1,"2-ethyl-9-methyl-4-phenyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine",/,/,,,,Annex IVb,,
23/3/2022,DESCHLOROKETAMINE,7063-30-1,CNC1(CCCCC1=O)C2=CC=CC=C2,CNC1(c2ccccc2)CCCCC1=O,2-(methylamino)-2-phenylcyclohexan-1-one,/,/,,,,Annex IVb,,
23/3/2022,DESCHLORO-N-ETHYL-KETAMINE,6740-82-5,CCNC1(CCCCC1=O)C2=CC=CC=C2,CCNC1(c2ccccc2)CCCCC1=O,2-(ethylamino)-2-phenylcyclohexan-1-one,/,/,,,,Annex IVb,,
,DESOMORPHINE,427-00-9,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3CCC4,CN1CC[C@]23c4c5ccc(O)c4O[C@H]2CCC[C@H]3[C@H]1C5,Dihydrodesoxymorphine,Schedule I + IV,1961,,,,Annex Ia,024000,
6/9/2017,DESOXY-D2PM,383127-45-5,C1CC(NC1)C(C2=CC=CC=C2)C3=CC=CC=C3,c1ccc(C(c2ccccc2)C2CCCN2)cc1,2-(diphenylmethyl)pyrrolidine,/,/,,,,Annex IVb,,
6/9/2017,DESOXYPIPRADROL(2DPMP),519-74-4,C1CCNC(C1)C(C2=CC=CC=C2)C3=CC=CC=C3,c1ccc(C(c2ccccc2)C2CCCCN2)cc1,2-(diphenylmethyl)piperidine,/,/,,,,Annex IVb,,
,DEXAMFETAMINE,51-64-9,C[C@@H](CC1=CC=CC=C1)N,C[C@H](N)Cc1ccccc1,(+)-α-methylphenethylamine,Schedule II,1971,,,,Annex IIb,502000,
,DEXTROMORAMIDE,357-56-2,C[C@H](CN1CCOCC1)C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N4CCCC4,C[C@H](CN1CCOCC1)C(C(=O)N1CCCC1)(c1ccccc1)c1ccccc1,"(+)-4-[2-methyl-4-oxo-3,3-diphenyl-4-(1-pyrrolidinyl)butyl]morpholine",Schedule I,1961,,,,Annex Ia,025000,
1/10/1981,DEXTROPROPOXYPHENE,469-62-5,CCC(=O)O[C@](CC1=CC=CC=C1)(C2=CC=CC=C2)[C@H](C)CN(C)C,CCC(=O)O[C@](Cc1ccccc1)(c1ccccc1)[C@H](C)CN(C)C,"α-(+)-4-dimethylamino-1,2-diphenyl-3-methyl-2-butanol propionate",Schedule II,1961,,,,Annex Ib,203000,
,DIAMPROMIDE,552-25-0,CCC(=O)N(CC(C)N(C)CCC1=CC=CC=C1)C2=CC=CC=C2,CCC(=O)N(CC(C)N(C)CCc1ccccc1)c1ccccc1,N-[2-(methylphenethylamino)-propyl]propionanilide,Schedule I,1961,,,,Annex Ia,026000,
,DIAZEPAM,439-14-5,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,CN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21,"7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one",Schedule IV,1971,,,,Annex III,715000,
25/11/2015,DIBUTYLONE (bk-DMBDB),802286-83-5,CCC(C(=O)C1=CC2=C(C=C1)OCO2)N(C)C,CCC(C(=O)c1ccc2c(c1)OCO2)N(C)C,"1-(2H-1,3-benzodioxol-5-yl)-2-(dimethylamino)butan-1-one",/,/,,,,Annex IVa - cathinone,,
23/3/2022,DICLAZEPAM,2894-68-0,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3Cl,CN1C(=O)CN=C(c2ccccc2Cl)c2cc(Cl)ccc21,"7-chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one",Schedule IV,1971,,,,Annex III,,
,DIETHYLTHIAMBUTENE,86-14-6,CCN(CC)C(C)C=C(C1=CC=CS1)C2=CC=CS2,CCN(CC)C(C)C=C(c1cccs1)c1cccs1,"3-diethylamino-1,1-di-(2’-thienyl)-1-butene",Schedule I,1961,,,,Annex Ia,027000,
,DIETHYLTRYPTAMINE (DET),61-51-8,CCN(CC)CCC1=CNC2=CC=CC=C21,CCN(CC)CCc1c[nH]c2ccccc12,3-[2-(diethylamino)ethyl]indole,Schedule I,1971,,,,Annex IIa,402000,
31/7/1974,DIFENOXIN,28782-42-5,C1CN(CCC1(C2=CC=CC=C2)C(=O)O)CCC(C#N)(C3=CC=CC=C3)C4=CC=CC=C4,N#CC(CCN1CCC(C(=O)O)(c2ccccc2)CC1)(c1ccccc1)c1ccccc1,"1-(3-cyano-3,3-diphenylpropyl)-4-phenylisonipecotic acid",Schedule I,1961,,,,Annex Ia,028000,
,DIHYDROCODEINE,125-28-0,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](CC4)O,COc1ccc2c3c1O[C@H]1[C@@H](O)CC[C@H]4[C@@H](C2)N(C)CC[C@@]341,"(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,5,6,7,7a,13-octahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol",Schedule II,1961,,,,Annex Ib,204000,
16/11/1999,DIHYDROETORFINE,14357-76-7,CCC[C@](C)([C@H]1C[C@@]23CC[C@@]1([C@H]4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)C)OC)O,CCC[C@@](C)(O)[C@H]1C[C@@]23CC[C@]1(OC)[C@@H]1Oc4c(O)ccc5c4[C@@]12CCN(C)[C@@H]3C5,"7,8-dihydro-7α-[1-(R)-hydroxy-1-methylbutyl]-6,14-endoethanotetrahydrooripavine",Schedule I,1961,,,,Annex Ia,,
,DIHYDROMORPHINE,509-60-4,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](CC4)O,CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)CC[C@H]3[C@H]1C5,"(1S,5R,13R,14S,17R)-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0¹,¹³.0⁵,¹⁷.0⁷,¹⁸]octadeca-7,9,11(18)-triene-10,14-diol",Schedule I,1961,,,,Annex Ia,029000,
,DIMENOXADOL,509-78-4,CCOC(C1=CC=CC=C1)(C2=CC=CC=C2)C(=O)OCCN(C)C,CCOC(C(=O)OCCN(C)C)(c1ccccc1)c1ccccc1,"2-dimethylaminoethyl-1-ethoxy-1,1-diphenylacetate",Schedule I,1961,,,,Annex Ia,030000,
,DIMEPHEPTANOL,545-90-4,CCC(C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2)O,CCC(O)C(CC(C)N(C)C)(c1ccccc1)c1ccccc1,"6-dimethylamino-4,4-diphenyl-3-heptanol",Schedule I,1961,,,,Annex Ia,031000,
23/3/2022,DIMETHOCAINE,94-15-5,CCN(CC)CC(C)(C)COC(=O)C1=CC=C(C=C1)N,CCN(CC)CC(C)(C)COC(=O)c1ccc(N)cc1,"[3-(diethylamino)-2,2-dimethylpropyl]4-aminobenzoate",/,/,,,,Annex IVb,,
6/9/2017,DIMETHYLCATHINONE,15351-09-4,CC(C(=O)C1=CC=CC=C1)N(C)C,CC(C(=O)c1ccccc1)N(C)C,,/,/,,,,annex IVa - cathinone,,
,DIMETHYLHEPTYLPYRAN (DMHP),32904-22-6,CCCCCC(C)C(C)C1=CC(=C2C3=C(CCC(C3)C)C(OC2=C1)(C)C)O,CCCCCC(C)C(C)c1cc(O)c2c(c1)OC(C)(C)C1=C2CC(C)CC1,"3-(1,2-dimethylheptyl)-7,8,9,10-tetrahydro-6,6,9-trimethyl-6Hdibenzo[b,d]pyran-1-ol",Schedule I,1971,,,,Annex IIa,404000,
25/11/2015,DIMETHYLONE (bk-MDDMA),191916-43-5,,,"1-(2H-1,3-benzodioxol-5-yl)-2-(dimethylamino)propan-1-one",/,/,,,,Annex IVa - cathinone,,
,DIMETHYLTHIAMBUTENE,524-84-5,CC(C=C(C1=CC=CS1)C2=CC=CS2)N(C)C,CC(C=C(c1cccs1)c1cccs1)N(C)C,"3-dimethylamino-1,1-di-(2’-thienyl)-1-butene",Schedule I,1961,,,,Annex Ia,032000,
,DIMETHYLTRYPTAMINE (DMT),61-50-7,CN(C)CCC1=CNC2=CC=CC=C21,CN(C)CCc1c[nH]c2ccccc12,[3-[2-(dimethylamino)ethyl]indole,Schedule I,1971,,,,Annex IIa,405000,
,DIOXAPHETYL BUTYRATE,467-86-7,CCOC(=O)C(CCN1CCOCC1)(C2=CC=CC=C2)C3=CC=CC=C3,CCOC(=O)C(CCN1CCOCC1)(c1ccccc1)c1ccccc1,"ethyl-4-morpholino-2,2-diphenylbutyrate",Schedule I,1961,,,,Annex Ia,016000,
25/11/2015 + 23/03/2022,DIPHENIDINE,36794-52-2,C1CCN(CC1)C(CC2=CC=CC=C2)C3=CC=CC=C3,c1ccc(CC(c2ccccc2)N2CCCCC2)cc1,"1-(1,2-diphenylethyl)piperidine",Schedule II,1971,,,,Annex IIb,849000,
,DIPHENOXYLATE,915-30-0,CCOC(=O)C1(CCN(CC1)CCC(C#N)(C2=CC=CC=C2)C3=CC=CC=C3)C4=CC=CC=C4,CCOC(=O)C1(c2ccccc2)CCN(CCC(C#N)(c2ccccc2)c2ccccc2)CC1,"1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidine-4-carboxylic acid ethylester",Schedule I,1961,,,,Annex Ia,033000,
6/9/2017,DIPHENYLPROLINOL (D2PM),22348-32-9,C1C[C@@H](NC1)C(C2=CC=CC=C2)(C3=CC=CC=C3)O,OC(c1ccccc1)(c1ccccc1)[C@H]1CCCN1,"1,2-diphenyl(pyrrolidin-2-yl)methanol",/,/,,,,Annex IVb,850000,
,DIPIPANONE,467-83-4,CCC(=O)C(CC(C)N1CCCCC1)(C2=CC=CC=C2)C3=CC=CC=C3,CCC(=O)C(CC(C)N1CCCCC1)(c1ccccc1)c1ccccc1,"4,4-diphenyl-6-piperidine-3-heptanone",Schedule I,1961,,,,Annex Ia,034000,
,DIPROPYLTRYPTAMINE (DPT),61-52-9,CCCN(CCC)CCC1=CNC2=CC=CC=C21,CCCN(CCC)CCc1c[nH]c2ccccc12,N-[2-(1H-indol-3-yl)ethyl]-N-propylpropan-1-amine,/,/,,,,Annex IVa - tryptamine,,
06/09/2017 + 27/12/2021,DOC,64-85-7,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)CO)CCC4=CC(=O)CC[C@]34C,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2C(=O)CO,"4-Chloro-2,5-dimethoxyamfetamine",Schedule I,1971,,,,Annex IIa,,
,DRONABINOL (DELTA-9-TETRAHYDROCANNABINOL),1972-08-3,CCCCCC1=CC(=C2[C@@H]3C=C(CC[C@H]3C(OC2=C1)(C)C)C)O,CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CCC(C)=C[C@@H]21,"(6aR,10aR)-6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol",Schedule II,1971,,,,Annex IIb,514000,
26/9/2011,DROTEBANOL,3176-03-2,CN1CC[C@]23C[C@@H](CC[C@]2([C@H]1CC4=C3C(=C(C=C4)OC)OC)O)O,COc1ccc2c(c1OC)[C@]13CCN(C)[C@H](C2)[C@]1(O)CC[C@@H](O)C3,"3,4-dimethoxy-17-methylmorphinan-6β,14-diol",Schedule I,1961,,,,Annex Ia,035000,
25/11/2015,EAM-2201,1364933-60-7,CCC1=CC=C(C2=CC=CC=C12)C(=O)C3=CN(C4=CC=CC=C43)CCCCCF,CCc1ccc(C(=O)c2cn(CCCCCF)c3ccccc23)c2ccccc12,3-(4-ethylnaphthalene-1-carbonyl)-1-(5-fluoropentyl)-1H-indole,/,/,,,,Annex IVa - synth. cann. 4a,,
,ECGONINE (+ESTERS!),481-37-8,CN1[C@H]2CC[C@@H]1[C@H]([C@H](C2)O)C(=O)O,CN1[C@H]2CC[C@@H]1[C@@H](C(=O)O)[C@@H](O)C2,"(3S,4R)-3-hydroxy-8-methyl-8-azabicyclo[3.2.1]octane-4-carboxylic acid",Schedule I,1961,,,,Annex Ia,036000,
,ECGONINE BENZOYLESTER (BENZOYLECGONINE),519-09-5,CN1[C@H]2CC[C@@H]1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)O,CN1[C@H]2CC[C@@H]1[C@@H](C(=O)O)[C@@H](OC(=O)c1ccccc1)C2,"(1S,3S,4R,5R)-3-benzoyloxy-8-methyl-8-azabicyclo[3.2.1]octane-4-carboxylic acid",Schedule I,1961,,,,Annex Ia,036100,
,ECGONINE BENZOYLETHYLESTER (COCAETHYLENE),529-38-4,CCOC(=O)[C@@H]1[C@H]2CC[C@H](N2C)C[C@@H]1OC(=O)C3=CC=CC=C3,CCOC(=O)[C@H]1[C@@H](OC(=O)c2ccccc2)C[C@@H]2CC[C@H]1N2C,"ethyl (1S,3S,4R,5R)-3-benzoyloxy-8-methyl-8-azabicyclo[3.2.1]octane-4-carboxylate",Schedule I,1961,,,,Annex Ia,036200,
25/11/2015,EG-018,2219320-91-7,CCCCCN1C2=C(C=C(C=C2)C(=O)C3=CC=CC4=CC=CC=C43)C5=CC=CC=C51,CCCCCn1c2ccccc2c2cc(C(=O)c3cccc4ccccc34)ccc21,3-(naphthalene-1-carbonyl)-9-pentyl-9H-carbazole,/,/,,,,Annex IVb,,
6/9/2017,"EMB-FUBINACA (AEB-FUBINACA, FUB-AEB)",2365470-94-4,CCOC(=O)[C@H](C(C)C)NC(=O)C1=NN(C2=CC=CC=C21)CC3=CC=C(C=C3)F,CCOC(=O)[C@@H](NC(=O)c1nn(Cc2ccc(F)cc2)c2ccccc12)C(C)C,ethyl 2-[[1-[(4-fluorophenyl)methyl]indazole-3-carbonyl]amino]-3-methyl-butanoate,/,/,,,,Annex Iva - synth. cann. 4e,,
,ESTAZOLAM,29975-16-4,C1C2=NN=CN2C3=C(C=C(C=C3)Cl)C(=N1)C4=CC=CC=C4,Clc1ccc2c(c1)C(c1ccccc1)=NCc1nncn1-2,"8-chloro-6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine",Schedule IV,1971,,,,Annex III,716000,
6/9/2017,ETAQUALONE,7432-25-9,CCC1=CC=CC=C1N2C(=NC3=CC=CC=C3C2=O)C,CCc1ccccc1-n1c(C)nc2ccccc2c1=O,"3-(2-ethylphenyl)-2-methyl-3,4-dihydroquinazolin-4-one ",/,/,,,,Annex IVb,851000,
08/02/2023+ 24/04/2024,ETAZENE (ETODESNITAZENE),14030-76-3,CCN(CC)CCN1C2=CC=CC=C2N=C1CC3=CC=C(C=C3)OCC,CCOc1ccc(Cc2nc3ccccc3n2CCN(CC)CC)cc1,"2-[2-[(4-Ethoxyphenyl)methyl]benzimidazol-1-yl]-
N,N-diethylethanamine",Schedule I,1961,,,,Annex Ia,,
25/11/2015,ETHCATHINONE,18259-37-5,CCNC(C)C(=O)C1=CC=CC=C1,CCNC(C)C(=O)c1ccccc1,2-(ethylamino)-1-phenylpropan-1-one,/,/,,,,Annex IVa - cathinone,,
,ETHCHLORVYNOL,113-18-8,CCC(/C=C/Cl)(C#C)O,C#CC(O)(/C=C/Cl)CC,1-chloro-3-ethyl-1-penten-4-yn-3-ol,Schedule IV,1971,,,,Annex III,717000,
25/11/2015,ETHILAMFETAMINE (N-ethylamphetamine),457-87-4,CCNC(C)CC1=CC=CC=C1,CCNC(C)Cc1ccccc1,N-ethyl-α-methylphenethylamine,Schedule IV,1971,,,,Annex IIb,719000,
,ETHINAMATE,126-52-3,C#CC1(CCCCC1)OC(=O)N,C#CC1(OC(N)=O)CCCCC1,1-ethynylcyclohexanolcarbamate,Schedule IV,1971,,,,Annex III,718000,
8/2/2023,ETH-LAD,65527-62-0,CCN1C[C@@H](C=C2[C@H]1CC3=CNC4=CC=CC2=C34)C(=O)N(CC)CC,CCN(CC)C(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(CC)C1,"(8β)-N,N,6-Triethyl-9,10-didehydroergoline-8-carboxamide",/,/,,,,Annex IVb,,
,ETHYLLOFLAZEPATE,29177-84-2,CCOC(=O)C1C(=O)NC2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3F,CCOC(=O)C1N=C(c2ccccc2F)c2cc(Cl)ccc2NC1=O,"ethyl 7-chloro-5-(o-fluorophenyl)-2,3-dihydro-2-oxo-1H-1,4-benzodiazepine-3-carboxylate",Schedule IV,1971,,,,Annex III,729000,
,ETHYLMETHYLTHIAMBUTENE,441-61-2,CCN(C)C(C)C=C(C1=CC=CS1)C2=CC=CS2,CCN(C)C(C)C=C(c1cccs1)c1cccs1,"3-ethylmethylamino-1,1-di-(2’-thienyl)-1-butene",Schedule I,1961,,,,Annex Ia,037000,
,ETHYLMORPHINE,76-58-4,CCOC1=C2C3=C(C[C@@H]4[C@H]5[C@]3(CCN4C)[C@@H](O2)[C@H](C=C5)O)C=C1,CCOc1ccc2c3c1O[C@H]1[C@@H](O)C=C[C@H]4[C@@H](C2)N(C)CC[C@@]341,3-ethylmorphine,Schedule II,1961,,,,Annex Ib,205000,
25/11/2015 + 09/12/2019,ETHYLONE (bk-MDEA),1112937-64-0,CCNC(C)C(=O)C1=CC2=C(C=C1)OCO2,CCNC(C)C(=O)c1ccc2c(c1)OCO2,"1-(2H-1,3-benzodioxol-5-yl)-2-(ethylamino)propan-1-one",Schedule II,1971,,,,Annex IIb,519000,
06/09/2017 + 09/12/2019,ETHYLPHENIDATE,‎57413-43-1,,,ethyl 2-phenyl-2-(piperidin-2-yl)acetate,Schedule II,1971,,,,Annex IIb,518000,
,ETICYCLIDINE (PCE),2201-15-2,CCNC1(CCCCC1)C2=CC=CC=C2,CCNC1(c2ccccc2)CCCCC1,N-ethyl-1-phenylcyclohexylamine,Schedule I,1971,,,,Annex IIa,407000,
25/11/2015 + 27/12/2021,ETIZOLAM,40054-69-1,CCC1=CC2=C(S1)N3C(=NN=C3CN=C2C4=CC=CC=C4Cl)C,CCc1cc2c(s1)-n1c(C)nnc1CN=C2c1ccccc1Cl,"4-(2-Chlorophenyl)-2-ethyl-9-methyl-6H-thieno[3,2- f][1,2,4]triazolo[4,3a][1,4]diazepine",Schedule IV,1971,,,,Annex III,818000,
24/4/2024,"ETOMETHAZENE (5-METHYL  ETAZENE, 5-METHYL ETODESNITAZENE)",,CC(=O)N[C@@H]1[C@H](C[C@](O[C@H]1[C@@H]([C@@H](CO)O)O)(C(=O)O)O)O,CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)O[C@](O)(C(=O)O)C[C@@H]1O,"2-[(4-ethoxyphenyl)methyl]-N,N-diethyl-5-methyl-1H-benzimidazole-1-ethanamine, 2-hydroxypropane",/,/,,,,Annex IVb,,
,ETONITAZENE,911-65-9,CCN(CC)CCN1C2=C(C=C(C=C2)[N+](=O)[O-])N=C1CC3=CC=C(C=C3)OCC,CCOc1ccc(Cc2nc3cc([N+](=O)[O-])ccc3n2CCN(CC)CC)cc1,1-diethylaminoethyl-2-p-ethoxybenzyl-5-nitrobenzimidazole,Schedule I,1961,,,,Annex Ia,038000,
8/2/2023,ETONITAZEPIPNE,734496-28-7,CCOC1=CC=C(C=C1)CC2=NC3=C(N2CCN4CCCCC4)C=CC(=C3)[N+](=O)[O-],CCOc1ccc(Cc2nc3cc([N+](=O)[O-])ccc3n2CCN2CCCCC2)cc1,2-[(4-Ethoxyphenyl)methyl]-5-nitro-1-(2-piperidin-1-ylethyl)benzimidazole,/,/,,,,Annex IVb,,
27/12/2021 + 8/02/2023 + 24/04/2024,ETONITAZEPYNE,2785346-75-8,CCOC1=CC=C(C=C1)CC2=NC3=C(N2CCN4CCCC4)C=CC(=C3)[N+](=O)[O-],CCOc1ccc(Cc2nc3cc([N+](=O)[O-])ccc3n2CCN2CCCC2)cc1,2-(4-ethoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzo[d]imidazole,Schedule I,1961,,,,Annex Ia,,
26/9/2011,ETORPHINE ,14521-96-1,CCC[C@](C)([C@H]1C[C@@]23C=C[C@@]1([C@H]4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)C)OC)O,CCC[C@@](C)(O)[C@H]1C[C@@]23C=C[C@]1(OC)[C@@H]1Oc4c(O)ccc5c4[C@@]12CCN(C)[C@@H]3C5,"tetrahydro-7α-(1-hydroxy-1-methylbutyl)-6,14-endo-ethenooripavine",Schedule I + IV,1961,,,,Annex Ia,039000,
,ETOXERIDINE,469-82-9,CCOC(=O)C1(CCN(CC1)CCOCCO)C2=CC=CC=C2,CCOC(=O)C1(c2ccccc2)CCN(CCOCCO)CC1,1-[2-(2-hydroxyethoxy)-ethyl]-4-phenylpiperidine-4-carboxylic acid ethyl ester,Schedule I,1961,,,,Annex Ia,040000,
,ETRYPTAMINE,2235-90-7,CCC(CC1=CNC2=CC=CC=C21)N,CCC(N)Cc1c[nH]c2ccccc12,3-(2-aminobutyl)indole,Schedule I,1971,,,,Annex IIa,425000,
06/09/2017 + 8/02/2023,EUTYLONE,802855-66-9,CCC(C(=O)C1=CC2=C(C=C1)OCO2)NCC,CCNC(CC)C(=O)c1ccc2c(c1)OCO2,"1-(Benzo[d][1,3]dioxol-5-yl)-2- (ethylamino)butan-1-one",Schedule II,1971,,,,Annex IIb,,
6/9/2017,FDU-BP-22,,CC(=O)N[C@@H]1[C@H](C[C@](O[C@H]1[C@@H]([C@@H](CO)O)O)(C(=O)O)O)O,CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)O[C@](O)(C(=O)O)C[C@@H]1O,naphthalen-1-yl 1-(4-fluorobenzyl)-1H-indole-3-carboxylate,/,/,,,,Annex IVa - synth. cann. 4a,,
,FENCAMFAMIN,1209-98-9,CCNC1C2CCC(C2)C1C3=CC=CC=C3,CCNC1C2CCC(C2)C1c1ccccc1,N-ethyl-3-phenyl-2-norbornanamine,Schedule IV,1971,,,,Annex III,720000,
,FENETYLLINE,3736-08-1,CC(CC1=CC=CC=C1)NCCN2C=NC3=C2C(=O)N(C(=O)N3C)C,CC(Cc1ccccc1)NCCn1cnc2c1c(=O)n(C)c(=O)n2C,7-[2-[(α-methylphenethyl)amino]ethyl]theophylline,Schedule II,1971,,,,Annex IIb,806000,
,FENPROPOREX,16397-28-7,CC(CC1=CC=CC=C1)NCCC#N,CC(Cc1ccccc1)NCCC#N,(±)-3-[(α-methylphenylethyl)amino]propionitrile,Schedule IV,1971,,,,Annex IIb,721000,
10/4/1964,FENTANYL,437-38-7,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,1-phenethyl-4-N-propionylanilinopiperidine,Schedule I,1961,,,,Annex Ia,041000,
25/11/2015,FLEPHEDRONE (4-FLUOROMETHCATHINONE),447-40-5,CC(C(=O)C1=CC=C(C=C1)F)NC,CNC(C)C(=O)c1ccc(F)cc1,1-(4-fluorophenyl)-2-(methylamino)propan-1-one,/,/,,,,Annex IVa - cathinone,,
27/12/2021,FLUALPRAZOLAM,28910-91-0 ,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F,Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2,"8-Chloro-6-(2-fluoro-phenyl)-1-methyl-4h-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepime",Schedule IV,1971,,,,Annex III,,
24/4/2024,FLUBROMAZEPAM,2647-50-9,C1C(=O)NC2=C(C=C(C=C2)Br)C(=N1)C3=CC=CC=C3F,O=C1CN=C(c2ccccc2F)c2cc(Br)ccc2N1,"7-bromo-5-(2-fluorophenyl)-1,3-dihydro-14-benzodiazepin-2-one",/,/,,,,Annex IVb,,
27/12/2021 + 23/03/2022,FLUBROMAZOLAM,612526-40-6,CC1=NN=C2N1C3=C(C=C(C=C3)Br)C(=NC2)C4=CC=CC=C4F,Cc1nnc2n1-c1ccc(Br)cc1C(c1ccccc1F)=NC2,"8-bromo-6-(2-fluorophenyl)-1-methyl-4Hbenzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine",Schedule IV,1971,,,,Annex III,,
8/2/2023,FLUBROTIZOLAM,57801-95-3,CC1=NN=C2N1C3=C(C=C(S3)Br)C(=NC2)C4=CC=CC=C4F,Cc1nnc2n1-c1sc(Br)cc1C(c1ccccc1F)=NC2,"2-Bromo-4-(2-fluorophenyl)-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine",/,/,,,,Annex IVb,,
,FLUDIAZEPAM,3900-31-0,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3F,CN1C(=O)CN=C(c2ccccc2F)c2cc(Cl)ccc21,"7-chloro-5-(o-fluorophenyl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one",Schedule IV,1971,,,,Annex III,722000,
8/2/2023,FLUETIZOLAM,40054-88-4,CCC1=CC2=C(S1)N3C(=NN=C3CN=C2C4=CC=CC=C4F)C,CCc1cc2c(s1)-n1c(C)nnc1CN=C2c1ccccc1F,"2-ethyl-4-(2-fluorophenyl)-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine",/,/,,,,Annex IVb,,
18/10/2004 + 25/11/2015,FLUNITRAZEPAM,1622-62-4,CN1C(=O)CN=C(C2=C1C=CC(=C2)[N+](=O)[O-])C3=CC=CC=C3F,CN1C(=O)CN=C(c2ccccc2F)c2cc([N+](=O)[O-])ccc21,"5-(o-fluorophenyl)-1,3-dihydro-1-methyl-7-nitro-2H-1,4-benzodiazepin-2-one",Schedule III,1971,,,,Annex IIb,723000,
8/2/2023,FLUNITRAZOLAM,2243815-18-9,CC1=NN=C2N1C3=C(C=C(C=C3)[N+](=O)[O-])C(=NC2)C4=CC=CC=C4F,Cc1nnc2n1-c1ccc([N+](=O)[O-])cc1C(c1ccccc1F)=NC2,"6-(2-Fluorophenyl)-1-methyl-8-nitro-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine",/,/,,,,Annex IVb,,
20/3/2013,FLUOROAMPHETAMINE,459-02-9,CC(CC1=CC=C(C=C1)F)N,CC(N)Cc1ccc(F)cc1,"(1-(Fluorophenyl)propan-2-amine)
",/,/,,,,Annex IVa - amfetamine,,
27/12/2021,FLUORODESCHLOROKETAMINE (FLUOROKETAMINE),"111982-50-4
",,,2-(Fluorophenyl)-2-(methylamino)cyclohexanone,/,/,,,,Annex IVb,,
8/2/2023,FLUOROETHYLPHENIDATE,2160555-59-7,CCOC(=O)C(C1CCCCN1)C2=CC=C(C=C2)F,CCOC(=O)C(c1ccc(F)cc1)C1CCCCN1,ethyl(fluorophenyl)(piperidin-2-yl)acetate,/,/,,,,Annex IVb,,
25/11/2015,FLUOROMETHAMPHETAMINE,351-03-1,CC(CC1=CC=C(C=C1)F)NC,CNC(C)Cc1ccc(F)cc1,[1-(fluorophenyl)propan-2-yl](methyl)amine,/,/,,,,Annex IVa - amfetamine,,
27/12/2021,FLUOROMETHYLPHENIDATE,1253910-15-4,COC(=O)[C@@H]([C@H]1CCCCN1)C2=CC=C(C=C2)F,COC(=O)[C@H](c1ccc(F)cc1)[C@H]1CCCCN1,methyl (2R)-(fluorophenyl)[(2R)-piperidin-2-yl]acetate,/,/,,,,Annex IVb,,
27/12/2021,FLUOROPHENMETRAZINE,1350768-28-3,CC1C(OCCN1)C2=CC(=CC=C2)F,CC1NCCOC1c1cccc(F)c1,2-(Fluorophenyl)-3-methylmorpholine,/,/,,,,Annex IVb,,
,FLURAZEPAM,17617-23-1,CCN(CC)CCN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3F,CCN(CC)CCN1C(=O)CN=C(c2ccccc2F)c2cc(Cl)ccc21,"7-chloro-1-[2-(diethylamino)ethyl]-5-(o-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one",Schedule IV,1971,,,,Annex III,724000,
25/11/2015,FUB-AKB48 (FUB-APINACA),2180933-90-6,C1C2CC3CC1CC(C2)(C3)NC(=O)C4=NN(C5=CC=CC=C54)CC6=CC=C(C=C6)F,O=C(NC12CC3CC(CC(C3)C1)C2)c1nn(Cc2ccc(F)cc2)c2ccccc12,1-[(4-fluorophenyl)methyl]-N-(adamantan-1-yl)-1H-indazole-3-carboxamide,/,/,,,,Annex IVa - synth. cann. 4e,,
06/09/2017 + 09/12/2019,"FUB-AMB (MMB-FUBINACA, AMB-FUMINACA)",1971007-92-7,CC(C)[C@@H](C(=O)OC)NC(=O)C1=NN(C2=CC=CC=C21)CC3=CC=C(C=C3)F,COC(=O)[C@@H](NC(=O)c1nn(Cc2ccc(F)cc2)c2ccccc12)C(C)C,Methyl N-{[1-(4-fluorobenzyl)-1H-indazol-3-yl]carbonyl}valinate ,Schedule II,1971,,,,Annex IIb,,
25/11/2015,FUBIMINA,1984789-90-3,C1=CC=C2C(=C1)C=CC=C2C(=O)C3=NC4=CC=CC=C4N3CCCCCF,O=C(c1cccc2ccccc12)c1nc2ccccc2n1CCCCCF,"1-(5-fluoropentyl)-2-(naphthalene-1-carbonyl)-1H-1,3-benzodiazole",/,/,,,,Annex IVa - synth. cann. 4c,,
6/9/2017,FUB-JWH-018,2365471-45-8,C1=CC=C2C(=C1)C=CC=C2C(=O)C3=CN(C4=CC=CC=C43)CC5=CC=C(C=C5)F,O=C(c1cccc2ccccc12)c1cn(Cc2ccc(F)cc2)c2ccccc12,(1-(4-fluorobenzyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone,/,/,,,,Annex IVa - synth. cann. 4a,,
25/11/2015,FUB-PB-22,1800098-36-5,C1=CC=C2C(=C1)C(=CN2CC3=CC=C(C=C3)F)C(=O)OC4=CC=CC5=C4N=CC=C5,O=C(Oc1cccc2cccnc12)c1cn(Cc2ccc(F)cc2)c2ccccc12,quinolin-8-yl 1-[(4-fluorophenyl)methyl]-1H-indole-3-carboxylate,/,/,,,,Annex IVa - synth. cann. 4a,,
06/09/2017 + 09/12/2019,FURANYLFENTANYL,101345-66-8,C1CN(CCC1N(C2=CC=CC=C2)C(=O)C3=CC=CO3)CCC4=CC=CC=C4,O=C(c1ccco1)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]furan-2-carboxamide,Schedule I,1961,2017/2170,,,Annex Ia,102000,
,FURETHIDINE,2385-81-1,CCOC(=O)C1(CCN(CC1)CCOCC2CCCO2)C3=CC=CC=C3,CCOC(=O)C1(c2ccccc2)CCN(CCOCC2CCCO2)CC1,1-(2-tetrahydrofurfuryloxyethyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester,Schedule I,1961,,,,Annex Ia,042000,
,FURFENOREX,3776-93-0 / 13445-60-8,,,(furan-2-ylmethyl)(methyl)(1-phenylpropan-2-yl)amine,/,/,,,,Annex IVb,803000,
,GHB (gamma-HYDROXYBUTYRIC ACID; oxybate),591-81-1,C(CC(=O)O)CO,O=C(O)CCCO,γ-hydroxybutyric acid,Schedule II,1971,,,,Annex IIb,811000,
8/2/2023,GIDAZEPAM,129186-29-4,C1C(=O)N(C2=C(C=C(C=C2)Br)C(=N1)C3=CC=CC=C3)CC(=O)NN,NNC(=O)CN1C(=O)CN=C(c2ccccc2)c2cc(Br)ccc21,"2-(7-Bromo-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-1-yl)acetohydrazide",/,/,,,,Annex IVb,,
,GLUTETHIMIDE,77-21-4,CCC1(CCC(=O)NC1=O)C2=CC=CC=C2,CCC1(c2ccccc2)CCC(=O)NC1=O,2-ethyl-2-phenylglutarimide,Schedule III,1971,,,,Annex III,605000,
,HALAZEPAM,23092-17-3,C1C(=O)N(C2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3)CC(F)(F)F,O=C1CN=C(c2ccccc2)c2cc(Cl)ccc2N1CC(F)(F)F,"7-chloro-1,3-dihydro-5-phenyl-1-(2,2,2-trifluoroethyl)-2H-1,4-benzodiazepin-2-one",Schedule IV,1971,,,,Annex III,725000,
,HALOXAZOLAM,59128-97-1,C1COC2(N1CC(=O)NC3=C2C=C(C=C3)Br)C4=CC=CC=C4F,O=C1CN2CCOC2(c2ccccc2F)c2cc(Br)ccc2N1,"10-bromo-11b-(o-fluorophenyl)-2,3,7,11btetrahydrooxazolo[3,2-d] [1,4]benzodiazepin-6(5H)-one",Schedule IV,1971,,,,Annex III,726000,
,HEROIN (DIAMORPHINE),561-27-3,CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C,CC(=O)Oc1ccc2c3c1O[C@H]1[C@@H](OC(C)=O)C=C[C@H]4[C@@H](C2)N(C)CC[C@@]341,diacetylmorphine,Schedule I + IV,1961,,,,Annex Ia,043000,
8/2/2023,HEXAHYDROCANNABINOL (HHC),6692-85-9,CCCCCC1=CC(=C2C3CC(CCC3C(OC2=C1)(C)C)C)O,CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CCC(C)CC21,"6,6,9-trimethyl-3-pentyl-6a,7,8,9,10,10a-hexahydro-6H-benzo[c]chromen-1-ol",/,/,,,,Annex IVb,,
24/4/2024,HHCP (HEXAHYDROCANNABIPHOROL),,CC(=O)N[C@@H]1[C@H](C[C@](O[C@H]1[C@@H]([C@@H](CO)O)O)(C(=O)O)O)O,CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)O[C@](O)(C(=O)O)C[C@@H]1O,"3-heptyl-6,6,9-trimethyl-6a,7,8,9,10,10a-hexahydro-6H-benzo[c]chromen-1-ol",/,/,,,,Annex IVb,,
26/9/2011,HU-210,112830-95-2,CCCCCCC(C)(C)C1=CC(=C2[C@@H]3CC(=CC[C@H]3C(OC2=C1)(C)C)CO)O,CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)[C@@H]1CC=C(CO)C[C@@H]21,"9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6H,6aH,7H,10H,10aH-benzo[c]isochromen-1-ol",/,/,,,,Annex IVb,836000,
6/9/2017,HU-331,137252-25-6,CCCCCC1=CC(=O)C(=C(C1=O)O)[C@@H]2C=C(CC[C@H]2C(=C)C)C,C=C(C)[C@@H]1CCC(C)=C[C@H]1C1=C(O)C(=O)C(CCCCC)=CC1=O,"3-hydroxy-2-[3-methyl-6-(prop-1-en-2-yl)cyclohex-2-en-1-yl]-5-pentylcyclohexa-2,5-diene-1,4-dione",/,/,,,,Annex IVb,,
,HYDROCODONE (DIHYDROCODEINONE),125-29-1,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3C(=O)CC4,COc1ccc2c3c1O[C@H]1C(=O)CC[C@H]4[C@@H](C2)N(C)CC[C@]314,dihydrocodeinone,Schedule I,1961,,,,Annex Ia,044000,
,HYDROMORPHINOL,2183-56-4,CN1CC[C@]23[C@@H]4[C@H](CC[C@]2([C@H]1CC5=C3C(=C(C=C5)O)O4)O)O,CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)CC[C@@]3(O)[C@H]1C5,14-hydroxydihydromorphine,Schedule I,1961,,,,Annex Ia,045000,
,HYDROMORPHONE,466-99-9,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3C(=O)CC4,CN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@H]3[C@H]1C5,dihydromorphinone,Schedule I,1961,,,,Annex Ia,046000,
8/2/2023,"HYDROXETAMINE (HXE ,3-HO-2'-OXO-PCE)",1620054-73-0,CCNC1(CCCCC1=O)C2=CC(=CC=C2)O,CCNC1(c2cccc(O)c2)CCCCC1=O,2-(ethylamino)-2-(3-hydroxyphenyl)cyclohexan-1-one,/,/,,,,Annex IVb,,
24/4/2024,HYDROXY HHC (HYDROXY HEXAHYDROCANNABINOL),36028-45-2,CCCCCC1=CC(=C2C3CC(CC[C@H]3C(OC2=C1)(C)C)(C)O)O,CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CCC(C)(O)CC21,"(6aR,9R,10aR)-6a,7,8,9,10,10a-hexahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1,9-diol",/,/,,,,Annex IVb,,
,HYDROXYPETHIDINE,468-56-4,CCOC(=O)C1(CCN(CC1)C)C2=CC(=CC=C2)O,CCOC(=O)C1(c2cccc(O)c2)CCN(C)CC1,4-m-hydroxyphenyl-1-methylpiperidine-4-carboxylic acid ethyl ester,Schedule I,1961,,,,Annex Ia,047000,
23/3/2022,HYDROXYPHENCYCLIDINE (HO-PCP),79787-43-2,C1CCC(CC1)(C2=CC(=CC=C2)O)N3CCCCC3,Oc1cccc(C2(N3CCCCC3)CCCCC2)c1,1-(piperidin-1-yl)cyclohexyl]phenol,/,/,,,,Annex IVb,,
6/9/2017,hydroxytolyl mephedrone,,CC(=O)N[C@@H]1[C@H](C[C@](O[C@H]1[C@@H]([C@@H](CO)O)O)(C(=O)O)O)O,CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)O[C@](O)(C(=O)O)C[C@@H]1O,,/,/,,,,Annex IVa - cathinone,,
,IBOGAINE,83-74-9,CC[C@H]1C[C@@H]2C[C@@H]3[C@H]1N(C2)CCC4=C3NC5=C4C=C(C=C5)OC,CC[C@H]1C[C@@H]2C[C@H]3c4[nH]c5ccc(OC)cc5c4CCN(C2)[C@@H]13,"17-ethyl-7-methoxy-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraene",/,/,,,,Annex IVb,807000,
24/4/2024,ISO-HHC (ISO-HEXAHYDROCANNABINOL; DIHYDRO-ISO-TETRAHYDROCANNABINOL),,CC(=O)N[C@@H]1[C@H](C[C@](O[C@H]1[C@@H]([C@@H](CO)O)O)(C(=O)O)O)O,CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)O[C@](O)(C(=O)O)C[C@@H]1O,"(2α,5α,6α)-(-)-3,4,5,6-tetrahydro-2-methyl-5-(1-methylethyl)-9-pentyl-2,6-methano-2H-1-benzoxocin-7-ol",/,/,,,,Annex IVb,,
,ISOMETHADONE,466-40-0,CCC(=O)C(C1=CC=CC=C1)(C2=CC=CC=C2)C(C)CN(C)C,CCC(=O)C(c1ccccc1)(c1ccccc1)C(C)CN(C)C,"6-dimethylamino-5-methyl-4,4-diphenyl-3-hexanone",Schedule I,1961,,,,Annex Ia,048000,
25/11/2015,ISOPENTEDRONE,1429402-11-8,CCCC(=O)C(C1=CC=CC=C1)NC,CCCC(=O)C(NC)c1ccccc1,1-(methylamino)-1-phenylpentan-2-one,/,/,,,,Annex IVb,,
27/12/2021 + 23/03/2022,ISOTONITAZENE,14188-81-9,CCN(CC)CCN1C2=C(C=C(C=C2)[N+](=O)[O-])N=C1CC3=CC=C(C=C3)OC(C)C,CCN(CC)CCn1c(Cc2ccc(OC(C)C)cc2)nc2cc([N+](=O)[O-])ccc21,"N,N-diethyl-2-(2-(4-isopropoxybenzyl)-5-nitro-1Hbenzo[d]imidazol-1-yl)ethan-1-amine",Schedule I,1961,2020/1687,,,Annex Ia,,
6/9/2017,JTE-907,282089-49-0,CCCCCOC1=C(C=CC2=C1NC(=O)C(=C2)C(=O)NCC3=CC4=C(C=C3)OCO4)OC,CCCCCOc1c(OC)ccc2cc(C(=O)NCc3ccc4c(c3)OCO4)c(=O)[nH]c12,"N-(1,3-benzodioxol-5-ylmethyl)-7-methoxy-2-oxo-8-pentoxy-1H-quinoline-3-carboxamide",/,/,,,,Annex IVb,,
26/09/2011 + 25/11/2015,JWH-018 (AM-678),209414-07-3,CCCCCN1C=C(C2=CC=CC=C21)C(=O)C3=CC=CC4=CC=CC=C43,CCCCCn1cc(C(=O)c2cccc3ccccc23)c2ccccc21,Naphthalene-1-yl(1-pentyl-1H-indol-3-yl)methanone,Schedule II,1971,,,,Annex IIb,820000,
6/9/2017,JWH-019,209414-08-4,CCCCCCN1C=C(C2=CC=CC=C21)C(=O)C3=CC=CC4=CC=CC=C43,CCCCCCn1cc(C(=O)c2cccc3ccccc23)c2ccccc21,(1-hexyl-1H-indol-3-yl)(naphthalen-1-yl)methanone,/,/,,,,Annex IVa - synth. cann. 4a,,
26/9/2011,JWH-073,208987-48-8,CCCCN1C=C(C2=CC=CC=C21)C(=O)C3=CC=CC4=CC=CC=C43,CCCCn1cc(C(=O)c2cccc3ccccc23)c2ccccc21,(1-butylindol-3-yl)-naphthalen-1-ylmethanone,/,/,,,,Annex IVa - synth. cann. 4a,810000,
6/9/2017,JWH-081,210179-46-7,CCCCCN1C=C(C2=CC=CC=C21)C(=O)C3=CC=C(C4=CC=CC=C43)OC,CCCCCn1cc(C(=O)c2ccc(OC)c3ccccc23)c2ccccc21,(4-methoxynaphthalen-1-yl)(1-pentyl-1H-indol-3-yl)methanone,/,/,,,,Annex IVa - synth. cann. 4a,,
25/11/2015,JWH-122,619294-47-2,CCCCCN1C=C(C2=CC=CC=C21)C(=O)C3=CC=C(C4=CC=CC=C43)C,CCCCCn1cc(C(=O)c2ccc(C)c3ccccc23)c2ccccc21,3-(4-methylnaphthalene-1-carbonyl)-1-pentyl-1H-indole,/,/,,,,Annex IVa - synth. cann. 4a,,
6/9/2017,"JWH-200 (WIN 55,225)",103610-04-4,C1COCCN1CCN2C=C(C3=CC=CC=C32)C(=O)C4=CC=CC5=CC=CC=C54,O=C(c1cccc2ccccc12)c1cn(CCN2CCOCC2)c2ccccc12,[1-[2-(4-morpholinyl)ethyl]-1H-indol-3-yl]-1-naphthalenyl-methanone,/,/,,,,Annex IVa - synth. cann. 4a,,
26/9/2011,JWH-210,824959-81-1,CCCCCN1C=C(C2=CC=CC=C21)C(=O)C3=CC=C(C4=CC=CC=C43)CC,CCCCCn1cc(C(=O)c2ccc(CC)c3ccccc23)c2ccccc21,(4-ethylnaphthalen-1-yl)-(1-pentylindol-3-yl)methanone,/,/,,,,Annex IVa - synth. cann. 4a,,
26/9/2011,JWH-250,864445-43-2,CCCCCN1C=C(C2=CC=CC=C21)C(=O)CC3=CC=CC=C3OC,CCCCCn1cc(C(=O)Cc2ccccc2OC)c2ccccc21,2-(2-methoxyphenyl)-1-(1-pentylindol-3-yl)ethanone,/,/,,,,Annex IVa - synth. cann. 4a,,
20/3/2013,JWH-307,914458-26-7,CCCCCN1C=C(C=C1C2=CC=CC=C2F)C(=O)C3=CC=CC4=CC=CC=C43,CCCCCn1cc(C(=O)c2cccc3ccccc23)cc1-c1ccccc1F,[5-(2-fluorophenyl)-1-pentylpyrrol-3-yl]-naphthalen-1-ylmethanone,/,/,,,,Annex IVa - synth. cann. 4i,816000,
26/9/2011,JWH-398,1292765-18-4,CCCCCN1C=C(C2=CC=CC=C21)C(=O)C3=CC=C(C4=CC=CC=C43)Cl,CCCCCn1cc(C(=O)c2ccc(Cl)c3ccccc23)c2ccccc21,(4-chloronaphthalen-1-yl)-(1-pentylindol-3-yl)methanone,/,/,,,,Annex IVa - synth. cann. 4a,,
,KETAMINE,6740-88-1,CNC1(CCCCC1=O)C2=CC=CC=C2Cl,CNC1(c2ccccc2Cl)CCCCC1=O,2-(2-chlorophenyl)-2-(methylamino)cyclohexan-1-one,/,/,,,,Annex IVb,804000,
,KETAZOLAM,27223-35-4,CC1=CC(=O)N2CC(=O)N(C3=C(C2(O1)C4=CC=CC=C4)C=C(C=C3)Cl)C,CC1=CC(=O)N2CC(=O)N(C)c3ccc(Cl)cc3C2(c2ccccc2)O1,"11-chloro-8,12b-dihydro-2,8-dimethyl-12b-phenyl-4H-[1,3]oxazino[3,2-d][1,4]benzodiazepin-4,7(6H)-dione",Schedule IV,1971,,,,Annex III,727000,
,KETOBEMIDONE/CETOBEMIDONE,469-79-4,CCC(=O)C1(CCN(CC1)C)C2=CC(=CC=C2)O,CCC(=O)C1(c2cccc(O)c2)CCN(C)CC1,4-m-hydroxyphenyl-1-methyl-4-propionylpiperidine,Schedule I + IV,1961,,,,Annex Ia,018000,
22/10/2006,KHAT (QAT),,CC(=O)N[C@@H]1[C@H](C[C@](O[C@H]1[C@@H]([C@@H](CO)O)O)(C(=O)O)O)O,CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)O[C@](O)(C(=O)O)C[C@@H]1O,delen van de plant ‘Catha edulis’ die cathinone bevatten,/,/,,,,Annex IVb,,
24/4/2024,KRATOM,4098-40-2,CC[C@@H]1CN2CCC3=C([C@@H]2C[C@@H]1/C(=C\OC)/C(=O)OC)NC4=C3C(=CC=C4)OC,CC[C@@H]1CN2CCc3c([nH]c4cccc(OC)c34)[C@@H]2C[C@@H]1/C(=C\OC)C(=O)OC,,/,/,,,,Annex IVb,,
,LEFETAMINE (SPA),7262-75-1,CN(C)[C@H](CC1=CC=CC=C1)C2=CC=CC=C2,CN(C)[C@H](Cc1ccccc1)c1ccccc1,"(–)-N,N-dimethyl-1,2-diphenylethylamine",Schedule IV,1971,,,,Annex III,728000,
,LEVAMFETAMINE,156-34-3,C[C@H](CC1=CC=CC=C1)N,C[C@@H](N)Cc1ccccc1,(–)-(R)-α-methylphenethylamine,Schedule II,1971,,,,Annex IIb,509000,
isomeer van,LEVOACETYLMETHADOL (LAAM),1477-40-3,CC[C@@H](C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2)OC(=O)C,CC[C@H](OC(C)=O)C(C[C@H](C)N(C)C)(c1ccccc1)c1ccccc1,,Schedule I,1961,,,,Annex Ia,,
,LEVOMETAMFETAMINE,33817-09-3,C[C@H](CC1=CC=CC=C1)NC,CN[C@H](C)Cc1ccccc1,"(–)-N,α-dimethylphenethylamine",Schedule II,1971,,,,Annex IIb,510000,
,LEVOMETHORPHAN,125-70-2,CN1CC[C@]23CCCC[C@H]2[C@H]1CC4=C3C=C(C=C4)OC,COc1ccc2c(c1)[C@@]13CCCC[C@H]1[C@@H](C2)N(C)CC3,(-)-3-methoxy-N-methylmorphinan,Schedule I,1961,,,,Annex Ia,049000,
,LEVOMORAMIDE,5666-11-5,C[C@@H](CN1CCOCC1)C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N4CCCC4,C[C@@H](CN1CCOCC1)C(C(=O)N1CCCC1)(c1ccccc1)c1ccccc1,"(-)-4-[2-methyl-4-oxo-3,3-diphenyl-4-(1-pyrrolidinyl)butyl]morpholine",Schedule I,1961,,,,Annex Ia,050000,
,LEVOPHENACYLMORPHAN,10061-32-2,C1CC[C@@]23CCN([C@@H]([C@@H]2C1)CC4=C3C=C(C=C4)O)CC(=O)C5=CC=CC=C5,O=C(CN1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(O)cc13)c1ccccc1,(-)-3-hydroxy-N-phenacylmorphinan,Schedule I,1961,,,,Annex Ia,051000,
,LEVORPHANOL,77-07-6,CN1CC[C@]23CCCC[C@H]2[C@H]1CC4=C3C=C(C=C4)O,CN1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(O)cc13,(-)-3-hydroxy-N-methylmorphinan,Schedule I,1961,,,,Annex Ia,052000,
25/11/2015,LISDEXAMFETAMINE,608137-32-2,C[C@@H](CC1=CC=CC=C1)NC(=O)[C@H](CCCCN)N,C[C@@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN,"2,6-diamino-N-[1-phenylpropan-2-yl]hexanamide",/,/,,,,Annex IVb,815000,
6/9/2017,Lofentanil,60645-00-3,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2C)CCC3=CC=CC=C3)C(=O)OC,CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCc2ccccc2)CC1C,methyl 3-methyl-1-(2-phenylethyl)-4-(N-propanoylanilino)piperidine-4-carboxylate,/,/,,,,Annex IVa - fentanyl 3b,844000,
,LOPRAZOLAM,61197-73-7,CN1CCN(CC1)/C=C\2/C(=O)N3C(=N2)CN=C(C4=C3C=CC(=C4)[N+](=O)[O-])C5=CC=CC=C5Cl,CN1CCN(/C=C2\N=C3CN=C(c4ccccc4Cl)c4cc([N+](=O)[O-])ccc4N3C2=O)CC1,"6-(o-chlorophenyl)-2,4-dihydro-2-[(4-methyl-1-piperazinyl)methylene]-8-nitro-1H-imidazo[1,2-a][1,4]benzodiazepin-1-one",Schedule IV,1971,,,,Annex III,730000,
,LORAZEPAM,846-49-1,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,O=C1Nc2ccc(Cl)cc2C(c2ccccc2Cl)=NC1O,"7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one",Schedule IV,1971,,,,Annex III,731000,
,LORMETAZEPAM,848-75-9,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3Cl,CN1C(=O)C(O)N=C(c2ccccc2Cl)c2cc(Cl)ccc21,"7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-1-methyl-2H-1,4-benzodiazepin-2-one",Schedule IV,1971,,,,Annex III,732000,
8/2/2023,"LSZ (LYSERGIC ACID 2,4-DIMETHYLAZETIDIDE)",470666-31-0,C[C@H]1C[C@@H](N1C(=O)[C@H]2CN([C@@H]3CC4=CNC5=CC=CC(=C45)C3=C2)C)C,C[C@H]1C[C@H](C)N1C(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1,"[(2S,4S)-2,4-Dimethyl-1-azetidinyl][(8β)-6-methyl-9,10-didehydroergolin-8-yl]methanone ",/,/,,,,Annex IVb,,
6/9/2017,LY2183240,874902-19-9,CN(C)C(=O)N1C(=NN=N1)CC2=CC=C(C=C2)C3=CC=CC=C3,CN(C)C(=O)n1nnnc1Cc1ccc(-c2ccccc2)cc1,"N,N-dimethyl-5-[(4-phenylphenyl)methyl]tetrazole-1-carboxamide",/,/,,,,Annex IVb,,
,"LYSERGIDE (+) (LSD, LSD-25)",50-37-3,CCN(CC)C(=O)[C@H]1CN([C@@H]2CC3=CNC4=CC=CC(=C34)C2=C1)C,CCN(CC)C(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1,"9,10-didehydro-N,N-diethyl-6-methylergoline-8β-carboxamide",Schedule I,1971,,,,Annex IIa,408000,
6/9/2017,M α PPP (4'-Methyl-α-pyrrolidinopropiophenone),,CC(=O)N[C@@H]1[C@H](C[C@](O[C@H]1[C@@H]([C@@H](CO)O)O)(C(=O)O)O)O,CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)O[C@](O)(C(=O)O)C[C@@H]1O,1-(4-methylphenyl)-2-(pyrrolidin-1-yl)propan-1-one,/,/,,,,Annex IVb,,
25/11/2015,MAB-CHMINACA,1185887-13-1,CC(C)(C)[C@@H](C(=O)N)NC(=O)C1=NN(C2=CC=CC=C21)CC3CCCCC3,CC(C)(C)[C@H](NC(=O)c1nn(CC2CCCCC2)c2ccccc12)C(N)=O,"2-{[1-(cyclohexylmethyl)-1H-indazol-3-yl]formamido}-3,3-dimethylbutanamide",/,/,,,,Annex IVa - synth. cann. 4e,,
26/9/2011,M-ALPHA,127292-43-7,CCC(C1=CC2=C(C=C1)OCO2)NC,CCC(NC)c1ccc2c(c1)OCO2,"[1-(2H-1,3-benzodioxol-5-yl)propyl](methyl)amine ",/,/,,,,Annex IVb,,
25/11/2015,MAM-2201,1354631-24-5,CC1=CC=C(C2=CC=CC=C12)C(=O)C3=CN(C4=CC=CC=C43)CCCCCF,Cc1ccc(C(=O)c2cn(CCCCCF)c3ccccc23)c2ccccc12,1-(5-fluoropentyl)-3-(4-methylnaphthalene-1-carbonyl)-1H-indole,/,/,,,,Annex IVa - synth. cann. 4a,,
,MAZINDOL,22232-71-9,C1CN2C(=N1)C3=CC=CC=C3C2(C4=CC=C(C=C4)Cl)O,OC1(c2ccc(Cl)cc2)c2ccccc2C2=NCCN21,"5-(p-chlorophenyl)-2,5-dihydro-3H-imidazo[2,1-a]isoindol-5-ol",Schedule IV,1971,,,,Annex III,733000,
,MBDB,103818-46-8,CCC(CC1=CC2=C(C=C1)OCO2)NC,CCC(Cc1ccc2c(c1)OCO2)NC,"1-(1,3-benzodioxol-5-yl)-N-methylbutan-2-amine",/,/,,,,Annex IVa - amfetamine,,
22/10/2006,m-CHLOROPHENYLPIPERAZINE (mCPP),6640-24-0,C1CN(CCN1)C2=CC(=CC=C2)Cl,Clc1cccc(N2CCNCC2)c1,1-(3-chlorophenyl)piperazine,/,/,,,,Annex IVa - piperazine 6b,809000,
,"MDMA (XTC) (3,4-MethyleneDioxyMethAmphetamine)",42542-10-9,CC(CC1=CC2=C(C=C1)OCO2)NC,CNC(C)Cc1ccc2c(c1)OCO2,"(±)-N,α-dimethyl-3,4-(methylenedioxy)phenethylamine",Schedule I,1971,,,,Annex IIa,409000,
23/3/2022,MDMB-4EN-PINACA,2504100-70-1,CC(C)(C)[C@@H](C(=O)OC)NC(=O)C1=NN(C2=CC=CC=C21)CCCC=C,C=CCCCn1nc(C(=O)N[C@H](C(=O)OC)C(C)(C)C)c2ccccc21,"methyl 3,3-dimethyl-2-[1-(pent-4-en-1-yl)-1H-indazole-3-carboxamido]butanoate",Schedule II,1971,2021/802,,,Annex IIb,,
06/09/2017 + 09/12/2019,MDMB-CHMICA,?,,,Methyl N-{[1-(cyclohexylmethyl)-1H-indol-3-yl]carbonyl}-3-methyl-L-valinate ,Schedule II,1971,2017/369,,,Annex IIb,,
6/9/2017,"MDPHP (3,4-Methylenedioxy-α-Pyrrolidinohexanophenone)",776994-64-0,CCCCC(C(=O)C1=CC2=C(C=C1)OCO2)N3CCCC3,CCCCC(C(=O)c1ccc2c(c1)OCO2)N1CCCC1,,/,/,,,,Annex IVa - cathinone,,
20/03/2013 + 25/11/2015,"MDPV (3,4-METHYLENEDIOXYPYROVALERONE)",687603-66-3,CCCC(C(=O)C1=CC2=C(C=C1)OCO2)N3CCCC3,CCCC(C(=O)c1ccc2c(c1)OCO2)N1CCCC1,"(RS)-1-(Benzo[d][1,3]dioxol-5-yl)-2-(pyrrolidin-1-yl)pentan-1-one",Schedule II,1971,2014/688/EU + 2015/1875,,,Annex IIb,821000,
,MECLOQUALONE,340-57-8,CC1=NC2=CC=CC=C2C(=O)N1C3=CC=CC=C3Cl,Cc1nc2ccccc2c(=O)n1-c1ccccc1Cl,3-(o-chlorophenyl)-2-methyl-4(3H)-quinazolinone,Schedule II,1971,,,,Annex IIb,503000,
,MEDAZEPAM,2898-12-6,CN1CCN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,CN1CCN=C(c2ccccc2)c2cc(Cl)ccc21,"7-chloro-2,3-dihydro-1-methyl-5-phenyl-1H-1,4-benzodiazepine",Schedule IV,1971,,,,Annex III,734000,
16/11/1999 + 25/11/2015,MEFENOREX,17243-57-1,CC(CC1=CC=CC=C1)NCCCCl,CC(Cc1ccccc1)NCCCCl,N-(3-chloropropyl)-α-methylphenethylamine,Schedule IV,1971,,,,Annex IIb,735000,
6/9/2017,MEO-PCE,1364933-80-1,CCNC1(CCCCC1)C2=CC(=CC=C2)OC,CCNC1(c2cccc(OC)c2)CCCCC1,N-ethyl-1-(methoxyphenyl)cyclohexan-1-amine,/,/,,,,Annex IVb,,
6/9/2017,MEO-PCP (Methoxyphencyclidine),91164-58-8,COC1=CC=CC(=C1)C2(CCCCC2)N3CCCCC3.Cl,COc1cccc(C2(N3CCCCC3)CCCCC2)c1.Cl,1-[1-(methoxyphenyl)cyclohexyl]piperidine,/,/,,,,Annex IVb,,
8/2/2023,Me-PCP,2201-30-1,CC1=CC(=CC=C1)C2(CCCCC2)N3CCCCC3,Cc1cccc(C2(N3CCCCC3)CCCCC2)c1,1-[1-(methylphenyl)cyclohexyl]piperidine,/,/,,,,Annex IVb,,
8/2/2023,Me-PCPy,1622348-63-3,CC1=CC(=CC=C1)C2(CCCCC2)N3CCCC3,Cc1cccc(C2(N3CCCC3)CCCCC2)c1,1-[1-(methylphenyl)cyclohexyl]pyrrolidine,/,/,,,,Annex IVb,,
13/06/2010 + 25/11/2015,MEPHEDRONE (4-METHYLMETHCATHINONE),1189805-46-6,CC1=CC=C(C=C1)C(=O)C(C)NC,CNC(C)C(=O)c1ccc(C)cc1,(RS)-2-methylamino-1-(4-methylphenyl)propan-1-one,Schedule II,1971,2010/759/EU,,,Annex IIb,817000,
,MEPROBAMATE,57-53-4,CCCC(C)(COC(=O)N)COC(=O)N,CCCC(C)(COC(N)=O)COC(N)=O,"2-methyl-2-propyl-1,3-propanedioldicarbamate",Schedule IV,1971,,,,Annex III,736000,
,MESCALINE,54-04-6,COC1=CC(=CC(=C1OC)OC)CCN,COc1cc(CCN)cc(OC)c1OC,"3,4,5-trimethoxyphenethylamine",Schedule I,1971,,,,Annex IIa,410000,
,MESOCARB,34262-84-5,CC(CC1=CC=CC=C1)[N+]2=NOC(=C2)/N=C(/NC3=CC=CC=C3)\[O-],CC(Cc1ccccc1)[n+]1cc(/N=C(\[O-])Nc2ccccc2)on1,3-(α-methylphenethyl)-N-(phenylcarbamoyl)sydnone imine,Schedule IV,1971,,,,Annex III,760000,
25/11/2015,METACETIN (4-AcO-MET),246-87-2,,,3-{2-[ethyl(methyl)amino]ethyl}-1H-indol-4-yl acetate,/,/,,,,Annex IVa - tryptamine,,
,METAMFETAMINE,537-46-2,C[C@@H](CC1=CC=CC=C1)NC,CN[C@@H](C)Cc1ccccc1,"(+)-(S)-N,α-dimethylphenethylamine",Schedule II,1971,,,,Annex IIb,504000,
,METAMFETAMINE RACEMATE,7632-10-2,CC(CC1=CC=CC=C1)NC,CNC(C)Cc1ccccc1,"(±)-N,α-dimethylphenethylamine",Schedule II,1971,,,,Annex IIb,513000,
,METAZOCINE,3734-52-9,C[C@H]1[C@H]2CC3=C([C@@]1(CCN2C)C)C=C(C=C3)O,C[C@H]1[C@H]2Cc3ccc(O)cc3[C@]1(C)CCN2C,"2-hydroxy-2,5,9-trimethyl-6,7-benzomorphan",Schedule I,1961,,,,Annex Ia,053000,
,METHADONE,76-99-3,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,CCC(=O)C(CC(C)N(C)C)(c1ccccc1)c1ccccc1,"6-dimethylamino-4,4-diphenyl-3-heptanone",Schedule I,1961,,,,Annex Ia,054000,
,METHADONE INTERMEDIATE,125-79-1,CC(CC(C#N)(C1=CC=CC=C1)C2=CC=CC=C2)N(C)C,CC(CC(C#N)(c1ccccc1)c1ccccc1)N(C)C,"4-cyano-2-dimethylamino-4,4-diphenylbutane",Schedule I,1961,,,,Annex Ia,055000,
,METHAQUALONE,72-44-6,CC1=CC=CC=C1N2C(=NC3=CC=CC=C3C2=O)C,Cc1ccccc1-n1c(C)nc2ccccc2c1=O,2-methyl-3-o-tolyl-4(3H)-quinazolinone,Schedule II,1971,,,,Annex IIb,505000,
,METHCATHINONE,5650-44-2,CC(C(=O)C1=CC=CC=C1)NC,CNC(C)C(=O)c1ccccc1,2-(methylamino)-1-phenylpropan-1-one,Schedule I,1971,,,,Annex IIa,426000,
26/9/2011,METHEDRONE (bk-PMMA),530-54-1,CC(C(=O)C1=CC=C(C=C1)OC)NC,CNC(C)C(=O)c1ccc(OC)cc1,1-(4-methoxyphenyl)-2-(methylamino)propan-1-one,/,/,,,,Annex IVa - cathinone,,
25/11/2015 + 09/12/2019,METHIOPROPAMINE (MPA),801156-47-8,CC(CC1=CC=CS1)NC,CNC(C)Cc1cccs1,N-methyl-1-(2-thienyl)-2-propanamine,Schedule II,1971,,,,Annex IIb,,
25/11/2015,METHOXETAMINE (MXE),1239943-76-0,CCNC1(CCCCC1=O)C2=CC(=CC=C2)OC,CCNC1(c2cccc(OC)c2)CCCCC1=O,2-(ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one ,Schedule II,1971,2014/688/EU + 2015/1875,,,Annex IIb,,
25/11/2015,METHOXPHENIDINE (MXP),127529-46-8,COC1=CC=CC=C1C(CC2=CC=CC=C2)N3CCCCC3,COc1ccccc1C(Cc1ccccc1)N1CCCCC1,1-[1-(2-methoxyphenyl)-2-phenylethyl]piperidine,/,/,,,,Annex IVb,,
23/3/2022,"METHOXPROPAMINE (MXPR, 2-OXO-3’-METHOXY-PCPR)",2504100-71-2,CCCNC1(CCCCC1=O)C2=CC(=CC=C2)OC,CCCNC1(c2cccc(OC)c2)CCCCC1=O,2-(3-methoxyphenyl)-2-(propylamino)cyclohexan-1-one,/,/,,,,Annex IVb,,
06/09/2017 + 09/12/2019,METHOXYACETYLFENTANYL,101345-67-9,COCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,COCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide,Schedule I,1961,2018/1463,,,Annex Ia,,
,METHYL-4 AMINOREX,3568-94-3,CC1C(OC(=N1)N)C2=CC=CC=C2,CC1N=C(N)OC1c1ccccc1,(±)-cis-2-amino-4-methyl-5-phenyl-2-oxazoline,Schedule I,1971,,,,Annex IIa,411000,
,METHYLDESORPHINE,16008-36-9,CC1=CC[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)O)CCN3C,CC1=CC[C@H]2[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3C)[C@H]1O5,6-methyl-Δ6-deoxymorphine,Schedule I,1961,,,,Annex Ia,056000,
,METHYLDIHYDROMORPHINE,509-56-8,C[C@@]1(CC[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)O)CCN3C)O,CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@](C)(O)CC[C@H]3[C@H]1C5,6-methyldihydromorphine,Schedule I,1961,,,,Annex Ia,057000,
25/11/2015,METHYLHEXANAMINE (DIMETHYLAMYLAMINE),105-41-9 ,CCC(C)CC(C)N,CCC(C)CC(C)N,4-methylhexan-2-amine,/,/,,,,Annex IVb,,
27/12/2021,METHYLISOPROPYLLYSERGAMIDE (MIPLA),,CC(=O)N[C@@H]1[C@H](C[C@](O[C@H]1[C@@H]([C@@H](CO)O)O)(C(=O)O)O)O,CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)O[C@](O)(C(=O)O)C[C@@H]1O,"(8β)-9,10-didehydro-N,6-dimethyl-N-(1-methylethyl)-ergoline-8-carboxamide",/,/,,,,Annex IVb,,
25/11/2015,METHYLONE (bk-MDMA),186028-79-5,CC(C(=O)C1=CC2=C(C=C1)OCO2)NC,CNC(C)C(=O)c1ccc2c(c1)OCO2,"(RS)- 2-methylamino-1-(3,4-methylenedioxyphenyl)propan-1-one",Schedule II,1971,,,,Annex IIb,516000,
,METHYLPHENIDATE,113-45-1,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,COC(=O)C(c1ccccc1)C1CCCCN1,methyl α-phenyl-2-piperidine acetate,Schedule II,1971,,,,Annex IIb,506000,
,METHYLPHENOBARBITAL,115-38-8,CCC1(C(=O)NC(=O)N(C1=O)C)C2=CC=CC=C2,CCC1(c2ccccc2)C(=O)NC(=O)N(C)C1=O,5-ethyl-1-methyl-5-phenylbarbituric acid,Schedule IV,1971,,,,Annex III,737000,
,METHYPRYLON,125-64-4,CCC1(C(=O)C(CNC1=O)C)CC,CCC1(CC)C(=O)NCC(C)C1=O,"3,3-diethyl-5-methyl-2,4-piperidine-dione",Schedule IV,1971,,,,Annex III,738000,
23/3/2022,METIZOLAM (DESMETHYLETIZOLAM),40054-68-0,CCC1=CC2=C(S1)N3C=NN=C3CN=C2C4=CC=CC=C4Cl,CCc1cc2c(s1)-n1cnnc1CN=C2c1ccccc1Cl,"4-(2-Chlorophenyl)-2-ethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine",/,/,,,,Annex IVb,,
25/11/2015,"METOCIN (4-HO-MET, 4-HYDROXY-MET)",77872-41-4,CCN(C)CCC1=CNC2=C1C(=CC=C2)O,CCN(C)CCc1c[nH]c2cccc(O)c12,3-{2-[ethyl(methyl)amino]ethyl}-1H-indol-4-ol,/,/,,,,Annex IVa - tryptamine,,
27/12/2021,METODESNITAZENE,28117-80-8,CC1=CC=C(C=C1)C(=O)C(C)N2CCCC2,Cc1ccc(C(=O)C(C)N2CCCC2)cc1,"N,N-diethyl-2-[2-[(4-methoxyphenyl)methyl]benzimidazol-1-yl]ethanamine",/,/,,,,Annex IVb,,
27/12/2021 + 8/02/2023 + 24/04/2024,METONITAZENE,14680-51-4,CCN(CC)CCN1C2=C(C=C(C=C2)[N+](=O)[O-])N=C1CC3=CC=C(C=C3)OC,CCN(CC)CCn1c(Cc2ccc(OC)cc2)nc2cc([N+](=O)[O-])ccc21,"N,N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1H-benzo[d]imidazol-1-yl)ethan-1-amine",Schedule I,1961,,,,Annex Ia,,
,METOPON,143-52-2,C[C@]12C(=O)CC[C@@H]3[C@]14CCN([C@@H]3CC5=C4C(=C(C=C5)O)O2)C,CN1CC[C@]23c4c5ccc(O)c4O[C@@]2(C)C(=O)CC[C@H]3[C@H]1C5,5-methyldihydromorphinone,Schedule I,1961,,,,Annex Ia,058000,
,MIDAZOLAM,59467-70-8,CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F,Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2,"8-chloro-6-(o-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine",Schedule IV,1971,,,,Annex III,739000,
24/4/2024,MITRAGYNINE,4098-40-2,CC[C@@H]1CN2CCC3=C([C@@H]2C[C@@H]1/C(=C\OC)/C(=O)OC)NC4=C3C(=CC=C4)OC,CC[C@@H]1CN2CCc3c([nH]c4cccc(OC)c34)[C@@H]2C[C@@H]1/C(=C\OC)C(=O)OC,"methyl (E)-2-[(2S,3S,12bS)-3-ethyl-8-methoxy-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl]-3-methoxyprop-2-enoate",/,/,,,,Annex IVb,,
25/11/2015,MMB-2201,,CC(=O)N[C@@H]1[C@H](C[C@](O[C@H]1[C@@H]([C@@H](CO)O)O)(C(=O)O)O)O,CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)O[C@](O)(C(=O)O)C[C@@H]1O,methyl-2-{[1-(5-fluoropentyl)-1H-indol-3-yl]formamido}-3-methylbutanoate,/,/,,,,Annex IVa - synth. cann. 4d,,
,MMDA,13674-05-0,CC(CC1=CC2=C(C(=C1)OC)OCO2)N,COc1cc(CC(C)N)cc2c1OCO2,"5-methoxy-α-methyl-3,4-(methylenedioxy)phenethylamine",Schedule I,1971,,,,Annex IIa,412000,
6/9/2017,MO-CHMINACA (MO-AMB),,CC(=O)N[C@@H]1[C@H](C[C@](O[C@H]1[C@@H]([C@@H](CO)O)O)(C(=O)O)O)O,CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)O[C@](O)(C(=O)O)C[C@@H]1O,"1-methoxy-3,3-dimethyl-1-oxobutan-2-yl 1-(cyclohexylmethyl)-1H-indazole-3-carboxylate",/,/,,,,Annex IVa - synth. cann. 4a,,
,MORAMIDE INTERMEDIATE,3626-55-9,CC(CN1CCOCC1)C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)O,CC(CN1CCOCC1)C(C(=O)O)(c1ccccc1)c1ccccc1,"2-methyl-3-morpholino-1,1-diphenylpropane carboxylic acid",Schedule I,1961,,,,Annex Ia,059000,
,MORPHERIDINE,469-81-8,CCOC(=O)C1(CCN(CC1)CCN2CCOCC2)C3=CC=CC=C3,CCOC(=O)C1(c2ccccc2)CCN(CCN2CCOCC2)CC1,1-(2-morpholinoethyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester,Schedule I,1961,,,,Annex Ia,060000,
,MORPHINE,57-27-2,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O,CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5,"(4R,4aR,7S,7aR,12bS)-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9-diol",Schedule I,1961,,,,Annex Ia,061000,
,MORPHINE METHOBROMIDE,125-23-5,C[N+]1(CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O)C.[Br-],C[N+]1(C)CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5.[Br-],"(5α,6α)-17-Methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol - bromomethane",Schedule I,1961,,,,Annex Ia,,
,MORPHINE-N-OXIDE/N-OXYMORPHINE,639-46-3,C[N+]1(CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O)[O-],C[N+]1([O-])CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5,"(4R,4aR,7S,7aR,12bS)-3-methyl-3-oxido-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-3-ium-7,9-diol",Schedule I,1961,,,,Annex Ia,063000,
26/9/2011,MPPP (4'-METHYL-ALPHA-PYRROLIDINOPROPIOPHENONE),28117-80-8,CC1=CC=C(C=C1)C(=O)C(C)N2CCCC2,Cc1ccc(C(=O)C(C)N2CCCC2)cc1,1-(4-methylphenyl)-2-(pyrrolidin-1-yl)propan-1-one,/,/,,,,Annex IVa - cathinone,,
21/12/1988,MPPP (DESMETHYLPRODINE),13147-09-6,CCC(=O)OC1(CCN(CC1)C)C2=CC=CC=C2,CCC(=O)OC1(c2ccccc2)CCN(C)CC1,1-methyl-4-phenyl-4-piperidinol propionate,Schedule I + IV,1961,,,,Annex Ia,,
25/11/2015,MT-45,41537-67-1,C1CCC(CC1)N2CCN(CC2)C(CC3=CC=CC=C3)C4=CC=CC=C4,c1ccc(CC(c2ccccc2)N2CCN(C3CCCCC3)CC2)cc1,"1-cyclohexyl-4-(1,2-diphenylethyl)piperazine",Schedule I ,1961,2015/1873,,,Annex Ia,,
,MYROPHINE (myristylbenzylmorphine),467-18-5,CCCCCCCCCCCCCC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OCC6=CC=CC=C6)CCN3C,CCCCCCCCCCCCCC(=O)O[C@H]1C=C[C@H]2[C@H]3Cc4ccc(OCc5ccccc5)c5c4[C@@]2(CCN3C)[C@H]1O5,Myristylbenzylmorphine,Schedule I,1961,,,,Annex Ia,064000,
6/9/2017,N-(1-BENZYLPIPERIDIN-4-YL)-N-PHENYLACETAMIDE,1237-52-1,CC(=O)N(C1CCN(CC1)CC2=CC=CC=C2)C3=CC=CC=C3,CC(=O)N(c1ccccc1)C1CCN(Cc2ccccc2)CC1,N-(1-Benzylpiperidin-4-yl)-N-phenylacetamide ,/,/,,,,Annex IVa - fentanyl 3b,,
25/11/2015,"N,N-DIISOPROPYLTRYPTAMINE (DiPT)",14780-24-6,CC(C)N(CCC1=CNC2=CC=CC=C21)C(C)C,CC(C)N(CCc1c[nH]c2ccccc12)C(C)C,[2-(1H-indol-3-yl)ethyl]bis(propan-2-yl)amine,/,/,,,,Annex IVa - tryptamine,,
26/09/2011 + 25/11/2015,NALBUPHINE,20594-83-6,C1CC(C1)CN2CC[C@]34[C@@H]5[C@H](CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O)O,Oc1ccc2c3c1O[C@H]1[C@@H](O)CC[C@@]4(O)[C@@H](C2)N(CC2CCC2)CC[C@]314,"3-(cyclobutylmethyl)-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,7,9-triol",/,/,,,,Annex IVb,822000,
,"N-ETHYL MDA (MDE, MDEA)",82801-81-8,CCNC(C)CC1=CC2=C(C=C1)OCO2,CCNC(C)Cc1ccc2c(c1)OCO2,"(±)-N-ethyl-α-methyl-3,4-(methylenedioxy)phenethylamine",Schedule I,1971,,,,Annex IIa,413000,
25/11/2015,N-ETHYLBUPHEDRONE (NEB),1354631-28-9,CCC(C(=O)C1=CC=CC=C1)NCC,CCNC(CC)C(=O)c1ccccc1,2-(ethylamino)-1-phenylbutan-1-one,/,/,,,,Annex IVa - cathinone,,
06/09/2017 + 27/12/2021,N-ETHYLHEXEDRONE ,802857-66-5,CCCCC(C(=O)C1=CC=CC=C1)NCC,CCCCC(NCC)C(=O)c1ccccc1,2-(Ethylamino)-1-phenyl-1-hexanone,Schedule II,1971,,,,Annex IIb,,
06/09/2017 + 09/12/2019,N-ETHYLNORPENTYLONE (EPHYLONE),952016-47-6,CCCC(CC1=CC2=C(C=C1)OCO2)NCC,CCCC(Cc1ccc2c(c1)OCO2)NCC,"1-(2H-1,3-benzodioxol-5-yl)-2-(ethylamino)pentan-1-one",Schedule II,1971,,,,Annex IIb,,
,N-HYDROXY MDA,74698-47-8,CC(CC1=CC2=C(C=C1)OCO2)NO,CC(Cc1ccc2c(c1)OCO2)NO,"(±)-N[α-methyl-3,4-(methylenedioxy)phenethyl]hydroxylamine",Schedule I,1971,,,,Annex IIa,414000,
,NICOCODINE (NICOCODEINE),3688-66-2,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)OC(=O)C6=CN=CC=C6,COc1ccc2c3c1O[C@H]1[C@@H](OC(=O)c4cccnc4)C=C[C@H]4[C@@H](C2)N(C)CC[C@@]341,6-nicotinylcodeine,Schedule II,1961,,,,Annex Ib,206000,
26/9/2011,NICODICODINE (NICODICODEINE),808-24-2,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](CC4)OC(=O)C6=CN=CC=C6,COc1ccc2c3c1O[C@H]1[C@@H](OC(=O)c4cccnc4)CC[C@H]4[C@@H](C2)N(C)CC[C@@]341,6-nicotinyldihydrocodeine,Schedule II,1961,,,,Annex Ib,207000,
,NICOMORPHINE,639-48-5,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC(=O)C6=CN=CC=C6)O[C@H]3[C@H](C=C4)OC(=O)C7=CN=CC=C7,CN1CC[C@]23c4c5ccc(OC(=O)c6cccnc6)c4O[C@H]2[C@@H](OC(=O)c2cccnc2)C=C[C@H]3[C@H]1C5,"3,6-dinicotinylmorphine",Schedule I,1961,,,,Annex Ia,065000,
,NIMETAZEPAM,2011-67-8,CN1C(=O)CN=C(C2=C1C=CC(=C2)[N+](=O)[O-])C3=CC=CC=C3,CN1C(=O)CN=C(c2ccccc2)c2cc([N+](=O)[O-])ccc21,"1,3-dihydro-1-methyl-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-one",Schedule IV,1971,,,,Annex III,740000,
,NITRAZEPAM,146-22-5,C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3,O=C1CN=C(c2ccccc2)c2cc([N+](=O)[O-])ccc2N1,"1,3-dihydro-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-one",Schedule IV,1971,,,,Annex III,741000,
8/2/2023,NM-2AI (N-METHYL-2-AMINOINDANE),24445-44-1,CNC1CC2=CC=CC=C2C1,CNC1Cc2ccccc2C1,"N-methyl-2,3-dihydro-1H-inden-2-amine",/,/,,,,Annex IVb,,
,NORACYMETHADOL,1477-39-0,CCC(C(CC(C)NC)(C1=CC=CC=C1)C2=CC=CC=C2)OC(=O)C,CCC(OC(C)=O)C(CC(C)NC)(c1ccccc1)c1ccccc1,"(±)-α-3-acetoxy-6-methylamino-4,4-diphenylheptane",Schedule I,1961,,,,Annex Ia,066000,
,NORCODEINE,467-15-2,COC1=C2C3=C(C[C@@H]4[C@H]5[C@]3(CCN4)[C@@H](O2)[C@H](C=C5)O)C=C1,COc1ccc2c3c1O[C@H]1[C@@H](O)C=C[C@H]4[C@@H](C2)NCC[C@@]341,N-demethylcodeine,Schedule II,1961,,,,Annex Ib,208000,
,NORDAZEPAM,1088-11-5,C1C(=O)NC2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3,O=C1CN=C(c2ccccc2)c2cc(Cl)ccc2N1,"7-chloro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one",Schedule IV,1971,,,,Annex III,742000,
24/4/2024,"NORFLUDIAZEPAM (NORFLURAZEPAM, DESALKYLFLURAZEPAM)",2886-65-9,C1C(=O)NC2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3F,O=C1CN=C(c2ccccc2F)c2cc(Cl)ccc2N1,"7-chloro-5-(2-fluorophenyl)-1,3-dihydro-1,4-benzodiazepin-2-one",/,/,,,,Annex IVb,,
,NORLEVORPHANOL,1531-12-0,C1CC[C@@]23CCN[C@@H]([C@@H]2C1)CC4=C3C=C(C=C4)O,Oc1ccc2c(c1)[C@@]13CCCC[C@H]1[C@@H](C2)NCC3,(-)-3-hydroxymorphinan,Schedule I,1961,,,,Annex Ia,067000,
,NORMETHADONE,467-85-6,CCC(=O)C(CCN(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,CCC(=O)C(CCN(C)C)(c1ccccc1)c1ccccc1,"6-dimethylamino-4,4-diphenyl-3-hexanone",Schedule I,1961,,,,Annex Ia,068000,
,NORMORPHINE,466-97-7,C1CN[C@@H]2CC3=C4[C@@]15[C@H]2C=C[C@@H]([C@@H]5OC4=C(C=C3)O)O,Oc1ccc2c3c1O[C@H]1[C@@H](O)C=C[C@H]4[C@@H](C2)NCC[C@@]341,demethylmorphine,Schedule I,1961,,,,Annex Ia,069000,
10/4/1964,NORPIPANONE,561-48-8,CCC(=O)C(CCN1CCCCC1)(C2=CC=CC=C2)C3=CC=CC=C3,CCC(=O)C(CCN1CCCCC1)(c1ccccc1)c1ccccc1,"4,4-diphenyl-6-piperidino-3-hexanone",Schedule I,1961,,,,Annex Ia,070000,
,N-OXYCODEINE (CODEINE-N-OXIDE),3688-65-1,C[N+]1(CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O)[O-],COc1ccc2c3c1O[C@H]1[C@@H](O)C=C[C@H]4[C@@H](C2)[N+](C)([O-])CC[C@@]341,"(1S,4S,5R,13R,14S,17R)-14-hydroxy-10-methoxy-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0¹,¹³.0⁵,¹⁷.0⁷,¹⁸]octadeca-7,9,11(18),15-tetraen-4-ium-4-olate",Schedule I (ether Morphine-N-oxide)),1961,,,,Annex Ia,062000,
25/11/2015 + 09/12/2019,OCFENTANIL,101343-69-5,COCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3F,COCC(=O)N(c1ccccc1F)C1CCN(CCc2ccccc2)CC1,N-(2-fluorophenyl)-2-methoxy-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide,Schedule I,1961,,,,Annex Ia,,
22/10/2006,o-CHLOROPHENYLPIPERAZINE (oCPP),39512-50-0,C1CN(CCN1)C2=CC=CC=C2Cl,Clc1ccccc1N1CCNCC1,1-(2-chlorophenyl)piperazine,/,/,,,,Annex IVa - piperazine 6b,823000,
6/9/2017,O-DESMETHYLTRAMADOL,80456-81-1,CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)O)O,CN(C)C[C@H]1CCCC[C@]1(O)c1cccc(O)c1,3-{2-[(dimethylamino)methyl]-1-hydroxycyclohexyl}phenol,/,/,,,,Annex IVb,825000,
8/2/2023,O-PCE (ETICYCLIDONE),4551-92-2,CCNC1(CCCCC1=O)C2=CC=CC=C2.Cl,CCNC1(c2ccccc2)CCCCC1=O.Cl,2-(Ethylamino)-2-phenylcyclohexan-1-one,/,/,,,,Annex IVb,,
,OPIUM,8008-60-4,,,,Schedule I,1961,,,,Annex Ia,071000,10% bereidingen + 171 000
26/9/2011,ORIPAVINE,467-04-9,CN1CC[C@]23[C@@H]4C(=CC=C2[C@H]1CC5=C3C(=C(C=C5)O)O4)OC,COC1=CC=C2[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3C)[C@H]1O5,3-O-demethylthebaine,Schedule I,1961,,,,Annex Ia,085000,
06/09/2017 + 09/12/2019,ORTHOFLUOROFENTANYL,910616-29-4,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3F,CCC(=O)N(c1ccccc1F)C1CCN(CCc2ccccc2)CC1,N-(2-fluorophenyl)-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide,Schedule I,1961,,,,Annex Ia,,
,OXAZEPAM,604-75-1,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O,O=C1Nc2ccc(Cl)cc2C(c2ccccc2)=NC1O,"7-chloro-1,3-dihydro-3-hydroxy-5-phenyl-2H-1,4-benzodiazepin-2-one",Schedule IV ,1971,,,,Annex III,743000,
,OXAZOLAM,24143-17-7,CC1CN2CC(=O)NC3=C(C2(O1)C4=CC=CC=C4)C=C(C=C3)Cl,CC1CN2CC(=O)Nc3ccc(Cl)cc3C2(c2ccccc2)O1,"10-chloro-2,3,7,11b-tetrahydro-2-methyl-11bphenyloxazolo[3,2-d][1,4]benzodiazepin-6(5H)-one",Schedule IV ,1971,,,,Annex III,744000,
,OXYCODONE,76-42-6,CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O,COc1ccc2c3c1O[C@H]1C(=O)CC[C@@]4(O)[C@@H](C2)N(C)CC[C@]314,14-hydroxydihydrocodeinone,Schedule I,1961,,,,Annex Ia,072000,
,OXYMORPHONE,76-41-5,CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)O)O4)O,CN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5,14-hydroxydihydromorphinone,Schedule I,1961,,,,Annex Ia,073000,
24/4/2024,PAGOCLONE,133737-32-3,CC(C)CCC(=O)CC1C2=CC=CC=C2C(=O)N1C3=NC4=C(C=C3)C=CC(=N4)Cl,CC(C)CCC(=O)CC1c2ccccc2C(=O)N1c1ccc2ccc(Cl)nc2n1,"2-(7-Chloro-1,8-naphthyridin-2-yl)-3-(5-methyl-2-oxohexyl)-1-isoindolinone",/,/,,,,Annex IVb,,
06/09/2017 + 09/12/2019,PARAFLUOROBUTYRYLFENTANYL,244195-31-1,CCCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=C(C=C3)F,CCCC(=O)N(c1ccc(F)cc1)C1CCN(CCc2ccccc2)CC1,N-(4-fluorophenyl)-N-[1-(2-phenylethyl)piperidin-4-yl]butanamide,Schedule I,1961,,,,Annex Ia,,
26/9/2011,PARA-FLUOROFENTANYL ,90736-23-5,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=C(C=C3)F,CCC(=O)N(c1ccc(F)cc1)C1CCN(CCc2ccccc2)CC1,4’-fluoro-N-(1-phenethyl-4-piperidyl)propionanilide,Schedule I + IV,1961,,,,Annex Ia,097000,
,PARAHEXYL,117-51-1,CCCCCCC1=CC(=C2C3=C(CCC(C3)C)C(OC2=C1)(C)C)O,CCCCCCc1cc(O)c2c(c1)OC(C)(C)C1=C2CC(C)CC1,"3-hexyl-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran-1-ol",Schedule I,1971,,,,Annex IIa,415000,
6/9/2017,Para-Methoxy-N-Ethylamphetamine (PMEA),14367-46-5,CCNC(C)CC1=CC=C(C=C1)OC,CCNC(C)Cc1ccc(OC)cc1,N-ethyl-1-(4-methoxyphenyl)propan-2-amine,/,/,,,,Annex IVa - amfetamine,826000,
22/10/2006,p-CHLOROPHENYLPIPERAZINE (pCPP),38212-33-8,C1CN(CCN1)C2=CC=C(C=C2)Cl,Clc1ccc(N2CCNCC2)cc1,1-(4-chlorophenyl)piperazine,/,/,,,,Annex IVa - piperazine 6b,824000,
,PEMOLINE,2152-34-3,C1=CC=C(C=C1)C2C(=O)N=C(O2)N,NC1=NC(=O)C(c2ccccc2)O1,2-amino-5-phenyl-2-oxazolin-4-one,Schedule IV,1971,,,,Annex III,745000,
,PENTAZOCINE,55643-30-6,CC1C2CC3=C(C1(CCN2CC=C(C)C)C)C=C(C=C3)O,CC(C)=CCN1CCC2(C)c3cc(O)ccc3CC1C2C,"(2R*,6R*,11R*)-1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol",Schedule III,1971,,,,Annex III,606000,
25/11/2015 + 09/12/2019,PENTEDRONE,879722-57-3,CCCC(C(=O)C1=CC=CC=C1)NC,CCCC(NC)C(=O)c1ccccc1,2-(methylamino)-1-phenylpentan-1-one,Schedule II,1971,,,,Annex IIb,517000,
,PENTOBARBITAL,76-74-4,CCCC(C)C1(C(=O)NC(=O)NC1=O)CC,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,5-ethyl-5-(1-methylbutyl)barbituric acid,Schedule III,1971,,,,Annex III,607000,
26/9/2011,PENTYLONE (bk-MBDP),698963-77-8,CCCC(C(=O)C1=CC2=C(C=C1)OCO2)NC,CCCC(NC)C(=O)c1ccc2c(c1)OCO2,"1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one",/,/,,,,Annex IVa - cathinone,,
21/12/1988,PEPAP,64-52-8,CC(=O)OC1(CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,CC(=O)OC1(c2ccccc2)CCN(CCc2ccccc2)CC1,1-phenethyl-4-phenyl-4-piperidinol acetate,Schedule I + IV,1961,,,,Annex Ia,,
,PETHIDINE,57-42-1,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,CCOC(=O)C1(c2ccccc2)CCN(C)CC1,1-methyl-4-phenylpiperidine-4-carboxylic acid ethyl ester,Schedule I,1961,,,,Annex Ia,074000,
,PETHIDINE INTERMEDIATE A,3627-62-1,CN1CCC(CC1)(C#N)C2=CC=CC=C2,CN1CCC(C#N)(c2ccccc2)CC1,4-cyano-1-methyl-4-phenylpiperidine,Schedule I,1961,,,,Annex Ia,075000,
,"PETHIDINE INTERMEDIATE B (norpethidine, normeperidine)",77-17-8,CCOC(=O)C1(CCNCC1)C2=CC=CC=C2,CCOC(=O)C1(c2ccccc2)CCNCC1,4-phenylpiperidine-4-carboxylic acid ethyl ester,Schedule I,1961,,,,Annex Ia,076000,
,PETHIDINE INTERMEDIATE C,3627-48-3,CN1CCC(CC1)(C2=CC=CC=C2)C(=O)O,CN1CCC(C(=O)O)(c2ccccc2)CC1,1-methyl-4-phenylpiperidine-4-carboxylic acid,Schedule I,1961,,,,Annex Ia,077000,
,PEYOTE (PEYOTL),51753-57-2,C1C(=O)NC2=C(C=C(C=C2)Br)C(=N1)C3=CC=CC=C3Cl,O=C1CN=C(c2ccccc2Cl)c2cc(Br)ccc2N1,,/,/,,,,Annex IVb,,
20/3/2013,p-FLUORO-PHENYLPIPERAZINE (pFPP),2252-63-3,C1CN(CCN1)C2=CC=C(C=C2)F,Fc1ccc(N2CCNCC2)cc1,1-(4-fluorophenyl)piperazine,/,/,,,,Annex IVa - piperazine 6b,845000,
,PHENADOXONE,467-84-5,CCC(=O)C(CC(C)N1CCOCC1)(C2=CC=CC=C2)C3=CC=CC=C3,CCC(=O)C(CC(C)N1CCOCC1)(c1ccccc1)c1ccccc1,"6-morpholino-4,4-diphenyl-3-heptanone",Schedule I,1961,,,,Annex Ia,078000,
,PHENAMPROMIDE,129-83-9,CCC(=O)N(C1=CC=CC=C1)C(C)CN2CCCCC2,CCC(=O)N(c1ccccc1)C(C)CN1CCCCC1,N-(1-methyl-2-piperidinoethyl)propionanilide,Schedule I,1961,,,,Annex Ia,079000,
6/9/2017,PHENAZEPAM,51753-57-2,C1C(=O)NC2=C(C=C(C=C2)Br)C(=N1)C3=CC=CC=C3Cl,O=C1CN=C(c2ccccc2Cl)c2cc(Br)ccc2N1,"7-bromo-5-(2-chlorophenyl)-1,3-dihydro-1,4-benzodiazepin-2-one",Schedule IV,1971,,,,Annex III,,
,PHENAZOCINE,127-35-5,CC1C2CC3=C(C1(CCN2CCC4=CC=CC=C4)C)C=C(C=C3)O,CC1C2Cc3ccc(O)cc3C1(C)CCN2CCc1ccccc1,"2’-hydroxy-5,9-dimethyl-2-phenethyl-6,7-benzomorphan",Schedule I,1961,,,,Annex Ia,080000,
,PHENCYCLIDINE (PCP),77-10-1,C1CCC(CC1)(C2=CC=CC=C2)N3CCCCC3,c1ccc(C2(N3CCCCC3)CCCCC2)cc1,1-(1-phenylcyclohexyl)piperidine,Schedule II,1971,,,,Annex IIb,507000,
,PHENDIMETRAZINE,634-03-7,C[C@H]1[C@@H](OCCN1C)C2=CC=CC=C2,C[C@H]1[C@H](c2ccccc2)OCCN1C,"(+)-(2S,3S)-3,4-dimethyl-2-phenylmorpholine",Schedule IV,1971,,,,Annex III,746000,
,PHENMETRAZINE,134-49-6,CC1C(OCCN1)C2=CC=CC=C2,CC1NCCOC1c1ccccc1,3-methyl-2-phenylmorpholine,Schedule II,1971,,,,Annex IIb,508000,
,PHENOBARBITAL,50-06-6,CCC1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2,CCC1(c2ccccc2)C(=O)NC(=O)NC1=O,5-ethyl-5-phenylbarbituric acid,Schedule IV,1971,,,,Annex III,747000,
,PHENOMORPHAN,468-07-5,C1CC[C@@]23CCN([C@@H]([C@@H]2C1)CC4=C3C=C(C=C4)O)CCC5=CC=CC=C5,Oc1ccc2c(c1)[C@@]13CCCC[C@H]1[C@@H](C2)N(CCc1ccccc1)CC3,3-hydroxy-N-phenethylmorphinan,Schedule I,1961,,,,Annex Ia,081000,
,PHENOPERIDINE,562-26-5,CCOC(=O)C1(CCN(CC1)CCC(C2=CC=CC=C2)O)C3=CC=CC=C3,CCOC(=O)C1(c2ccccc2)CCN(CCC(O)c2ccccc2)CC1,1-(3-hydroxy-3-phenylpropyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester,Schedule I,1961,,,,Annex Ia,082000,
,PHENTERMINE,122-09-8,CC(C)(CC1=CC=CC=C1)N,CC(C)(N)Cc1ccccc1,"α,α-dimethylphenethylamine",Schedule IV,1971,,,,Annex III,748000,
,PHOLCODINE,509-67-1,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OCCN6CCOCC6)O[C@H]3[C@H](C=C4)O,CN1CC[C@]23c4c5ccc(OCCN6CCOCC6)c4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5,morpholinylethylmorphine,Schedule II,1961,,,,Annex Ib,209000,
,PIMINODINE,13495-09-5,CCOC(=O)C1(CCN(CC1)CCCNC2=CC=CC=C2)C3=CC=CC=C3,CCOC(=O)C1(c2ccccc2)CCN(CCCNc2ccccc2)CC1,4-phenyl-1-(3-phenylaminopropyl)piperidine-4-carboxylic acid ethyl ester,Schedule I,1961,,,,Annex Ia,083000,
,PINAZEPAM,52463-83-9,C#CCN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,C#CCN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21,"7-chloro-1,3-dihydro-5-phenyl-1-(2-propynyl)-2H-1,4-benzodiazepin-2-one",Schedule IV,1971,,,,Annex III,749000,
25/11/2015,PIPRADROL,467-60-7,C1CCNC(C1)C(C2=CC=CC=C2)(C3=CC=CC=C3)O,OC(c1ccccc1)(c1ccccc1)C1CCCCN1,"1,1-diphenyl-1-(2-piperidyl)methanol",Schedule IV,1971,,,,Annex IIb,750000,
5/7/1971,PIRITRAMIDE,302-41-0,C1CCN(CC1)C2(CCN(CC2)CCC(C#N)(C3=CC=CC=C3)C4=CC=CC=C4)C(=O)N,N#CC(CCN1CCC(C(N)=O)(N2CCCCC2)CC1)(c1ccccc1)c1ccccc1,"1-(3-cyano-3,3-diphenylpropyl)-4-(1-piperidino)piperidine-4-carboxylic acid amide",Schedule I,1961,,,,Annex Ia,084000,
,PMA (Para-MethoxyAmphetamine),64-13-1,CC(CC1=CC=C(C=C1)OC)N,COc1ccc(CC(C)N)cc1,p-methoxy-α-methylphenethylamine,Schedule I,1971,,,,Annex IIa,416000,
30/4/2002,"PMMA (4-MMA, para-Methoxy-N-MethylAmphetamine)",3398-68-3,CC(CC1=CC=C(C=C1)OC)NC.Cl,CNC(C)Cc1ccc(OC)cc1.Cl,1-(4-methoxyphenyl)-N-methylpropan-2-amine,Schedule I,1971,,,,Annex IIa,,
,POPPY STRAW,,CC(=O)N[C@@H]1[C@H](C[C@](O[C@H]1[C@@H]([C@@H](CO)O)O)(C(=O)O)O)O,CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)O[C@](O)(C(=O)O)C[C@@H]1O,,/,/,,,,Annex IVb,,
,PRAZEPAM,2955-38-6,C1CC1CN2C(=O)CN=C(C3=C2C=CC(=C3)Cl)C4=CC=CC=C4,O=C1CN=C(c2ccccc2)c2cc(Cl)ccc2N1CC1CC1,"7-chloro-1-(cyclopropylmethyl)-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one",Schedule IV,1971,,,,Annex III,751000,
,PROHEPTAZINE,77-14-5,CCC(=O)OC1(CCCN(CC1C)C)C2=CC=CC=C2,CCC(=O)OC1(c2ccccc2)CCCN(C)CC1C,"1,3-dimethyl-4-phenyl-4-propionoxyazacycloheptane",Schedule I,1961,,,,Annex Ia,,
,PROPERIDINE,561-76-2,CC(C)OC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,CC(C)OC(=O)C1(c2ccccc2)CCN(C)CC1,1-methyl-4-phenylpiperidine-4-carboxylic acid isopropyl ester,Schedule I,1961,,,,Annex Ia,086000,
26/9/2011,PROPIRAM,15686-91-6,CCC(=O)N(C1=CC=CC=N1)C(C)CN2CCCCC2,CCC(=O)N(c1ccccn1)C(C)CN1CCCCC1,N-(1-methyl-2-piperidinoethyl)-N-2-pyridylpropionamide,Schedule II,1961,,,,Annex Ib,210000,
27/12/2021,PROPYLPHENIDATE (PPH),99088-50-3,CCCOC(=O)[C@@H]([C@H]1CCCCN1)C2=CC=CC=C2,CCCOC(=O)[C@H](c1ccccc1)[C@H]1CCCCN1,Propyl phenyl(2-piperidinyl)acetate,/,/,,,,Annex IVb,,
08/02/2023 + 24/04/2024,PROTONITAZENE,95958-84-2,CCCOC1=CC=C(C=C1)CC2=NC3=C(N2CCN(CC)CC)C=CC(=C3)[N+](=O)[O-],CCCOc1ccc(Cc2nc3cc([N+](=O)[O-])ccc3n2CCN(CC)CC)cc1,"N,N-Diethyl-2-[(4-propoxyphenyl)methyl]-5-nitro-1Hbenzimidazole-
1-ethanamine",Schedule I,1961,,,,Annex Ia,,
,PSILOCINE (PSILOTSIN),520-53-6,CN(C)CCC1=CNC2=C1C(=CC=C2)O,CN(C)CCc1c[nH]c2cccc(O)c12,3-[2-(dimethylamino)ethyl]indol-4-ol,Schedule I,1971,,,,Annex IIa,417000,
,PSILOCYBINE,520-52-5,CN(C)CCC1=CNC2=C1C(=CC=C2)OP(=O)(O)O,CN(C)CCc1c[nH]c2cccc(OP(=O)(O)O)c12,3-[2-(dimethylamino)ethyl]indol-4-yl dihydrogen phosphate,Schedule I,1971,,,,Annex IIa,418000,
25/11/2015,PV-8 (alpha-PHPP),1801552-04-4,CCCCCC(C(=O)C1=CC=C(C=C1)OC)N2CCCC2,CCCCCC(C(=O)c1ccc(OC)cc1)N1CCCC1,1-phenyl-2-(pyrrolidin-1-yl)heptan-1-one,/,/,,,,Annex IVa - cathinone,,
23/3/2022,PYRAZOLAM,39243-02-2,CC1=NN=C2N1C3=C(C=C(C=C3)Br)C(=NC2)C4=CC=CC=N4,Cc1nnc2n1-c1ccc(Br)cc1C(c1ccccn1)=NC2,"8-bromo-1-methyl-6-(pyridin-2-yl)-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine",/,/,,,,Annex IVb,,
,PYROVALERONE,3563-49-3,CCCC(C(=O)C1=CC=C(C=C1)C)N2CCCC2,CCCC(C(=O)c1ccc(C)cc1)N1CCCC1,4’-methyl-2-(1-pyrrolidinyl)valerophenone,Schedule IV,1971,,,,Annex III,752000,
,RACEMETHORPHAN,510-53-2,CN1CCC23CCCCC2C1CC4=C3C=C(C=C4)OC,COc1ccc2c(c1)C13CCCCC1C(C2)N(C)CC3,(±)-3-methoxy-N-methylmorphinan,Schedule I,1961,,,,Annex Ia,087000,
,RACEMORAMIDE,545-59-5,CC(CN1CCOCC1)C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N4CCCC4,CC(CN1CCOCC1)C(C(=O)N1CCCC1)(c1ccccc1)c1ccccc1,"(±)-4-[2-methyl-4-oxo-3,3-diphenyl-4-(1-pyrrolidinyl)butyl]morpholine",Schedule I,1961,,,,Annex Ia,088000,
,RACEMORPHAN,297-90-5,CN1CC[C@]23CCCC[C@H]2[C@H]1CC4=C3C=C(C=C4)O,CN1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(O)cc13,(±)-3-hydroxy-N-methylmorphinan,Schedule I,1961,,,,Annex Ia,089000,
6/9/2017,"RCS-4 (SR-19, OBT-199, BTM-4, E-4)",1345966-78-0,CCCCCN1C=C(C2=CC=CC=C21)C(=O)C3=CC=C(C=C3)OC,CCCCCn1cc(C(=O)c2ccc(OC)cc2)c2ccccc21,(4-methoxyphenyl)(1-pentyl-1H-indol-3-yl)methanone,/,/,,,,Annex IVa - synth. cann. 4a,,
16/11/1999,REMIFENTANIL,132875-61-7,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC,CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCC(=O)OC)CC1,1-(2-methoxycarbonylethyl)-4-(phenylpropionylamino)-piperidine-4-carboxylic acid methyl ester,Schedule I,1961,,,,Annex Ia,099000,
25/11/2015,RH-34,1028307-48-3,COC1=CC=CC=C1CNCCN2C(=O)C3=CC=CC=C3NC2=O,COc1ccccc1CNCCn1c(=O)[nH]c2ccccc2c1=O,"3-(2-{[(2-methoxyphenyl)methyl]amino}ethyl)-1,2,3,4-tetrahydroquinazoline-2,4-dione",/,/,,,,Annex IVb,,
,"ROLICYCLIDINE (PHP, PCPY)",2201-39-0,C1CCC(CC1)(C2=CC=CC=C2)N3CCCC3,c1ccc(C2(N3CCCC3)CCCCC2)cc1,1-(1-phenylcyclohexyl)pyrrolidine,Schedule I,1971,,,,Annex IIa,419000,
22/10/2006,SALVIA DIVINORUM,,CC(=O)N[C@@H]1[C@H](C[C@](O[C@H]1[C@@H]([C@@H](CO)O)O)(C(=O)O)O)O,CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)O[C@](O)(C(=O)O)C[C@@H]1O,,/,/,,,,Annex IVb,,
22/10/2006 + 18/10/2004,SALVINORINE A (DIVINORINE A),83729-01-5,CC(=O)O[C@H]1C[C@H]([C@@]2(CC[C@H]3C(=O)O[C@@H](C[C@@]3([C@H]2C1=O)C)C4=COC=C4)C)C(=O)OC,COC(=O)[C@@H]1C[C@H](OC(C)=O)C(=O)[C@H]2[C@@]1(C)CC[C@H]1C(=O)O[C@H](c3ccoc3)C[C@]21C,"methyl-9-acetyloxy-2-(furan-3-yl)-6a,10b-dimethyl-4,10-dioxo-2,4a,5,6,7,8,9,10a-octahydro-1H-benzo[f]isochromene-7-carboxylate",/,/,,,,Annex IVb,852000,
,SECBUTABARBITAL,125-40-6,CCC(C)C1(C(=O)NC(=O)NC1=O)CC,CCC(C)C1(CC)C(=O)NC(=O)NC1=O,5-sec-butyl-5-ethylbarbituric acid,Schedule IV,1971,,,,Annex III,753000,
,SECOBARBITAL,76-73-3,CCCC(C)C1(C(=O)NC(=O)NC1=O)CC=C,C=CCC1(C(C)CCC)C(=O)NC(=O)NC1=O,5-allyl-5-(1-methylbutyl)barbituric acid,Schedule II,1971,,,,Annex IIb,608000,
,STP (DOM),15588-95-1,CC1=CC(=C(C=C1OC)CC(C)N)OC,COc1cc(CC(C)N)c(OC)cc1C,"2,5-dimethoxy-α,4-dimethylphenethylamine",Schedule I,1971,,,,Annex IIa,420000,
5/8/1980,SUFENTANIL,56030-54-7,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC,CCC(=O)N(c1ccccc1)C1(COC)CCN(CCc2cccs2)CC1,N-[4-(methoxymethyl)-1-[2-(2-thienyl)ethyl]-4-piperidyl]propionanilide,Schedule I,1961,,,,Annex Ia,090000,
26/9/2011,TAPENTADOL,175591-23-8,CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C,CC[C@@H](c1cccc(O)c1)[C@@H](C)CN(C)C,3-[-1-(dimethylamino)-2-methylpentan-3-yl]phenol,/,/,,,,Annex IVb,814000,
,TEMAZEPAM,846-50-4,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,CN1C(=O)C(O)N=C(c2ccccc2)c2cc(Cl)ccc21,"7-chloro-1,3-dihydro-3-hydroxy-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one",Schedule IV,1971,,,,Annex III,754000,
,TENAMFETAMINE (MDA),4764-17-4,CC(CC1=CC2=C(C=C1)OCO2)N,CC(N)Cc1ccc2c(c1)OCO2,"α-methyl-3,4-(methylenedioxy)phenethylamine",Schedule I,1971,,,,Annex IIa,421000,
,TENOCYCLIDINE (TCP),21500-98-1,C1CCC(CC1)(C2=CC=CS2)N3CCCCC3,c1csc(C2(N3CCCCC3)CCCCC2)c1,1-[1-(2-thienyl)cyclohexyl]piperidine,Schedule I,1971,,,,Annex IIa,422000,
,TETRAHYDROCANNABINOL (+6 isomeres),"THC, delta-6a(10a)-THC, delta-6a(7)-THC, delta-7-THC, delta-8-THC, delta-10-THC, delta-9(11)-THC",,,"7,8,9,10-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol , (9R,10aR)-8,9,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6Hdibenzo[b,d]pyran-1-ol , (6aR,9R,10aR)-6a,9,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6Hdibenzo[b,d]pyran-1-ol, (6aR,10aR)-6a,7,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6Hdibenzo[b,d]pyran-1-ol , 6a,7,8,9-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol , (6aR,10aR)-6a,7,8,9,10,10a-hexahydro-6,6-dimethyl-9-methylene3-pentyl-6H-dibenzo[b,d]pyran-1-ol",Schedule I,1971,,,,Annex IIa,423000,
06/09/2017 + 09/12/2019,TETRAHYDROFURANYLFENTANYL (THF-F),2142571-01-3,C1CC(OC1)C(=O)N(C2CCN(CC2)CCC3=CC=CC=C3)C4=CC=CC=C4,O=C(C1CCCO1)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]tetrahydrofuran-2-carboxamide,Schedule I,1961,,,,Annex Ia,,
6/9/2017,TETRAMETHYLCYLCOPROPYLFENTANYL,,CC(=O)N[C@@H]1[C@H](C[C@](O[C@H]1[C@@H]([C@@H](CO)O)O)(C(=O)O)O)O,CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)O[C@](O)(C(=O)O)C[C@@H]1O,,/,/,,,,Annex IVa - fentanyl 3a,,
,TETRAZEPAM,10379-14-3,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CCCCC3,CN1C(=O)CN=C(C2=CCCCC2)c2cc(Cl)ccc21,"7-chloro-5-(1-cyclohexen-1-yl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one",Schedule IV,1971,,,,Annex III,755000,
18/10/2004,TFMPP,15532-75-9 ,C1CN(CCN1)C2=CC=CC(=C2)C(F)(F)F,FC(F)(F)c1cccc(N2CCNCC2)c1,"(6aR,9R,10aR)-6a,9,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6Hdibenzo[b,d]pyran-1-ol ,",/,/,,,,Annex IVa - piperazine 6b,846000,
,THEBACON,466-90-0,CC(=O)OC1=CC[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC)CCN3C,COc1ccc2c3c1O[C@H]1C(OC(C)=O)=CC[C@H]4[C@@H](C2)N(C)CC[C@]314,"(6aR,10aR)-6a,7,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6Hdibenzo[b,d]pyran-1-ol ,",Schedule I,1961,,,,Annex Ia,091000,
,THEBAINE,115-37-7,CN1CC[C@]23[C@@H]4C(=CC=C2[C@H]1CC5=C3C(=C(C=C5)OC)O4)OC,COC1=CC=C2[C@H]3Cc4ccc(OC)c5c4[C@@]2(CCN3C)[C@H]1O5,"6a,7,8,9-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol ,",Schedule I,1961,,,,Annex Ia,092000,
6/9/2017,THIAFENTANIL,"	
101345-60-2",,,methyl 4-(N-(2-methoxyacetyl)anilino)-1-(2-thiophen-2-ylethyl)piperidine-4-carboxylate,/,/,,,,Annex IVa - fentanyl 3d,,
26/9/2011,THIOFENTANYL ,1165-22-6,CCC(=O)N(C1CCN(CC1)CCC2=CC=CS2)C3=CC=CC=C3,CCC(=O)N(c1ccccc1)C1CCN(CCc2cccs2)CC1,"(6aR,10aR)-6a,7,8,9,10,10a-hexahydro-6,6-dimethyl-9-methylene3-pentyl-6H-dibenzo[b,d]pyran-1-ol",Schedule I + IV,1961,,,,Annex Ia,,
8/2/2023,THIOTHINONE (bk-MPA),24065-17-6,CC(C(=O)C1=CC=CS1)NC,CNC(C)C(=O)c1cccs1,2-(methylamino)-1-thiophen-2-ylpropan-1-one,/,/,,,,Annex IVb,,
25/11/2015,THJ-018,1364933-55-0,CCCCCN1C2=CC=CC=C2C(=N1)C(=O)C3=CC=CC4=CC=CC=C43,CCCCCn1nc(C(=O)c2cccc3ccccc23)c2ccccc21,3-(naphthalene-1-carbonyl)-1-pentyl-1H-indazole,/,/,,,,Annex IVa - synth. cann. 4b,,
25/11/2015,THJ-2201,1801552-01-1,C1=CC=C2C(=C1)C=CC=C2C(=O)C3=NN(C4=CC=CC=C43)CCCCCF,O=C(c1cccc2ccccc12)c1nn(CCCCCF)c2ccccc12,1-(5-fluoropentyl)-3-(naphthalene-1-carbonyl)-1H-indazole,/,/,,,,Annex IVa - synth. cann. 4b,,
8/2/2023,"TH-PVP (3',4'-TETRAMETHYLENE-alpha-PYRROLIDINOVALEROPHENONE)",2304915-07-7,CCCC(C(=O)C1=CC2=C(CCCC2)C=C1)N3CCCC3,CCCC(C(=O)c1ccc2c(c1)CCCC2)N1CCCC1,"2-(pyrrolidin-1-yl)-1-(5,6,7,8-tetrahydronaphthalen-2-yl)pentan-1-one",/,/,,,,Annex IVb,,
5/8/1980,TILIDINE,20380-58-9,CCOC(=O)[C@@]1(CCC=C[C@H]1N(C)C)C2=CC=CC=C2,CCOC(=O)[C@]1(c2ccccc2)CCC=C[C@H]1N(C)C,(±)-ethyl-trans-2-(dimethylamino)-1-phenyl-3-cyclohexene-1-carboxylate,Schedule I,1961,,,,Annex Ia,093000,
,TMA,1082-88-8,CC(CC1=CC(=C(C(=C1)OC)OC)OC)N,COc1cc(CC(C)N)cc(OC)c1OC,"(±)-3,4,5-trimethoxy-α-methylphenethylamine",Schedule I,1971,,,,Annex IIa,424000,
18/10/2004,TMA-2,1083-09-6,CC(CC1=CC(=C(C=C1OC)OC)OC)N,COc1cc(OC)c(OC)cc1CC(C)N,"1-(2,4,5-trimethoxyphenyl)propan-2-amine",/,/,,,,Annex IVa - amfetamine,,
27/12/2021,TRAMADOL,27203-92-5,CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O,COc1cccc([C@@]2(O)CCCC[C@@H]2CN(C)C)c1,2-[(Dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol,/,/,,,,Annex IVb,857000,
,TRIAZOLAM,28911-01-5,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl,Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1Cl)=NC2,"8-chloro-6-(o-chlorophenyl)-1-methyl-4H-s-triazolo[4,3-a][1,4] benzodiazepine",Schedule IV,1971,,,,Annex III,756000,
,TRIMEPERIDINE,64-39-1,CCC(=O)OC1(CC(N(CC1C)C)C)C2=CC=CC=C2,CCC(=O)OC1(c2ccccc2)CC(C)N(C)CC1C,"1,2,5-trimethyl-4-phenyl-4-propionoxypiperidine",Schedule I,1961,,,,Annex Ia,094000,
06/09/2017 + 09/12/2019,U-47700,121348-98-9,CN(C)C1CCCCC1N(C)C(=O)C2=CC(=C(C=C2)Cl)Cl,CN(C)C1CCCCC1N(C)C(=O)c1ccc(Cl)c(Cl)c1,"3,4-dichloro-N-(2-dimethylamino-cyclohexyl)-N-methyl-benzamide",Schedule I,1961,,,,Annex Ia,103000,
25/11/2015 + 09/12/2019,UR-144,1199943-44-6,CCCCCN1C=C(C2=CC=CC=C21)C(=O)C3C(C3(C)C)(C)C,CCCCCn1cc(C(=O)C2C(C)(C)C2(C)C)c2ccccc21,"(1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropoyl)methanone",Schedule II,1971,,,,Annex IIb,,
06/09/2017 + 27/12/2021,VALERYLFENTANYL,122882-90-0,CCCCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,CCCCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide,Schedule I,1961,,,,Annex Ia,,
,VINYLBITAL,2430-49-1,CCCC(C)C1(C(=O)NC(=O)NC1=O)C=C,C=CC1(C(C)CCC)C(=O)NC(=O)NC1=O,5-(1-methylbutyl)-5-vinylbarbituric acid,Schedule IV,1971,,,,Annex III,757000,
6/9/2017,W-15,,CC(=O)N[C@@H]1[C@H](C[C@](O[C@H]1[C@@H]([C@@H](CO)O)O)(C(=O)O)O)O,CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)O[C@](O)(C(=O)O)C[C@@H]1O,4-chloro-N-[1-(2-phenylethyl)piperidin-2-ylidene]benzene-1-sulfonamide,/,/,,,,Annex IVb,,
20/3/2013,"WIN 48,098 (PRAVADOLINE)",92623-83-1,CC1=C(C2=CC=CC=C2N1CCN3CCOCC3)C(=O)C4=CC=C(C=C4)OC,COc1ccc(C(=O)c2c(C)n(CCN3CCOCC3)c3ccccc23)cc1,(4-methoxyphenyl)-[2-methyl-1-(2-morpholin-4-ylethyl)indol-3-yl]methanone,/,/,,,,Annex IVa - synth. cann. 4a,,
6/9/2017,"WIN55,212-2",131543-22-1,CC1=C(C2=C3N1[C@@H](COC3=CC=C2)CN4CCOCC4)C(=O)C5=CC=CC6=CC=CC=C65,Cc1c(C(=O)c2cccc3ccccc23)c2cccc3c2n1[C@H](CN1CCOCC1)CO3,"2-methyl-11-[(morpholin-4-yl)methyl]-3-(naphthalene-1-carbonyl)-9-oxa-1-azatricyclo[6.3.1.0⁴,¹²]dodeca-2,4(12),5,7-tetraene",/,/,,,,Annex IVb,,
20/03/2013 + 09/12/2019,"XLR-11 (5FUR-144, 5-FLUORO UR-144)",1364933-54-9,CC1(C(C1(C)C)C(=O)C2=CN(C3=CC=CC=C32)CCCCCF)C,CC1(C)C(C(=O)c2cn(CCCCCF)c3ccccc23)C1(C)C,"[1-(5-Fluoropentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone",Schedule II,1971,,,,Annex IIb,,
,ZIPEPROL,34758-83-3,COC(CN1CCN(CC1)CC(C(C2=CC=CC=C2)OC)O)C3=CC=CC=C3,COC(CN1CCN(CC(O)C(OC)c2ccccc2)CC1)c1ccccc1,α-(α-methoxybenzyl)-4-(β-methoxyphenethyl)-1-piperazineethanol,Schedule II,1971,,,,Annex IIb,511000,
30/4/2002,ZOLPIDEM,82626-48-0,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,Cc1ccc(-c2nc3ccc(C)cn3c2CC(=O)N(C)C)cc1,"N,N,6-trimethyl-2-p-tolylimidazo[1,2-a]pyridine-3-acetamide",Schedule IV,1971,,,,Annex III,761000,
,,,,,,,,,,,,,
,1-phenyl-2-propanone,103-79-7,CC(=O)CC1=CC=CC=C1,CC(=O)Cc1ccccc1,(1-phenyl-2-propanone),Table I,1988,273/2004 + 111/2005,"Annex I, Category 1","Annex, Category 1",,,
,Diethyl (phenylacetyl) propanedioate (DEPAPD),20320-59-6,CCOC(=O)C(C(=O)CC1=CC=CC=C1)C(=O)OCC,CCOC(=O)C(C(=O)Cc1ccccc1)C(=O)OCC,,Table I,1988,273/2004 + 111/2005,"Annex I, Category 1","Annex, Category 1",,,
,Methyl alpha-phenylacetoacetate (MAPA),16648-44-5,CC(=O)C(C1=CC=CC=C1)C(=O)OC,COC(=O)C(C(C)=O)c1ccccc1,(methyl 3-oxo-2-phenylbutanoate),Table I,1988,273/2004 + 111/2005,"Annex I, Category 1","Annex, Category 1",,,
,Ethyl alpha-phenylacetoacetate (EAPA),5413-05-8,CCOC(=O)C(C1=CC=CC=C1)C(=O)C,CCOC(=O)C(C(C)=O)c1ccccc1,ethyl 3-oxo-2-phenylbutanoate,,1988,273/2004 + 111/2005,"Annex I, Category 1","Annex, Category 1",,,
,2-methyl-3-phenyloxirane-2-carboxylic acid,25547-51-7,CC1(C(O1)C2=CC=CC=C2)C(=O)O,CC1(C(=O)O)OC1c1ccccc1,,Table I,1988,273/2004 + 111/2005,"Annex I, Category 1","Annex, Category 1",,,
,N-acetylanthranilic acid,89-52-1,CC(=O)NC1=CC=CC=C1C(=O)O,CC(=O)Nc1ccccc1C(=O)O,"(benzoic acid, 2-(acetylamino)-)",Table I,1988,273/2004 + 111/2005,"Annex I, Category 1","Annex, Category 1",,,
,Alpha-phenylacetoacetamide (APAA),4433-77-6,CC(=O)C(C1=CC=CC=C1)C(=O)N,CC(=O)C(C(N)=O)c1ccccc1,"(benzeneacetamide, α-acetyl-)",Table I,1988,273/2004 + 111/2005,"Annex I, Category 1","Annex, Category 1",,,
,Alpha-phenylacetoacetonitrile (APAAN),4468-48-8,CC(=O)C(C#N)C1=CC=CC=C1,CC(=O)C(C#N)c1ccccc1,(3-oxo-2-phenylbutanenitrile),Table I,1988,273/2004 + 111/2005,"Annex I, Category 1","Annex, Category 1",,,
,Isosafrol (cis + trans),120-58-1,C/C=C/C1=CC2=C(C=C1)OCO2,C/C=C/c1ccc2c(c1)OCO2,"(1,3-benzodioxole,5-(1-propenyl)-)",Table I,1988,273/2004 + 111/2005,"Annex I, Category 1","Annex, Category 1",,,
,"3,4-methylenedioxyphenylpropan-2-one",4676-39-5,CC(=O)CC1=CC2=C(C=C1)OCO2,CC(=O)Cc1ccc2c(c1)OCO2,"(2-propanone,1-[3,4(methylenedioxy)phenyl]-)",Table I,1988,273/2004 + 111/2005,"Annex I, Category 1","Annex, Category 1",,,
,Piperonal,120-57-0,C1OC2=C(O1)C=C(C=C2)C=O,O=Cc1ccc2c(c1)OCO2,,,1988,273/2004 + 111/2005,"Annex I, Category 1","Annex, Category 1",,,
,Safrole,94-59-7,C=CCC1=CC2=C(C=C1)OCO2,C=CCc1ccc2c(c1)OCO2,,,1988,273/2004 + 111/2005,"Annex I, Category 1","Annex, Category 1",,,
,"Methyl 3-oxo-2-(3,4-methylenedioxyphenyl)butanoate (MAMDPA)",1369021-80-6,,,,,1988,273/2004 + 111/2005,"Annex I, Category 1","Annex, Category 1",,,
,"3-(1,3-benzodioxol-5-yl)-2-methyl-oxirane-2-carboxylic acid (PMK glycidic acid)",2167189-50-4,,,,Table I,1988,273/2004 + 111/2005,"Annex I, Category 1","Annex, Category 1",,,
,"Isopropylidene (2-(3,4-methylenedioxyphenyl)acetyl)malonate

(IMDPAM)",,,,,,1988,273/2004 + 111/2005,"Annex I, Category 1","Annex, Category 1",,,
,N-phenyl-1-(2-phenylethyl)piperidin-4-amine,21409-26-7,C1CN(CCC1NC2=CC=CC=C2)CCC3=CC=CC=C3,c1ccc(CCN2CCC(Nc3ccccc3)CC2)cc1,4-Anilino-N-phenethylpiperidine (ANPP),Table I,1988,273/2004 + 111/2005,"Annex I, Category 1","Annex, Category 1",,,
,1-(2-phenylethyl)piperidin-4-one,39742-60-4,C1CN(CCC1=O)CCC2=CC=CC=C2,O=C1CCN(CCc2ccccc2)CC1,N-Phenethyl-4-piperidone (NPP),Table I,1988,273/2004 + 111/2005,"Annex I, Category 1","Annex, Category 1",,,
,N-phenylpiperidin-4-amine (4-AP),23056-29-3,C1CNCCC1NC2=CC=CC=C2,c1ccc(NC2CCNCC2)cc1,"(4-Piperidinamine, N-phenyl-)",Table I,1988,273/2004 + 111/2005,"Annex I, Category 1","Annex, Category 1",,,
,Tert-butyl 4-anilinopiperidine-1-carboxylate (1-boc-4-AP),125541-22-2,CC(C)(C)OC(=O)N1CCC(CC1)NC2=CC=CC=C2,CC(C)(C)OC(=O)N1CCC(Nc2ccccc2)CC1,"(4-(phenylamino)-1-piperidinecarboxylic acid, 1,1dimethylethyl ester)",Table I,1988,273/2004 + 111/2005,"Annex I, Category 1","Annex, Category 1",,,
,N-phenyl-N-(piperidin-4-yl)propanamide (norfentanyl),1609-66-1,CCC(=O)N(C1CCNCC1)C2=CC=CC=C2,CCC(=O)N(c1ccccc1)C1CCNCC1,"(Propanamide, N-phenyl-N-4-piperidinyl-)",Table I,1988,273/2004 + 111/2005,"Annex I, Category 1","Annex, Category 1",,,
,Ephedrine,299-42-3,C[C@@H]([C@@H](C1=CC=CC=C1)O)NC,CN[C@@H](C)[C@H](O)c1ccccc1,"([R-(R*,S*)]-α-[1-(methylamino)ethyl]-benzenemethanol)",Table I,1988,273/2004 + 111/2005,"Annex I, Category 1","Annex, Category 1",,,
,Pseudoephedrine,90-82-4,C[C@@H]([C@H](C1=CC=CC=C1)O)NC,CN[C@@H](C)[C@@H](O)c1ccccc1,,,1988,273/2004 + 111/2005,"Annex I, Category 1","Annex, Category 1",,,
,Norephedrine,14838-15-4,C[C@@H]([C@@H](C1=CC=CC=C1)O)N,C[C@H](N)[C@H](O)c1ccccc1,"(R*,S*)-α-(1-aminoethyl)benzenemethanol",Table I,1988,273/2004 + 111/2005,"Annex I, Category 1","Annex, Category 1",,,
,Ergometrine,60-79-7,C[C@@H](CO)NC(=O)[C@H]1CN([C@@H]2CC3=CNC4=CC=CC(=C34)C2=C1)C,C[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1,"(ergoline-8-carboxamide,9,10-didehydro-N-(2-hydroxy1-methylethyl)-6-methyl-,[8ß(S)])",Table I,1988,273/2004 + 111/2005,"Annex I, Category 1","Annex, Category 1",,,
,Ergotamine,113-15-5,C[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)CC4=CC=CC=C4)NC(=O)[C@H]5CN([C@@H]6CC7=CNC8=CC=CC(=C78)C6=C5)C,CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)C[C@H]21,"(ergotaman-3',6',18'-trione, 12'-hydroxy-2'-methyl-5'-(phenylmethyl)-,(5α))",Table I,1988,273/2004 + 111/2005,"Annex I, Category 1","Annex, Category 1",,,
,Lysergic acid,82-58-6,CN1C[C@@H](C=C2[C@H]1CC3=CNC4=CC=CC2=C34)C(=O)O,CN1C[C@H](C(=O)O)C=C2c3cccc4[nH]cc(c34)C[C@H]21,"((8ß)-9,10-didehydro-6-methylergoline-8-carboxylic acid)",Table I,1988,273/2004 + 111/2005,"Annex I, Category 1","Annex, Category 1",,,
,"(1R,2S)-(-)-chloroephedrine",110925-64-9,CCOCCOCCOCCO,CCOCCOCCOCCO,,,1988,273/2004 + 111/2005,"Annex I, Category 1","Annex, Category 1",,,
,"(1S,2R)-(+)-chloroephedrine",1384199-95-4,,,,,1988,273/2004 + 111/2005,"Annex I, Category 1","Annex, Category 1",,,
,"(1S,2S)-(+)-chloropseudoephedrine",73393-61-0,C[C@@H]([C@H](C1=CC=CC=C1)Cl)NC,CN[C@@H](C)[C@@H](Cl)c1ccccc1,,,1988,273/2004 + 111/2005,"Annex I, Category 1","Annex, Category 1",,,
,"(1R,2R)-(-)-chloropseudoephedrine",771434-80-1,,,,,1988,273/2004 + 111/2005,"Annex I, Category 1","Annex, Category 1",,,
,,,,,,,1988,,,,,,
,,,,,,,1988,,,,,,
,Red phosphorus,7723-14-0,[P],[P],,,1988,273/2004 + 111/2005,"Annex I,II; Subcategory 2A","Annex, Category 2",,,
,Acetic anhydride,108-24-7,CC(=O)OC(=O)C,CC(=O)OC(C)=O,acetic oxide,Table I,1988,273/2004 + 111/2005,"Annex I,II;Subcategory 2A","Annex, Category 2",,,
,,,,,,,1988,,,,,,
,,,,,,,1988,,,,,,
,Phenylacetic acid and its salts,103-82-2,C1=CC=C(C=C1)CC(=O)O,O=C(O)Cc1ccccc1,benzeneacetic acid,Table I,1988,273/2004 + 111/2005,"Annex I,II; Subcategory 2B","Annex, Category 2",,,
,Anthranilic acid and its salts,118-92-3,C1=CC=C(C(=C1)C(=O)O)N,Nc1ccccc1C(=O)O,,,1988,273/2004 + 111/2005,"Annex I,II; Subcategory 2B","Annex, Category 2",,,
,Piperidine and its salts,110-89-4,C1CCNCC1,C1CCNCC1,,,1988,273/2004 + 111/2005,"Annex I,II; Subcategory 2B","Annex, Category 2",,,
,Potassium permanganate,7722-64-7,[O-][Mn](=O)(=O)=O.[K+],[K+].[O]=[Mn](=[O])(=[O])[O-],,,1988,273/2004 + 111/2005,"Annex I ,II; Subcategory 2B","Annex, Category 2",,,
,,,,,,,1988,,,,,,
,,,,,,,1988,,,,,,
,Hydrochloric acid,7647-01-0,Cl,Cl,,,1988,273/2004 + 111/2005,"Annex I, Category 3","Annex, Category 3",,,
,Sulphuric acid,7664-93-9,OS(=O)(=O)O,O=S(=O)(O)O,,,1988,273/2004 + 111/2005,"Annex I, Category 3","Annex, Category 3",,,
,Toluene,108-88-3,CC1=CC=CC=C1,Cc1ccccc1,,,1988,273/2004 + 111/2005,"Annex I, Category 3","Annex, Category 3",,,
,Ethyl ether,60-29-7,CCOCC,CCOCC,,,1988,273/2004 + 111/2005,"Annex I, Category 3","Annex, Category 3",,,
,Acetone,67-64-1,CC(=O)C,CC(C)=O,,,1988,273/2004 + 111/2005,"Annex I, Category 3","Annex, Category 3",,,
,Methylethylketone,78-93-3,CCC(=O)C,CCC(C)=O,,,1988,273/2004 + 111/2005,"Annex I, Category 3","Annex, Category 3",,,
,Medicinal products and veterinary medicinal products containing ephedrine or its salts,,,,,,1988,111/2005,,"Annex, Category 4",,,
,Medicinal products and veterinary medicinal products containing pseudo-ephedrine or its salts,,,,,,1988,111/2005,,"Annex, Category 4",,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,"tert-Butyl 4-oxopiperidine-1-carboxylate (1-piperidinecarboxylic acid, 4-oxo, 1,1-dimethylethyl
(1-boc-4-piperidone)",79099-07-3,,,"(1-piperidinecarboxylic acid, 4-oxo, 1,1-dimethylethyl ester)",Table I,1988,,,,,,
,"3,4-MDP-2-P methyl glycidate",13605-48-6,,,"(2-oxiranecarboxylic acid, 3-(1,3-benzodioxol-5-yl)-2-methyl-,methyl ester)",Table I,1988,,,,,,
,,,,,,,,,,,,,
,"3,4-MDP-2-P methyl glycidic acid, ethyl ester",28578-16-7,,,"(2-oxiranecarboxylic acid, 3-(1,3-benzodioxol-5-yl)-2-methyl-,ethyl ester)",Table I,1988,,,,,,
,"3,4-MDP-2-P methyl glycidic acid, propyl ester",,,,"(2-oxiranecarboxylic acid, 3-(1,3-benzodioxol-5-yl)-2-methyl-,ethyl ester)",Table I,1988,,,,,,
,"3,4-MDP-2-P methyl glycidic acid, isopropyl ester",,,,"(2-oxiranecarboxylic acid, 3-(1,3-benzodioxol-5-yl)-2-methyl-,isopropyl ester)",Table I,1988,,,,,,
,"3,4-MDP-2-P methyl glycidic acid, butyl ester",,,,"(2-oxiranecarboxylic acid, 3-(1,3-benzodioxol-5-yl)-2-methyl-,butyl ester)",Table I,1988,,,,,,
,"3,4-MDP-2-P methyl glycidic acid, isobutyl ester",,,,"(2-oxiranecarboxylic acid, 3-(1,3-benzodioxol-5-yl)-2-methyl-,",Table I,1988,,,,,,
,"3,4-MDP-2-P methyl glycidic acid, sec-butyl ester",,,,"(2-oxiranecarboxylic acid, 3-(1,3-benzodioxol-5-yl)-2-methyl-,sec-butyl ester)",Table I,1988,,,,,,
,"3,4-MDP-2-P methyl glycidic acid, tert-butyl ester",,,,"(2-oxiranecarboxylic acid, 3-(1,3-benzodioxol-5-yl)-2-methyl-,tert-butyl ester)",,,,,,,,
,,80532-66-7,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,update 1/06/2024,,,,,,,,,,,,